parsed_lemmas	candidate_id	curated_ctd	split
rna|DISEASE_ENTITY|virus|,|coronavirus|,|isolate|virus|release|early|infection|analyze|COMPOUND_ENTITY|gradient|sedimentation|electrophoresis|.	65876	0.0	11
COMPOUND_ENTITY|,|DISEASE_ENTITY|rheumatoid|arthritis|rheumatoid|factor|.	65897	0.0	10
brief|report|develop|idea|previous|work|underlie|possible|functional|disequilibrium|COMPOUND_ENTITY|metabolism|patient|affect|DISEASE_ENTITY|multiple|sclerosis|-lrb-|m.s.|-rrb-|animal|experimental|allergic|encephalomyelitis|.	65932	0.0	10
compare|normal|,|essential|DISEASE_ENTITY|demonstrate|significantly|lower|pge2|level|,|excrete|100|ng/24|hr|,|value|usually|subject|receive|prostaglandin|synthetase|inhibitor|,|COMPOUND_ENTITY|.	66091	0.0	10
patient|DISEASE_ENTITY|colitis|remission|randomly|allocate|treatment|COMPOUND_ENTITY|-lrb-|2|g/day|-rrb-|oral|sodium|cromoglycate|-lrb-|160|mg/day|2|g/day|-rrb-|,|relapse|rate|treatment|group|compare|continued|treatment|year|.	66144	0.0	10
epigenetic|activation|COMPOUND_ENTITY|hydroxylase|mouse|erythroleukemia|cell|cytoplast|rat|DISEASE_ENTITY|hepatoma|cell|.	66250	0.0	11
absorption|,|metabolism|excretion|COMPOUND_ENTITY|similar|volunteer|patient|DISEASE_ENTITY|ulcerative|colitis|crohn|disease|.	66388	0.0	10
fifty-nine|patient|stage|-lrb-|accord|A.|L.|Myasnikov|classification|-rrb-|coronary|DISEASE_ENTITY|23|healthy|person|age|test|content|rosette-forming|t|-|b-lymphocyte|,|immunoglobulin|class|,|lymphocyte|blast-cell|transformation|reaction|phage|antigen|normal|atherosclerotic|aorta|,|change|index|effect|miscleron|-lrb-|23|-rrb-|COMPOUND_ENTITY|acid|-lrb-|10|person|-rrb-|.	66452	0.0	10
effect|antileukemia|drug|,|4|'|-|-lrb-|9-acridinylamino|-rrb-|methanesulfon-m-anisidine|,|cyclic|adenosine|3|'|:5|'|-|monophosphate|COMPOUND_ENTITY|triphosphate|DISEASE_ENTITY|mastocytoma|cell|report|.	66695	0.0	11
analysis|double|immunodiffusion|COMPOUND_ENTITY|hydroxylase|source|identical|immunologic|determinant|,|immunotitration|reveal|small|significant|difference|enzyme|normal|adult|rat|liver|enzyme|culture|DISEASE_ENTITY|hepatoma|cell|.	66719	0.0	11
cytotoxicity|n6-subsituted|COMPOUND_ENTITY|analog|culture|DISEASE_ENTITY|trophoblastic|tumor|cell|.	66900	0.0	10
efficacy|combination|atenolol|,|COMPOUND_ENTITY|,|hydraliazine|twice|daily|assess|double-blind|trial|39|patient|moderate|severe|essential|DISEASE_ENTITY|hypertension|.	67000	0.0	10
contribution|atenolol|,|COMPOUND_ENTITY|,|hydrallazine|management|severe|DISEASE_ENTITY|hypertension|.	67137	0.0	10
postulate|DISEASE_ENTITY|effect|drug|like|clonidine|,|COMPOUND_ENTITY|beta-receptor-blocking|agent|relate|long-term|effect|presynaptic|adrenoceptor|.	67342	1.0	10
serum|prolactin|level|significantly|greater|DISEASE_ENTITY|patient|receive|COMPOUND_ENTITY|compare|level|week|discontinue|treatment|-lrb-|p|.005|-rrb-|.	67595	0.0	10
serum|sample|patient|DISEASE_ENTITY|psychosis|,|,|cause|reduction|COMPOUND_ENTITY|production|;|65|%|sample|depression|,|44|%|sample|manic|episode|23|%|sample|mood|normal|.	67655	0.0	10
Amitriptyline|,|imipramine|,|COMPOUND_ENTITY|,|meprobamate|,|chlordiazepoxide|,|diazepam|,|trifluoroperazine|,|haloperidol|,|thioridazine|,|chlorpromazine|,|phenobarbital|,|propranolol|diphenylhydantoin|active|protect|mouse|extensor|DISEASE_ENTITY|convulsion|lethality|.	67754	1.0	10
naturally-occurring|synthetic|analogue|COMPOUND_ENTITY|,|tyrosine|,|histidine|,|arginine|,|proline|,|tryptophan|sulphur|amino|acid|beeen|test|rat|reticulocyte|Reuber|h35|DISEASE_ENTITY|hepatoma|effect|protein|synthesis|protein|degradation|heat|lability|phosphoenolpyruvate|carboxykinase|-lrb-|ec|4.1.1.32|-rrb-|hepatoma|cell|.	67814	0.0	11
comparative|inhibitory|potency|papaverine|ro|20-1724|-lrb-|4|-|-lrb-|3-butoxy-4-methoxybenzyl|-rrb-|-2|-|imidazolidinone|-rrb-|cyclic|amp-phosphodiesterase|-lrb-|camp-pde|-rrb-|cyclic|gmp-phosphodiesterase|-lrb-|COMPOUND_ENTITY|-rrb-|activity|effect|level|camp|cgmp|examine|DISEASE_ENTITY|psoriatic|epidermis|.	68102	0.0	11
comparative|inhibitory|potency|papaverine|ro|20-1724|-lrb-|4|-|-lrb-|3-butoxy-4-methoxybenzyl|-rrb-|-2|-|imidazolidinone|-rrb-|cyclic|amp-phosphodiesterase|-lrb-|camp-pde|-rrb-|cyclic|gmp-phosphodiesterase|-lrb-|cgmp-pde|-rrb-|activity|effect|level|camp|COMPOUND_ENTITY|examine|DISEASE_ENTITY|psoriatic|epidermis|.	68107	0.0	11
influence|cannabidiol|COMPOUND_ENTITY|9-tetrahydrocannabinol|cobalt|DISEASE_ENTITY|epilepsy|rat|.	68202	0.0	11
DISEASE_ENTITY|therapy|cause|disorder|cerebral|carbohydrate|metabolism|similar|change|induce|COMPOUND_ENTITY|coma|.	68467	0.0	10
induction|DISEASE_ENTITY|tumor|BD-VI|rat|single|application|n-methyl-n|'|-|nitro-n-nitrosoguanidine|dimethylsulfoxide|-lrb-|COMPOUND_ENTITY|-rrb-|.	68541	0.0	10
conclude|-lrb-|1|-rrb-|cad|patient|sensitive|propranolol|digoxin-induced|av|block|normal|,|-lrb-|2|-rrb-|propranolol|change|magnitude|ischemic|exercise|st|segment|depression|,|-lrb-|3|-rrb-|digoxin|increase|DISEASE_ENTITY|depression|result|high|incidence|false-positive|exercise|test|,|-lrb-|4|-rrb-|addition|propranolol|digoxin|attenuate|effect|COMPOUND_ENTITY|exercise|st|segment|.	68575	0.0	10
low|sweat|na/k|ratio|-lrb-|0.25|-rrb-|good|suppress|efficacy|COMPOUND_ENTITY|spironolactone|DISEASE_ENTITY|hypertension|hypokalemic|alkalosis|agree|hypersecretion|mineralocorticoid|.	68800	1.0	10
glucose|,|lactate|,|pyruvate|level|,|COMPOUND_ENTITY|ratio|ph|study|serum|csf|patient|DISEASE_ENTITY|schizophrenia|,|reactive|psychosis|,|symptomatic|circular|psychosis|effect|atropine|coma|,|es|pentetrazole|convulsion|,|tranquilizer|treatment|combined|therapy|.	68851	0.0	11
find|DISEASE_ENTITY|ventilatory|parameter|,|group|peak-flow|sedation|COMPOUND_ENTITY|evening|operation|-lrb-|p|equal|0,05|-rrb-|.	69041	0.0	10
Properties|COMPOUND_ENTITY|hydroxylase|culture|DISEASE_ENTITY|hepatoma|cell|.	69627	0.0	11
kinetic|immunologic|property|COMPOUND_ENTITY|hydroxylase|adult|rat|liver|compare|property|similar|enzyme|present|culture|h4-ii-e-c3|DISEASE_ENTITY|hepatoma|cell|.	69923	0.0	11
adrenalectomy|change|essentially|content|camp|cgmp|adipocyte|,|reduce|COMPOUND_ENTITY|ratio|cell|half|;|content|camp|cgmp|greater|adipocyte|adrenalectomize|DISEASE_ENTITY|SHR|rat|adrenalectomized|animal|normal|pressure|.	69948	0.0	10
effect|COMPOUND_ENTITY|tolerance|DISEASE_ENTITY|convulsion|withdrawal|force|barbital|drinking|rat|.	69986	0.0	10
DISEASE_ENTITY|abstinence|reduce|8|h|COMPOUND_ENTITY|treatment|-lrb-|8mg/kg|-rrb-|day|3|.	70038	1.0	10
bronchodilator|effect|aerosol|high-dose|terbutaline|sulfate|-lrb-|1.5|mg|-rrb-|,|low-dose|terbutaline|sulfate|-lrb-|0.75|mg|-rrb-|,|COMPOUND_ENTITY|-lrb-|0.3|mg|-rrb-|,|placebo|compare|use|force|expiratory|spirometry|,|flow-volume|curve|,|body|plethysmography|double-blind|,|six-hour|,|controlled|study|25|patient|reversible|DISEASE_ENTITY|airflow|obstruction|.	70173	0.0	10
Piroxicam|-lrb-|COMPOUND_ENTITY|-rrb-|,|new|nonsteroidal|anti-inflammatory|agent|,|decrease|pain|,|stiffness|,|inflammation|increase|patient|ability|perform|task|double-blind|study|patient|active|,|DISEASE_ENTITY|definite|rheumatoid|arthritis|,|poorly|control|despite|standard|therapy|.	70346	1.0	11
-lsb-|combination|COMPOUND_ENTITY|pindolol|treatment|DISEASE_ENTITY|hypertension|-lrb-|author|transl|-rrb-|-rsb-|.	70439	1.0	10
-lsb-|treatment|DISEASE_ENTITY|cause|house-dust|mite|combination|intal|vaccine|adsorb|COMPOUND_ENTITY|-rsb-|.	70466	0.0	11
COMPOUND_ENTITY|kinase|mb|isoenzyme|diagnosis|DISEASE_ENTITY|acute|myocardial|infarction|.	70609	0.0	10
patient|systemic|lupus|erythematosus|-lrb-|DISEASE_ENTITY|-rrb-|lupus|retinopathy|resolution|subretinal|edema|document|COMPOUND_ENTITY|angiography|.	70926	0.0	11
autoradiographic|flow|microfluorometry|analysis|apply|study|perturb|cell|kinetics|9l|rat|DISEASE_ENTITY|tumor|cell|treat|dibutyryl|cyclic|amp|COMPOUND_ENTITY|combination|vitro|.	71272	0.0	11
management|vf|essential|DISEASE_ENTITY|daily|administration|timolol|maleate|COMPOUND_ENTITY|.	71443	0.0	10
difference|fractionation|assay|method|COMPOUND_ENTITY|phosphokinase|isoenzyme|produce|conflicting|documentation|presence|cpk-mb|tissue|myocardium|release|cpk-mb|condition|acute|DISEASE_ENTITY|myocardial|infarction|.	71824	0.0	10
mechanism|anticonvulsant|activity|cannabidiol|-lrb-|cbd|-rrb-|central|excitation|COMPOUND_ENTITY|9-tetrahydrocannabinol|-lrb-|delta|9-thc|-rrb-|investigate|electrophysiologically|conscious|,|unrestrained|cobalt|DISEASE_ENTITY|epileptic|rat|.	71846	0.0	11
test|clinical|efficacy|low|dose|COMPOUND_ENTITY|decanoate|-lrb-|1.25|mg|5.0|mg|biweekly|-rrb-|,|carry|separate|experiment|:|-lrb-|1|-rrb-|open|trial|57|DISEASE_ENTITY|schizophrenic|outpatient|,|6|month|;|-lrb-|2|-rrb-|double-blind|,|placebo-controlled|discontinuation|study|subgroup|patient|maintain|good|remission|entire|6-month|open|trial|.	71892	0.0	10
fourty-six|man|6|woman|aged|45|year|arterial|DISEASE_ENTITY|newly|diagnose|routine|medical|examination|out-patient|antihypertensive|treatment|prazosin|,|COMPOUND_ENTITY|+|hydrochlorothiazide|,|prazosin|+|hydrochlorothiazide|+|clonidine|.	72205	1.0	10
interaction|COMPOUND_ENTITY|cannabidiol|phenobarbitone|protect|mouse|electrically|induce|DISEASE_ENTITY|convulsion|.	72219	1.0	11
-lsb-|effect|COMPOUND_ENTITY|alpha-adrenergic|receptor|nervous|reflex|arc|essential|DISEASE_ENTITY|hypertension|-rsb-|.	72396	0.0	10
26-wk|double-blind|controlled|study|34|patient|DISEASE_ENTITY|poorly|control|despite|oral|steroid|,|valuable|clinical|pulmonary|function|improvement|derive|add|beclomethasone|aerosol|COMPOUND_ENTITY|regimen|.	72620	0.0	10
role|COMPOUND_ENTITY|management|DISEASE_ENTITY|hypertension|.	72626	1.0	10
evaluate|effectiveness|different|dose|nebulized|Sch|1000|-lrb-|40|microgram|80|microgram|-rrb-|aerosolized|COMPOUND_ENTITY|sulfate|-lrb-|1|mg|-rrb-|placebo|prevention|exercise-induced|bronchospasm|-lrb-|eib|-rrb-|20|child|DISEASE_ENTITY|atopic|bronchial|asthma|.	72662	0.0	10
COMPOUND_ENTITY|produce|significant|decrease|t-wave|amplitude|result|DISEASE_ENTITY|st|segment|depression|rest|ecg|.	72802	0.0	10
Atenolol|COMPOUND_ENTITY|treatment|DISEASE_ENTITY|hypertension|.	72999	1.0	10
intramuscular|injection|diazepam|rat|dose|0.01|2|mg/kg|25-30|min|COMPOUND_ENTITY|application|rat|brain|cortex|lead|alteration|periodic|appearance|epileptic|seizure|-lrb-|es|-rrb-|,|change|DISEASE_ENTITY|seizure|pattern|,|emergence|periodic|acceleration|epileptiform|discharge|-lrb-|ed|-rrb-|.	73193	0.0	10
electron-microscopic|study|reveal|proteinaceous|plasma-like|fluid|DISEASE_ENTITY|space|,|confirm|COMPOUND_ENTITY|induce|pulmonary|edema|.	73738	0.0	11
establish|DISEASE_ENTITY|COMPOUND_ENTITY|deficit|drop|activity|tryptophane|metabolism|serotonin|way|.	73793	0.0	10
finding|suggest|measurement|sp|concentration|saliva|convenient|,|noninvasive|method|monitor|indirectly|steady-state|plasma|-lrb-|serum|-rrb-|concentration|sp|patient|DISEASE_ENTITY|colitis|crohn|disease|receive|COMPOUND_ENTITY|.	74128	0.0	10
COMPOUND_ENTITY|monophosphate|-lrb-|camp|-rrb-|important|factor|regulate|expression|differentiate|function|DISEASE_ENTITY|neuroblastoma|cell|,|function|induce|agent|increase|intracellular|level|camp|.	74200	0.0	10
inhibitor|,|,|produce|dose-dependent|prolongation|time|onset|DISEASE_ENTITY|death|induce|COMPOUND_ENTITY|bicuculline|.	74322	0.0	10
eighteen|patient|DISEASE_ENTITY|participate|double-blind|,|randomized|study|evaluate|effect|trimazosin|,|COMPOUND_ENTITY|,|placebo|supine|stand|blood|pressure|heart|rate|.	74528	0.0	10
biochemical|effect|atenolol|,|,|advantage|COMPOUND_ENTITY|decide|first-line|treatment|essential|DISEASE_ENTITY|hypertension|.	74531	1.0	10
reversible|inactivation|COMPOUND_ENTITY|hydroxylase|catecholamine|culture|DISEASE_ENTITY|hepatoma|cell|.	74719	0.0	11
substantial|improvement|frequency|tumor|regression|record|gastric|carcinoma|combination|5-fu|bcnu|,|5-fu|methyl|ccnu|,|5-fu|,|mitomycin|c|,|cytosine|arabinoside|;|colorectal|carcinoma|,|combination|5-fu|,|methyl|CCNU|,|COMPOUND_ENTITY|;|carcinoid|tumor|DISEASE_ENTITY|islet|cell|carcinoma|,|combination|5-fu|streptozotocin|.	75034	0.0	10
COMPOUND_ENTITY|approximately|4|time|potent|diazepam|prevent|pentetrazol|DISEASE_ENTITY|convulsion|,|10|time|potent|inhibit|maximal|electroshock|convulsion|mouse|.	75110	1.0	11
scintiphotographic|finding|compare|size|DISEASE_ENTITY|infarct|calculate|measurement|activity|mb|isoenzyme|COMPOUND_ENTITY|kinase|-lrb-|ck-mb|-rrb-|serum|myocardium|autopsy|,|describe|Sobel|method|.	75441	0.0	10
continue|high|level|COMPOUND_ENTITY|hydroxylase|culture|h4-ii-e-c3|rat|DISEASE_ENTITY|hepatoma|cell|require|serum|glucocorticoid|culture|medium|.	75589	0.0	11
,|remain|accelerate|DISEASE_ENTITY|normal|renin|,|hypertension|alleviate|COMPOUND_ENTITY|.	75683	0.0	10
parenteral|COMPOUND_ENTITY|seriously|consider|sign|involvement|cns|p|falciparum|DISEASE_ENTITY|malaria|standard|form|antimalarial|therapy|.	75700	1.0	10
stationary-phase|,|minimal|deviation|DISEASE_ENTITY|h4-ii-e-c3|cell|culture|serum-deprived|respond|biphasic|time|course|COMPOUND_ENTITY|hydroxylase|induction|dialyze|fetal|calf|serum|insulin|add|.	75717	0.0	11
Atenolol|,|COMPOUND_ENTITY|,|chlorthalidone|moderate|DISEASE_ENTITY|hypertension|.	75987	0.0	10
-lsb-|experimental|acute|DISEASE_ENTITY|induce|mouse|COMPOUND_ENTITY|diet|dl-ethionine|-rsb-|.	76008	0.0	11
COMPOUND_ENTITY|-lrb-|CP|16171|-rrb-|DISEASE_ENTITY|rheumatoid|arthritis|:|controlled|clinical|trial|novel|assessment|technique|.	76061	1.0	11
Piroxicam|-lrb-|COMPOUND_ENTITY|-rrb-|DISEASE_ENTITY|rheumatoid|arthritis|:|controlled|clinical|trial|novel|assessment|technique|.	76064	1.0	11
treatment|low|differentiate|germinal|cancer|DISEASE_ENTITY|use|COMPOUND_ENTITY|.	76137	1.0	10
leukostasis|syndrome|associate|high|blast|cell|count|adult|DISEASE_ENTITY|leukemia|avoid|use|COMPOUND_ENTITY|manner|describe|.	76309	1.0	10
patient|chronic|myeloid|leukaemia|treat|busulphan|4-5|year|,|develop|sign|COMPOUND_ENTITY|toxicity|portal|DISEASE_ENTITY|hypertension|ascite|,|oesophageal|varice|jaundice|.	76676	0.0	10
low|dose|COMPOUND_ENTITY|decanoate|maintenance|treatment|DISEASE_ENTITY|schizophrenia|.	76693	1.0	10
COMPOUND_ENTITY|find|effective|DISEASE_ENTITY|MES|sign|neurological|toxicity|range|plasma|concentration|9.8|74.0|,|10.8|95.0|,|9.6|117.0|,|12.6|96.2|microgram/ml|mouse|,|rat|,|rabbit|,|dog|,|respectively|.	76823	1.0	11
interpretation|result|cytoplasm|rat|DISEASE_ENTITY|cell|contain|positively|acting|factor|-lrb-|s|-rrb-|COMPOUND_ENTITY|hydroxylase|gene|bring|activation|gene|erythroleukemia|cell|.	76947	0.0	11
treatment|painful|DISEASE_ENTITY|fluoride|,|calcium|,|COMPOUND_ENTITY|.	77063	1.0	11
remain|patient|difference|observe|response|treatment|patient|DISEASE_ENTITY|COMPOUND_ENTITY|placebo|.	77096	0.0	10
sulfinyl|-|sulfonylquinazoline|retain|antimalarial|effect|chloroquine|-|,|cycloguanil|-|,|COMPOUND_ENTITY|line|P.|bergheus|mouse|chloroquine|-|pyrimethamine-resistant|strain|P.|DISEASE_ENTITY|falciparum|owl|monkey|.	77230	0.0	10
cell|fuse|cytoplast|rat|DISEASE_ENTITY|cell|synthesize|COMPOUND_ENTITY|hydroxylase|constitutively|.	77399	0.0	11
patient|complain|mouth|dryness|feel|better|oral|COMPOUND_ENTITY|fewer|acute|episode|DISEASE_ENTITY|asthma|.	77501	0.0	10
eighty-one|chronic|DISEASE_ENTITY|patient|randomly|assign|receive|follow|treatment|:|standard|neuroleptic|,|pipotiazine|palmitate|,|COMPOUND_ENTITY|decanoate|.	77594	1.0	10
Solutions|reduce|hemoglobin|patient|ss|,|sc|,|cc|DISEASE_ENTITY|precipitate|heat|minute|100|degree|c|ph|9.20|presence|3.64|m|COMPOUND_ENTITY|,|hemolysate|normal|adult|aa|newborn|-lrb-|fa|hemoglobin|-rrb-|remain|clear|.	77777	0.0	11
52|patient|receive|mean|dose|2.5|g|COMPOUND_ENTITY|maintenance|therapy|DISEASE_ENTITY|ulcerative|colitis|,|35|find|drug-induced|red|cell|abnormality|,|find|50|normal|control|10|colitic|receive|sulphasalazine|.	77832	0.0	10
mode|action|COMPOUND_ENTITY|sodium|study|11|DISEASE_ENTITY|multiple|sclerosis|patient|spastic|paresis|leg|measurement|change|electromyographic|mechanomyographic|proprioceptive|reflex|response|voluntary|power|.	77945	0.0	11
comparison|pimozide|COMPOUND_ENTITY|treatment|Gilles|de|la|DISEASE_ENTITY|Tourette|syndrome|.	78105	1.0	10
cell-free|system|mitochondrial-microsomal|fraction|-lrb-|mmf|-rrb-|derive|mengovirus-infected|DISEASE_ENTITY|cell|nucleoside-triphosphate|medium|,|polymerase|activity|increase|60|min|-lrb-|mmf|obtain|homogenizer|-rrb-|120|min|-lrb-|mmf|prepare|COMPOUND_ENTITY|deoxycholate|disruption|-rrb-|.	78173	0.0	11
sixteen|patient|acute|blast|crisis|chronic|myeloid|leukaemia|-lrb-|DISEASE_ENTITY|-rrb-|treat|combination|vincristine|,|6-mercaptopurine|,|COMPOUND_ENTITY|prednisone|.	78583	1.0	10
COMPOUND_ENTITY|decanoate|vs|oral|antipsychotic|:|comparison|effectiveness|treatment|DISEASE_ENTITY|schizophrenia|measure|reduction|hospital|readmission|.	78585	1.0	10
study|technetium-99m|pyrophosphate|image|compare|frequent|determination|plasma|COMPOUND_ENTITY|kinase|,|mb|isoenzyme|-lrb-|mb|ck|-rrb-|activity|116|patient|admit|diagnosis|DISEASE_ENTITY|unstable|angina|.	78639	0.0	10
3|patient|DISEASE_ENTITY|infarction|pretreat|metoprolol|-lrb-|15|mg|-rrb-|infuse|COMPOUND_ENTITY|15|microgram|kg|--|1|min|--|1|10|min|.	78720	0.0	10
contrast|COMPOUND_ENTITY|9-thc|11-oh|metabolite|,|CBD|,|high|dose|,|induce|excitatory|effect|DISEASE_ENTITY|convulsion|.	78809	0.0	11
protein|methylase|iii|-lrb-|COMPOUND_ENTITY|:|proteinlysine|methyltransferase|;|ED|2.1.1.25|-rrb-|protein|methylase|-lrb-|s-adenosylmethionine|:|protein-arginine|methyltransferase|;|EC|2.1.1.23|-rrb-|activity|examine|isolate|nucleus|cytosol|fraction|,|respectively|,|DISEASE_ENTITY|hepatoma|different|growth|rate|.	78819	0.0	11
protein|methylase|iii|-lrb-|s-adenosylmethionine|:|proteinlysine|methyltransferase|;|ED|2.1.1.25|-rrb-|protein|methylase|-lrb-|COMPOUND_ENTITY|:|protein-arginine|methyltransferase|;|EC|2.1.1.23|-rrb-|activity|examine|isolate|nucleus|cytosol|fraction|,|respectively|,|DISEASE_ENTITY|hepatoma|different|growth|rate|.	78825	0.0	11
isolate|perfused|rat|heart|,|dose-related|cardiostimulation|produce|norepinephrine|-lrb-|ne|-rrb-|calcium|chloride|-lrb-|ca2|+|-rrb-|follow|corresponding|increase|coronary|flow|-lrb-|DISEASE_ENTITY|-rrb-|cardiac|level|adenosine|3|'|,5|'|-|cyclic|phosphate|-lrb-|COMPOUND_ENTITY|-rrb-|.	79062	0.0	10
plasma|COMPOUND_ENTITY|concentration|assess|series|hospitalize|DISEASE_ENTITY|schizophrenic|patient|receive|drug|double-blind|trial|amantadine|benztropine|treatment|neuroleptic-induced|extrapyramidal|symptom|-lrb-|ep|-rrb-|.	79227	0.0	10
mechanism|transport|edematous|fluid|alveolar|capillary|DISEASE_ENTITY|space|lung|COMPOUND_ENTITY|addict|consider|.	79423	0.0	11
COMPOUND_ENTITY|phosphokinase-mb|-lrb-|cpk-mb|-rrb-|diagnosis|DISEASE_ENTITY|myocardial|infarction|.	79429	0.0	10
hormonal|regulation|steroidogenesis|COMPOUND_ENTITY|monophosphate|DISEASE_ENTITY|embryonic-chick|ovary|.	79453	0.0	10
COMPOUND_ENTITY|reward|pathway|:|role|self-stimulation|,|memory|consolidation|,|DISEASE_ENTITY|schizophrenia|.	79787	0.0	10
-lsb-|therapeutic|effect|COMPOUND_ENTITY|premarin|acute|experimental|DISEASE_ENTITY|pancreatitis|-rsb-|.	79933	1.0	11
51-year-old|patient|DISEASE_ENTITY|anaemia|successful|allogeneic|bone-marrow|transplantation|perform|developed|acute|graft-versus-host|disease|spite|prophylactic|administration|COMPOUND_ENTITY|.	113497	1.0	11
finding|,|presence|fast|prepotential|COMPOUND_ENTITY|preparation|,|suggest|involvement|dendritic|activity|generation|DISEASE_ENTITY|epileptiform|discharge|.	113609	0.0	10
examine|11|previously|describe|culture|rat|DISEASE_ENTITY|mutant|absent|reduce|COMPOUND_ENTITY|hydroxylase|activity|-lrb-|Choo|Cotton|,|1977|-rrb-|.	114024	0.0	11
-lsb-|Assessment|nitrosurea|combine|cyclophosphamide|prednisone|versus|COMPOUND_ENTITY|prednisone|treatment|multiple|DISEASE_ENTITY|myeloma|-lrb-|author|transl|-rrb-|-rsb-|.	114087	1.0	10
crossover|clinical|trial|COMPOUND_ENTITY|,|indomethacin|ibuprofen|DISEASE_ENTITY|rheumatoid|arthritis|.	114249	1.0	11
equivalent|quantity|protein|recover|7|ms|6|DISEASE_ENTITY|brain|sample|PBS|wash|COMPOUND_ENTITY|acid|elution|.	114317	0.0	11
alkyating|agent|limited|role|treatment|lupus|nephropathy|cutaneous|vasculitis|COMPOUND_ENTITY|probably|value|DISEASE_ENTITY|sle|.	114323	0.0	10
epinephrine|produce|significant|DISEASE_ENTITY|dilatation|-lrb-|infrequently|follow|constriction|-rrb-|COMPOUND_ENTITY|produce|dilatation|normal|ph.|catecholamine-induced|dilatation|decrease|significantly|hypercapnic|acidosis|,|improve|nahco3|infusion|.	114405	0.0	10
Release|myoglobin|COMPOUND_ENTITY|serum|follow|acute|DISEASE_ENTITY|myocardial|infarction|.	114592	0.0	10
large|scale|study|general|practice|set|investigate|effect|transfer|DISEASE_ENTITY|patient|treatment|usually|1|g|daily|COMPOUND_ENTITY|atenolol|-lrb-|`|tenormin|'|-rrb-|100|mg|daily|.	114614	0.0	10
-lsb-|COMPOUND_ENTITY|k|deficiency|bleeding|lead|symptom|DISEASE_ENTITY|celiac|disease|-lrb-|author|transl|-rrb-|-rsb-|.	114634	0.0	11
indicator|DISEASE_ENTITY|emptying|,|plasma|COMPOUND_ENTITY|concentration|measure|dye|method|-lrb-|diphenylhydrazyl|-rrb-|,|mcg/ml|,|45|minute|ingestion|high|calory|pasty|test|meal|-lrb-|200|ml|-rrb-|1.5|gr|acetaminophen|.	114635	0.0	10
effect|cannabidiol|-lrb-|cbd|-rrb-|electrically|evoke|kindle|DISEASE_ENTITY|study|conscious|,|unrestrained|rat|chronically|implant|cortical|limbic|electrode|,|result|compare|delta|9-tetrahydrocannabinol|-lrb-|COMPOUND_ENTITY|-rrb-|,|phenytoin|-lrb-|pht|-rrb-|,|ethosuximide|-lrb-|esm|-rrb-|.	114800	0.0	11
ergotamine|tartrate|dose|normally|use|treatment|acute|DISEASE_ENTITY|2.0|mg|orally|,|2.0|mg|combine|100|mg|COMPOUND_ENTITY|rectally|0.5|mg|i.m.|plasma|ergotamine|concentration|determine|radioimmunoassay|.	114828	0.0	11
razor|thin|slice|white|matter|10|g|DISEASE_ENTITY|control|brain|wash|5|liter|phosphate-buffered|saline|-lrb-|PBS|-rrb-|,|treat|90|sec|COMPOUND_ENTITY|acid|,|ph|2.5|,|contain|pepstatin|epsilon-aminocaproic|acid|.	114879	0.0	11
patient|alcoholism|,|migraine|,|postoperative|pinealoma|,|panhypopituitarism|,|hereditary|dystonia|DISEASE_ENTITY|propranolol|exhibit|decrease|amplitude|diurnal|rhythm|COMPOUND_ENTITY|.	115035	0.0	11
validity|noninvasive|-lrb-|iodine-131|iodohippurate|renogram|,|iodine-131|ortho-iodohippurate|clearance|,|indium-113m|COMPOUND_ENTITY|--|technetium-99m|dtpa|sequential|renal|scan|-rrb-|invasive|-lrb-|xenon-133|washout|-rrb-|radionuclide|screening|test|evaluate|diagnosis|105|patient|DISEASE_ENTITY|unilateral|renovascular|hypertension|-lrb-|rvh|-rrb-|45|patient|essential|hypertension|-lrb-|eh|-rrb-|.	115142	0.0	10
method|apply|COMPOUND_ENTITY|kinase|-lrb-|ck|-rrb-|alpha-hydroxybutyrate|dehydrogenase|-lrb-|hbdh|-rrb-|plasma|activity|36|patient|acute|myocardial|infarction|-lrb-|DISEASE_ENTITY|AMI|-rrb-|.	115257	0.0	10
COMPOUND_ENTITY|hydrochloride|orally|administer|vasodilator|recently|available|treatment|DISEASE_ENTITY|hypertension|.	115534	1.0	10
aid|evaluation|diagnostic|performance|,|apply|immunological|COMPOUND_ENTITY|kinase-mb|assay|DISEASE_ENTITY|myocardial|infarction|.	115607	0.0	10
comparison|pimozide|COMPOUND_ENTITY|Gilles|de|la|DISEASE_ENTITY|Tourette|syndrome|.	115621	0.0	10
effect|COMPOUND_ENTITY|blood|pressure|vascular|disease|mouse|DISEASE_ENTITY|infarct-kidney|hypertension|.	115631	0.0	11
better|outcome|associate|treatment|prevention|DISEASE_ENTITY|,|partly|direct|indirect|effect|COMPOUND_ENTITY|uterine|activity|.	116101	0.0	10
medical|record|84|postmenopausal|woman|treat|oral|COMPOUND_ENTITY|acetate|-lrb-|nta|-rrb-|DISEASE_ENTITY|advanced|breast|cancer|retrospectively|analyze|.	116141	1.0	11
plasma|COMPOUND_ENTITY|level|radioimmunoassay|DISEASE_ENTITY|schizophrenic|patient|treat|depot|injection|fluphenazine|decanoate|.	116197	0.0	10
effect|antitumor|agent|vincristine|-lrb-|VCR|-rrb-|vincaleucoblastine|-lrb-|COMPOUND_ENTITY|-rrb-|cell|cycle|progression|different|ascite|tumor|cell|line|vivo|-lrb-|Ehrlich|,|Crocker|S|180|,|DISEASE_ENTITY|leukemia|l|1210|-rrb-|study|detail|flow|microfluorometric|technique|5-day|period|drug|treatment|post-treatment|course|.	116264	0.0	10
-lsb-|effect|serum|patient|DISEASE_ENTITY|syndrome|,|COMPOUND_ENTITY|creatinine|organotypic|nerve|tissue|culture|.	116566	0.0	11
effect|COMPOUND_ENTITY|early|infantile|DISEASE_ENTITY|autism|relation|serum|serotonin|level|.	116815	0.0	10
clinical|social|effect|flupenthixol|decanoate|COMPOUND_ENTITY|decanoate|compare|maintenance|treatment|population|chronic|DISEASE_ENTITY|schizophrenic|out-patient|period|9|month|.	117066	1.0	10
test|hypothesis|,|alter|dopamine|synthesis|COMPOUND_ENTITY|l-dopa|find|dopamine|synthesis|necessary|observe|DISEASE_ENTITY|depression|striatal|th|activity|methamphetamine|.	117286	0.0	10
capacity|release|non-esterified|acid|glycerol|abdominal|subcutaneous|adipose|tissue|medium|contain|different|concentration|COMPOUND_ENTITY|study|21|adult|different|body|weight|-lrb-|14|DISEASE_ENTITY|obese|,|7|control|-rrb-|.	117359	0.0	10
substrate|attach|material|-lrb-|sam|-rrb-|leave|plastic|dish|edta|treatment|normal|culture|rich|heparan|COMPOUND_ENTITY|,|SAM|DISEASE_ENTITY|glioma|cell|lack|heparan|sulphate|greatly|reduce|component|.	117561	0.0	10
-lsb-|role|genetic|factor|increase|serum|COMPOUND_ENTITY|dehydrogenase|activity|DISEASE_ENTITY|schizophrenic|patient|-rsb-|.	117830	0.0	11
reversal|cardiac|hypertrophy|prolonged|treatment|COMPOUND_ENTITY|-lrb-|range|3|6|week|-rrb-|established|phase|spontaneous|DISEASE_ENTITY|hypertension|normalize|arterial|blood|pressure|improve|ventricular|pump|ability|.	117978	0.0	10
twenty-five|patient|allergic|bronchopulmonary|aspergillosis|-lrb-|abpa|-rrb-|observe|period|12|month|10|year|-lrb-|average|duration|,|2.6|year|-rrb-|initial|therapy|COMPOUND_ENTITY|,|taper|discontinue|maintain|minimal|dose|require|control|DISEASE_ENTITY|asthma|.	118054	1.0	10
Propanolol|,|COMPOUND_ENTITY|,|clofibrate|,|different|class|pharmacological|agent|use|clinically|condition|relate|DISEASE_ENTITY|atherosclerosis|,|intrinsic|potentiating|effect|development|atherosclerosis|stumptail|macaque|feed|atherogenic|diet|.	118174	0.0	11
Propanolol|,|COMPOUND_ENTITY|,|clofibrate|,|different|class|pharmacological|agent|use|clinically|condition|relate|atherosclerosis|,|intrinsic|potentiating|effect|development|DISEASE_ENTITY|atherosclerosis|stumptail|macaque|feed|atherogenic|diet|.	118180	0.0	11
DISEASE_ENTITY|population|include|patient|known|occult|coronary|artery|disease|,|physician|use|COMPOUND_ENTITY|cautiously|subgroup|,|particularly|beta-adrenergic|antagonist|use|concurrently|.	118186	1.0	10
addition|COMPOUND_ENTITY|-lrb-|17|mm|-rrb-|incubation|medium|extracellular|marker|markedly|decrease|intracellular|concentration|c1|-|control|retina|,|block|inward|movement|ion|tissue|DISEASE_ENTITY|sd|change|k|+|movement|phenomenon|medium|2|mm|mgso4|.	118371	0.0	10
report|unusually|high|concentration|free|fatty|acid|glycerol|serum|patient|DISEASE_ENTITY|diabetes|,|accompany|alteration|COMPOUND_ENTITY|kinase|isoenzyme|mm|pattern|associate|patient|.	118373	0.0	10
Depot|COMPOUND_ENTITY|prevention|relapse|DISEASE_ENTITY|schizophrenia|:|evaluation|treatment|regimen|-lsb-|proceedings|-rsb-|.	118486	0.0	10
value|COMPOUND_ENTITY|phosphokinase|-lrb-|cpk|-rrb-|isoenzyme|,|presence|normal|total|CPK|,|assess|DISEASE_ENTITY|myocardial|infarction|discuss|.	118690	0.0	10
17-year|old|girl|receive|prednisone|COMPOUND_ENTITY|treatment|DISEASE_ENTITY|systemic|lupus|erythematosus|.	119397	1.0	10
-lsb-|reliability|immunologically|determine|COMPOUND_ENTITY|kinase|isoenzyme|mb|acute|DISEASE_ENTITY|myocardial|infarction|-rsb-|.	119503	0.0	10
inhale|corticosteroid|controlled|DISEASE_ENTITY|oral|COMPOUND_ENTITY|respond|therapy|initial|period|trial|.	119717	1.0	10
-lsb-|ultrastructural|change|DISEASE_ENTITY|cell|treatment|COMPOUND_ENTITY|-rsb-|.	119983	0.0	10
antiepileptic|prophylactic|effect|COMPOUND_ENTITY|-lrb-|delta9-thc|-rrb-|delta8-thc|examine|rat|develop|generalize|DISEASE_ENTITY|seizure|response|intermittent|electrical|stimulation|amygdala|-lrb-|kindling|-rrb-|.	120213	0.0	11
antiepileptic|prophylactic|effect|delta9-tetrahydrocannabinol|-lrb-|COMPOUND_ENTITY|-rrb-|delta8-thc|examine|rat|develop|generalize|DISEASE_ENTITY|seizure|response|intermittent|electrical|stimulation|amygdala|-lrb-|kindling|-rrb-|.	120220	0.0	11
untreated|lymphocyte|patient|DISEASE_ENTITY|anaemia|vitamin|b-12|folate|deficiency|lymphocyte|treat|COMPOUND_ENTITY|-lrb-|10|-lrb-|-5|-rrb-|m|-rrb-|hydroxyurea|-lrb-|5|.	120224	1.0	11
administration|isomer|COMPOUND_ENTITY|DISEASE_ENTITY|seizure|development|result|suppression|kindling|,|suggestive|prophylactic|effect|.	120268	1.0	11
improve|survival|time|DISEASE_ENTITY|myeloma|treat|COMPOUND_ENTITY|,|prednisone|,|cyclophosphamide|,|vincristine|bcnu|:|m-2|protocol|.	120299	1.0	10
COMPOUND_ENTITY|inhibition|platelet|mao|DISEASE_ENTITY|schizophrenic|patient|.	120625	0.0	10
immunological|two-dimensional|gel|electrophoretic|study|COMPOUND_ENTITY|hydroxylase|culture|normal|mutant|rat|DISEASE_ENTITY|hepatoma|cell|.	120979	0.0	11
Prostacyclin|,|stable|metabolite|6-keto-prostaglandin|f1|alpha|COMPOUND_ENTITY|e2|test|adenylate|cyclase|system|human|DISEASE_ENTITY|gastric|mucosa|.	121087	0.0	10
treatment|COMPOUND_ENTITY|capable|bring|elevated|systemic|arterial|pressure|thymus-dependent|phase|DISEASE_ENTITY|infarct-kidney|hypertension|mouse|;|marked|improvement|clinical|condition|treated|animal|observe|compare|untreated|hypertensive|mouse|.	121088	1.0	11
treatment|COMPOUND_ENTITY|capable|bring|elevated|systemic|arterial|pressure|thymus-dependent|phase|infarct-kidney|hypertension|mouse|;|marked|improvement|clinical|condition|treated|animal|observe|compare|untreated|DISEASE_ENTITY|hypertensive|mouse|.	121095	0.0	11
study|provide|reason|believe|culture|rat|DISEASE_ENTITY|cell|gene|code|single|polypeptide|chain|,|number|combine|form|active|COMPOUND_ENTITY|hydroxylase|multimer|:|-lrb-|1|-rrb-|analysis|purify|protein|two-dimensional|electrophoresis|reveal|single|polypeptide|chain|.	121181	0.0	11
DISEASE_ENTITY|brain|dopamine|,|COMPOUND_ENTITY|serotonin|significantly|increase|area|corpus|striatum|,|significant|change|enzyme|activity|monoamine|metabolite|concentration|brain|area|examine|.	121405	0.0	10
author|conduct|study|DISEASE_ENTITY|behavioral|disturbance|induce|member|macaque|social|colony|chronic|administration|COMPOUND_ENTITY|.	121449	0.0	10
patient|demonstrate|DISEASE_ENTITY|sensitivity|COMPOUND_ENTITY|react|nonsteroidal|,|anti-inflammatory|drug|similar|lesser|degree|.	121470	0.0	10
influence|clonidine|,|COMPOUND_ENTITY|hydralazine|noradrenergic|adrenergic|neuronal|activity|brainstem|nucleus|spontaneously|DISEASE_ENTITY|hypertensive|rat|-lsb-|proceedings|-rsb-|.	121500	0.0	10
-lsb-|Dynamics|necrotic|area|DISEASE_ENTITY|infarction|accord|datum|serial|examination|serum|COMPOUND_ENTITY|phosphokinase|-rsb-|.	121544	0.0	10
inject|20|mg|prednisolone|tebuate|COMPOUND_ENTITY|hexacetonide|knee|joint|7|patient|DISEASE_ENTITY|osteoarthritis|painful|effusion|.	121571	1.0	11
preliminary|datum|effect|COMPOUND_ENTITY|cfus|circulate|large|quantity|blood|mouse|friend|DISEASE_ENTITY|virus|leukaemia|indicate|tumorous|stem|cell|-lrb-|cfus|-rrb-|respond|cytostatic|similar|way|.	121619	0.0	10
electroophthalmological|COMPOUND_ENTITY|angiographic|study|perform|13|year|old|girl|exsudative|detachment|retina|DISEASE_ENTITY|hypertensive|crisis|.	122051	0.0	10
-lsb-|COMPOUND_ENTITY|turnover|neuroleptic|treatment|DISEASE_ENTITY|schizophrenic|syndrome|-lrb-|author|transl|-rrb-|-rsb-|.	122090	1.0	10
Peptichemio|:|new|oncolytic|drug|combination|vincristine|COMPOUND_ENTITY|treatment|DISEASE_ENTITY|non-hodgkin|lymphoma|.	122091	1.0	10
comparison|aerosolized|atropine|,|isoproterenol|,|COMPOUND_ENTITY|plus|isoproterenol|,|disodium|cromoglycate|placebo|prevention|exercise-induced|DISEASE_ENTITY|asthma|.	122349	1.0	10
severity|handling-induced|DISEASE_ENTITY|apparently|increase|COMPOUND_ENTITY|-lrb-|10-40|mg/kg|-rrb-|nabilone|-lrb-|2.5-10|mg/kg|-rrb-|drug|elicit|similar|convulsion|normal|mouse|expose|ethanol|.	122439	0.0	11
severity|handling-induced|convulsion|apparently|increase|COMPOUND_ENTITY|-lrb-|10-40|mg/kg|-rrb-|nabilone|-lrb-|2.5-10|mg/kg|-rrb-|drug|elicit|similar|DISEASE_ENTITY|convulsion|normal|mouse|expose|ethanol|.	122442	0.0	11
result|indicate|COMPOUND_ENTITY|nabilone|similar|action|abstinence|sign|ethanol-dependent|mouse|,|sign|-lrb-|responsiveness|electric|foot|shock|-rrb-|clearly|alleviate|,|-lrb-|handling-induced|DISEASE_ENTITY|convulsion|-rrb-|.	122464	0.0	11
4-year-old|girl|develop|DISEASE_ENTITY|accidental|ingestion|excessive|dosage|-lrb-|50|mg/kg|-rrb-|COMPOUND_ENTITY|acid|,|treat|drug|-lrb-|50|mg/kg/day|-rrb-|30|day|urinary|tract|infection|,|report|.	122556	0.0	11
base|result|,|state|COMPOUND_ENTITY|efficient|new|peripheral|vasodilator|good|patient|tolerance|treatment|arterial|DISEASE_ENTITY|hypertension|.	122751	1.0	10
hemodynamic|effect|COMPOUND_ENTITY|mitral|stenosis|DISEASE_ENTITY|congestive|cardiomyopahty|.	122883	0.0	11
COMPOUND_ENTITY|beclomethasone|treatment|DISEASE_ENTITY|asthma|.	123219	1.0	10
haemodynamic|long-term|effect|COMPOUND_ENTITY|plus|tolamolol|essential|DISEASE_ENTITY|hypertension|.	123249	0.0	10
effect|COMPOUND_ENTITY|cardiac|coronary|hemodynamic|myocardial|metabolism|patient|DISEASE_ENTITY|coronary|artery|disease|.	123262	0.0	11
-lsb-|DISEASE_ENTITY|attack|treatment|COMPOUND_ENTITY|:|role|sympathetic|nervous|system|-rsb-|.	123293	0.0	10
randomized|study|,|attempt|clarify|role|combined|COMPOUND_ENTITY|prednisone|therapy|versus|prednisone|severe|DISEASE_ENTITY|systemic|lupus|erythematosus|sustain|mollify|clinical|controversy|.	123294	0.0	10
isomer|COMPOUND_ENTITY|able|acutely|suppress|kindle|DISEASE_ENTITY|seizure|,|consistent|antiepileptic|effect|obtain|high|,|toxic|dosage|.	123323	0.0	11
effect|COMPOUND_ENTITY|barbiturate|withdrawal|DISEASE_ENTITY|convulsion|rat|.	123352	0.0	11
patient|severe|DISEASE_ENTITY|moderately|severe|renal|insufficiency|,|metolazone|furosemide|use|combination|propranolol|,|COMPOUND_ENTITY|,|hydralazine|augment|control|blood|pressure|.	123462	0.0	10
contrast|previous|study|rodent|tumour|,|potentially|synergistic|-lrb-|chloroquine|,|arginine|-rrb-|antagonistic|-lrb-|ascorbic|acid|,|leucine|-rrb-|compound|affect|toxicity|COMPOUND_ENTITY|human|DISEASE_ENTITY|melanoma|cell|line|.	123603	0.0	10
COMPOUND_ENTITY|dehydrogenase|isoenzyme|DISEASE_ENTITY|gastric|cancer|.	123811	0.0	10
pathological|change|kidney|heart|attribute|toxic|effect|COMPOUND_ENTITY|normotensive|DISEASE_ENTITY|hypertensive|mouse|treat|month|penicillamine|.	123865	0.0	11
follow|reduction|dose|antipsychotic|medication|,|complete|discontinuation|,|mesolimbic|dopamine|receptor|supersensitivity|reflect|rapid|relapse|schizophrenic|patient|,|development|DISEASE_ENTITY|symptom|patient|prior|history|schizophrenia|,|necessity|ever-increasing|dose|long-acting|depot|COMPOUND_ENTITY|maintain|remission|.	123892	0.0	10
DISEASE_ENTITY|patient|oral|COMPOUND_ENTITY|,|melphalan|find|plasma|urine|24|hr|.	123907	0.0	10
effect|exercise|DISEASE_ENTITY|control|metoprolol|COMPOUND_ENTITY|.	124133	0.0	10
letter|:|jaundice|associate|COMPOUND_ENTITY|treatment|DISEASE_ENTITY|breast|cancer|.	124176	1.0	11
oxprenolol|plus|cyclopenthiazide-kcl|versus|COMPOUND_ENTITY|treatment|DISEASE_ENTITY|hypertension|.	124479	1.0	10
oxprenolol|plus|COMPOUND_ENTITY|versus|methyldopa|treatment|DISEASE_ENTITY|hypertension|.	124486	1.0	10
-lsb-|determination|COMPOUND_ENTITY|phosphokinase|prehospital|stage|DISEASE_ENTITY|myocardial|infarct|diagnosis|-rsb-|.	124696	0.0	10
effect|COMPOUND_ENTITY|-lrb-|thc|-rrb-|nabilone|,|synthetic|cannabinoid|,|handling-induced|DISEASE_ENTITY|convulsion|responsiveness|electric|foot|shock|examine|abstinence|ethanol-dependent|mouse|.	125026	0.0	11
effect|delta9-tetrahydrocannabinol|-lrb-|COMPOUND_ENTITY|-rrb-|nabilone|,|synthetic|cannabinoid|,|handling-induced|DISEASE_ENTITY|convulsion|responsiveness|electric|foot|shock|examine|abstinence|ethanol-dependent|mouse|.	125029	0.0	11
specific|sensitive|gas-chromatographic|technique|use|common|extraction|procedure|quantitative|determination|amitriptyline|,|endogenous|COMPOUND_ENTITY|perphenazine|plasma|DISEASE_ENTITY|schizophrenic|patient|receive|therapeutic|dose|combination|amitriptyline|perphenazine|-lrb-|etrafon|-rrb-|develop|.	125110	0.0	11
gas|chromatographic|determination|amitriptyline|,|COMPOUND_ENTITY|perphenazine|plasma|DISEASE_ENTITY|schizophrenic|patient|administration|combination|amitriptyline|perphenazine|.	125116	0.0	11
``|recptor|unit|''|gamma-aminobutyric|acid|-lrb-|gaba|-rrb-|,|include|brainlike|receptor|binding|site|tritium-labeled|gaba|benzodiazepine|-lrb-|diazepam|,|clonazepam|,|COMPOUND_ENTITY|-rrb-|thermostable|endogenous|protein|-lrb-|gaba|modulin|-rrb-|inhibit|gaba|benzodiazepine|binding|,|demonstrate|membrane|prepare|nb2a|DISEASE_ENTITY|neuroblastoma|c6|glioma|clonal|cell|line|.	125335	0.0	11
-lsb-|glucose|assimilation|high-dose|COMPOUND_ENTITY|therapy|DISEASE_ENTITY|adenocarcinoma|corpus|uteri|-rsb-|.	125434	1.0	11
value|electrocardiogram|assess|infarct|size|study|use|serial|estimate|MB|isomer|COMPOUND_ENTITY|kinase|-lrb-|ck|mb|-rrb-|plasma|,|serial|35|lead|praecordial|map|28|patient|DISEASE_ENTITY|anterior|myocardial|infarction|,|serial|12|lead|electrocardiogram|17|patient|inferior|myocardial|infarction|.	125474	0.0	10
period|sternotomy|revascularization|,|patient|anesthetized|morphine|-lrb-|mean|2.1|mg/kg|-rrb-|significant|-lrb-|p|.05|-rrb-|increase|rate-pressure|product|,|tension-time|index|,|blood|pressure|,|heart|rate|,|relative|DISEASE_ENTITY|ischemia|,|evidence|significant|st-segment|depression|v5|lead|EKG|decrease|diastolic|pressure-time|index/tension-time|index|compare|patient|anesthetized|COMPOUND_ENTITY|-lrb-|mean|.75|cent|inspire|-rrb-|.	125932	0.0	11
effect|COMPOUND_ENTITY|response|muscle|DISEASE_ENTITY|5-ht|ach|similar|respective|change|induce|lower|calcium|concentration|,|reduce|addition|calcium|.	126219	0.0	11
differential|effect|dimethylsulfoxide|COMPOUND_ENTITY|synthetase|rat|liver|DISEASE_ENTITY|hepatoma|.	126232	0.0	11
-lsb-|blood|serum|concentration|long-acting|COMPOUND_ENTITY|patient|form|DISEASE_ENTITY|schizophrenia|-rsb-|.	126399	0.0	10
open|trial|COMPOUND_ENTITY|conduct|18|male|aged|18-68|year|-lrb-|mean|42.7|-rrb-|22|female|aged|23-70|year|-lrb-|mean|47.5|-rrb-|Lagos|University|Teaching|Hospital|DISEASE_ENTITY|hypertension|Clinic|.	161192	0.0	10
effect|COMPOUND_ENTITY|chloride|-lrb-|slow-k|600|mg|time|daily|-rrb-|spironolactone|-lrb-|Aldactone|A|25|mg|time|daily|-rrb-|compare|DISEASE_ENTITY|hypertensive|african|patient|frusemide|.	161220	0.0	10
regression|DISEASE_ENTITY|hypertension|therapy|COMPOUND_ENTITY|case|parallel|return|normal|exocrine|pancreatic|function|.	161410	1.0	11
result|indicate|intramuscularly|administer|COMPOUND_ENTITY|exert|convulsant|effect|cortical|structure|absence|subcortical|connection|,|generalize|DISEASE_ENTITY|epileptiform|activity|normal|animal|dependent|thalamocortical|connection|.	161517	0.0	10
COMPOUND_ENTITY|similar|experiment|significant|depression|intake|0.125|microgram/kg|,|50|%|DISEASE_ENTITY|depression|0.28|microgram/kg|,|intake|5.0|microgram/kg|.	161937	0.0	10
test|latency|DISEASE_ENTITY|lethality|associate|electroshock|sensitive|COMPOUND_ENTITY|.	162488	0.0	11
finding|indicate|treatment|COMPOUND_ENTITY|useful|DISEASE_ENTITY|osteoporosis|age|follow|corticosteroid|administration|.	162500	1.0	10
effect|arachidonic|acid|COMPOUND_ENTITY|vitro|release|prostaglandin|aortic|strip|spontaneously|DISEASE_ENTITY|hypertensive|rat|.	162528	0.0	10
COMPOUND_ENTITY|treatment|DISEASE_ENTITY|hypertension|.	162604	1.0	10
effect|indomethacin|COMPOUND_ENTITY|experimental|DISEASE_ENTITY|asthma|conscious|guinea|pig|.	162628	0.0	10
141|patient|DISEASE_ENTITY|infarction|,|COMPOUND_ENTITY|phosphokinase|isoenzyme|-lrb-|cpk-mb|-rrb-|determine|activation|method|dithiothreitol|-lrb-|rao|et|al.|:|clin|.	162770	0.0	10
introduction|antimicrobial|therapy|COMPOUND_ENTITY|cause|fall|serum|dph|level|recurrence|DISEASE_ENTITY|seizure|,|time|serum|gammagt|value|increase|.	162858	0.0	10
relief|acute|DISEASE_ENTITY|attack|analgesic/antihistamine|combination|contain|paracetamol|,|codeine|phosphate|,|doxylamine|succinate|COMPOUND_ENTITY|-lrb-|mersyndol|-rrb-|compare|achieve|placebo|study|double-blind|,|crossover|trial|.	163156	1.0	11
,|isomer|COMPOUND_ENTITY|exert|dose-related|antiepileptic|effect|established|kindle|DISEASE_ENTITY|convulsion|provoke|electrical|stimulation|amygdala|species|.	163202	1.0	11
metabolism|COMPOUND_ENTITY|study|12|patient|DISEASE_ENTITY|gastric|carcinoma|5|control|subject|peptic|ulcer|match|sex|,|body|weight|,|height|,|smoking|history|.	163219	0.0	11
patient|parapsoriasis|en|plaque|-lrb-|pep|-rrb-|,|DISEASE_ENTITY|fungoide|-lrb-|mf|-rrb-|,|s|zary|syndrome|-lrb-|ss|-rrb-|bath|small|COMPOUND_ENTITY|solution|add|,|expose|ultraviolet|-lrb-|uv|-rrb-|radiation|bank|dysprosium|lamp|.	163313	0.0	10
patient|parapsoriasis|en|plaque|-lrb-|pep|-rrb-|,|mycosis|fungoide|-lrb-|DISEASE_ENTITY|-rrb-|,|s|zary|syndrome|-lrb-|ss|-rrb-|bath|small|COMPOUND_ENTITY|solution|add|,|expose|ultraviolet|-lrb-|uv|-rrb-|radiation|bank|dysprosium|lamp|.	163318	0.0	10
comparison|COMPOUND_ENTITY|excess|thymidine|synchronize|agent|culture|l5178y|DISEASE_ENTITY|mouse|lymphoma|cell|.	163356	0.0	10
microsomal|enzyme|patient|DISEASE_ENTITY|carcinoma|determine|plasma|half-life|COMPOUND_ENTITY|.	163466	0.0	11
COMPOUND_ENTITY|dehydrogenase|estrogen-responsive|human|DISEASE_ENTITY|breast|cancer|cell|.	163488	0.0	10
similarily|,|mean|metabolic|clearance|rate|COMPOUND_ENTITY|significantly|lower|-lrb-|22.8|+|/|-|5.0|ml/hr/kg|-rrb-|patient|disseminate|DISEASE_ENTITY|gastric|carcinoma|compare|control|subject|-lrb-|52.6|+|/|-|13.4|ml/hr/kg|-rrb-|-lrb-|p|0.02|-rrb-|.	163516	0.0	11
respect|focal|DISEASE_ENTITY|cerebral|cortex|induce|local|application|COMPOUND_ENTITY|,|l-5418|suppressive|effect|frequency|duration|seizure|discharge|,|spread|seizure|discharge|brain|.	163740	0.0	10
study|bactericidal|power|antibiotic|combination|18|strain|staphylococcus|aureus|cause|DISEASE_ENTITY|combination|synergistic|indifferent|:|rifampicin|+|lincomycin|synergistine|,|COMPOUND_ENTITY|+|fusidic|acid|,|synergistine|+|fusidic|acid|trimethoprim-sulphamethoxazole|,|cephalosporin|+|gentamycin|,|rifampicin|fusidic|acid|+|gentamycin|,|trimethoprim-sulphamethoxazole|+|rifampicin|fusidic|acid|.	163791	0.0	11
study|bactericidal|power|antibiotic|combination|18|strain|staphylococcus|aureus|cause|DISEASE_ENTITY|combination|synergistic|indifferent|:|rifampicin|+|lincomycin|synergistine|,|rifampicin|+|fusidic|acid|,|synergistine|+|fusidic|acid|trimethoprim-sulphamethoxazole|,|cephalosporin|+|gentamycin|,|rifampicin|fusidic|acid|+|gentamycin|,|trimethoprim-sulphamethoxazole|+|COMPOUND_ENTITY|fusidic|acid|.	163801	0.0	11
pharmacokinetic|COMPOUND_ENTITY|oral|intravenous|administration|study|DISEASE_ENTITY|hypertensive|normotensive|patient|.	164254	0.0	10
datum|liberation|COMPOUND_ENTITY|amine|DISEASE_ENTITY|schizophrenia|displacement|noradrenaline|schizophrenia|isadrine|,|accumulate|normal|storage|site|,|suggest|storage|noradrenaline|impaired|schizophrenia|.	164295	0.0	10
datum|liberation|noradrenaline|amine|schizophrenia|displacement|COMPOUND_ENTITY|schizophrenia|isadrine|,|accumulate|normal|storage|site|,|suggest|storage|noradrenaline|impaired|DISEASE_ENTITY|schizophrenia|.	164320	0.0	10
immunological|method|determine|COMPOUND_ENTITY|isoenzyme|mb|differential-diagnostic|value|DISEASE_ENTITY|myocardial|infarction|.	164318	0.0	10
triamcinolone|acetonide|,|COMPOUND_ENTITY|methotrexate|,|know|useful|clinically|treatment|DISEASE_ENTITY|psoriasis|,|examine|ability|antagonize|development|retinoic-acid-induced|scaling|.	164394	1.0	10
-lsb-|lue|iii|-lrb-|follow|6-year-long|treatment|lues|ii|16|mega|COMPOUND_ENTITY|chronic|alcohol|abuse|DISEASE_ENTITY|psoriasis|-rsb-|.	164571	1.0	11
severe|DISEASE_ENTITY|ingestion|appetite|suppressant|-lrb-|phenylpropanolamine|-rrb-|COMPOUND_ENTITY|.	164642	0.0	10
study|design|evaluate|effect|COMPOUND_ENTITY|,|new|cardioselective|beta|adrenergic|agonist|,|cardiac|performance|myocardial|injury|patient|evolve|DISEASE_ENTITY|myocardial|infarction|.	165441	0.0	10
sympathetic|nervous|function|renin|activity|DISEASE_ENTITY|long|term|drug|treatment|propranolol|,|COMPOUND_ENTITY|bendrofluazide|.	165514	1.0	10
percent|lymphocyte|stain|COMPOUND_ENTITY|label|goat|anti-human|immunoglobulin|antisera|increase|DISEASE_ENTITY|sle|patient|-lrb-|35-9|+|/|-|20-2|vs|21-7|+|/|-|5-9|control|,|p|=|0-02|-rrb-|.	165716	0.0	11
70|year|old|male|develop|marrow|aplasia|pancytopenia|receive|10|mg|COMPOUND_ENTITY|intravenously|period|5|day|DISEASE_ENTITY|acute|gouty|arthritis|.	165775	1.0	11
activity|Krebs|cycle|enzyme|,|especially|nad-dependent|enzyme|inhibit|DISEASE_ENTITY|liver|terminal|period|growth|spontaneous|transplant|tumour|;|COMPOUND_ENTITY|dehydrogenase|activity|increase|-lrb-|exception|mitochondrial|lactate|dehydrogenase|rat|liver|transplant|sarcoma|-rrb-|.	165882	0.0	10
fluphenazine|decanoate|COMPOUND_ENTITY|enanthate|out-patient|management|chronic|DISEASE_ENTITY|schizophrenia|.	165906	0.0	10
-lsb-|intermittent|low|dose|COMPOUND_ENTITY|prednisone|multiple|DISEASE_ENTITY|myeloma|-rsb-|.	165947	0.0	10
DISEASE_ENTITY|dilation|produce|COMPOUND_ENTITY|unaltered|isosorbide|dinitrate|,|venodilation|significantly|attenuate|.	166005	0.0	10
-lsb-|urinary|excretion|vanilmandelic|acid|rat|experimental|DISEASE_ENTITY|,|treat|alpha|COMPOUND_ENTITY|-rsb-|.	166094	1.0	10
comparison|guanethidine|COMPOUND_ENTITY|essential|DISEASE_ENTITY|hypertension|:|controlled|study|.	166116	0.0	10
-lsb-|significance|COMPOUND_ENTITY|kinase|isoenzyme|mb|diagnosis|DISEASE_ENTITY|myocardial|infarct|coronary|surgery|-rsb-|.	166202	0.0	10
therapeutic|efficacy|antihypertensive|regimen|-lrb-|minoxidil|,|propranolol|,|hydrochlorothiazide|;|propranolol|hydrochlorothiazide|;|COMPOUND_ENTITY|hydroch-orothiazide|;|hydrochlorothiazide|-rrb-|evaluate|child|systolic|DISEASE_ENTITY|hypertension|child|systolic|diastolic|hypertension|.	166240	0.0	10
significant|difference|mean|COMPOUND_ENTITY|half-life|9|patient|localized|DISEASE_ENTITY|gastric|carcinoma|control|subject|.	166250	0.0	11
close|intraarterial|infusion|COMPOUND_ENTITY|papaverine|cause|prominent|DISEASE_ENTITY|tracheal|dilatation|,|suppress|cough|.	166300	0.0	10
COMPOUND_ENTITY|concentration|blood|,|urine|,|renal|tissue|patient|DISEASE_ENTITY|end-stage|renal|disease|.	166322	0.0	11
combination|chemotherapy|mopp-resistant|DISEASE_ENTITY|disease|adriamycin|,|bleomycin|,|dacarbazine|COMPOUND_ENTITY|-lrb-|abdv|-rrb-|.	166459	1.0	10
-lsb-|treatment|refractory|threatening|DISEASE_ENTITY|syndrome|injectable|COMPOUND_ENTITY|-rsb-|.	166470	1.0	11
1|use|standardized|form|mental|stress|,|21|patient|idiopathic|DISEASE_ENTITY|investigate|treatment|placebo|-lrb-|n|=|8|-rrb-|,|propranolol|-lrb-|n|=|7|-rrb-|COMPOUND_ENTITY|-lrb-|n|=|6|-rrb-|.	166648	1.0	10
effect|COMPOUND_ENTITY|sodium|diazepam|compare|double|crossover|study|42|patient|spasticity|stable|DISEASE_ENTITY|multiple|sclerosis|.	166740	0.0	11
Budralazine|orally|effective|type|DISEASE_ENTITY|rat|,|like|COMPOUND_ENTITY|unlike|hydralazine|,|produce|greater|pressure|reduction|hypertensive|normotensive|rat|.	167095	0.0	10
double-blind|placebo-controlled|trial|COMPOUND_ENTITY|dermatophagoide|pteronyssinus|vaccine|improvement|45|patient|DISEASE_ENTITY|asthma|sensitive|house|dust|mite|.	167942	0.0	11
urinary|gsa|increase|uremic|patient|-lrb-|30.5|+|/|-|12.9|mg/day|-rrb-|compare|normal|subject|-lrb-|7.5|+|/|-|1.9|mg/day|-rrb-|,|greater|DISEASE_ENTITY|patient|normal|subject|level|protein|intake|,|directly|correlate|protein|intake|urinary|COMPOUND_ENTITY|total|nitrogen|normal|uremic|subject|.	168260	0.0	11
double-blind|study|carry|compare|effect|COMPOUND_ENTITY|phenylbutazone|DISEASE_ENTITY|acute|gouty|arthritis|.	168282	0.0	11
spontaneous|-lrb-|slt|-rrb-|phytochemagglutinin|-lrb-|pha|-rrb-|stimulate|lymphocyte|transformation|study|DISEASE_ENTITY|sclerosis|-lrb-|ms|-rrb-|patient|suffer|acute|exacerbation|chronic|progressive|type|MS.|change|cell-mediated|immunity|observe|,|immunosuppressive|-lrb-|COMPOUND_ENTITY|-rrb-|treatment|.	168326	0.0	10
treatment|chondroitin|sulfate|isolate|culture|b16|mouse|DISEASE_ENTITY|cell|0.04|m|hcl|100|degree|c|90|min|release|45|%|o-sulfate|residue|free|inorganic|COMPOUND_ENTITY|.	168374	0.0	11
,|COMPOUND_ENTITY|60|mg|preparation|choice|coronary|heart|disease|accompany|tachyarrhythmic|DISEASE_ENTITY|hyperkinetic|symptom|.	168505	1.0	11
anticancer|drug|cell|cycle|phase-specific|characteristic|-lrb-|azathioprine|,|cytosine|arabinoside|,|COMPOUND_ENTITY|,|vincristine|-rrb-|individually|use|treat|12|patient|DISEASE_ENTITY|multiple|myeloma|partial|remission|-lrb-|ie|,|greater|equal|50|%|reduction|tumor|cell|number|-rrb-|cell|cycle|nonspecific|chemotherapy|.	168583	1.0	10
serial|pulmonary|function|test|include|single-breath|carbon|monoxide-diffusing|capacity|-lrb-|dlco|-rrb-|,|force|vital|capacity|-lrb-|fvc|-rrb-|,|force|expiratory|volume|1|sec|perform|relatively|homogeneous|group|male|patient|DISEASE_ENTITY|tumor|treat|COMPOUND_ENTITY|,|bleomycin|,|cis-diamminedichloroplatinum|.	168769	1.0	10
COMPOUND_ENTITY|administration|,|monitor|pharmacy-controlled|program|,|employ|38|subject|6-month|period|prevent|amphetamine-type|drug|abuse|,|manner|disulfiram|program|employ|DISEASE_ENTITY|alcohol|abuse|.	168877	0.0	10
patient|bronchial|asthma|undergo|long-term|corticosteroid|treatment|patient|DISEASE_ENTITY|osteoporosis|oral|dose|COMPOUND_ENTITY|d3|-lrb-|1alpha-oh-d3|-rrb-|calcium|.	169007	0.0	10
10-fold|stimulation|COMPOUND_ENTITY|polymerization|result|addition|poly|-lrb-|u|-rrb-|ribosome|zajdela|DISEASE_ENTITY|hepatoma|2-fold|enhancement|find|use|ribosome|normal|host|liver|.	169611	0.0	11
accumulate|COMPOUND_ENTITY|kinase|mb|isoenzyme|release|-lrb-|sigma|ck-mb|-rrb-|acute|myocardial|infarction|correlate|biplane|leave|ventricular|-lrb-|lv|-rrb-|angiographic|estimate|percent|abnormally|contract|segment|-lrb-|%|acs|-rrb-|ejection|fraction|-lrb-|ef|-rrb-|35|patient|undergo|diagnostic|angiography|mean|33|+|/|-|4|day|post|myocardial|infarction|-lrb-|DISEASE_ENTITY|mi|-rrb-|.	169630	0.0	10
subcortical|cortical|structure|prior|COMPOUND_ENTITY|elicit|spindle|activity|recruiting|response|significantly|effective|trigger|generalize|DISEASE_ENTITY|epileptic|burst|penicillin|injection|.	169697	0.0	10
add|sufficient|urea|dialysate|prevent|fall|plasma|COMPOUND_ENTITY|concentration|,|eliminate|increase|sensitivity|co2|DISEASE_ENTITY|uremic|patient|goat|.	169750	0.0	11
-lsb-|COMPOUND_ENTITY|treatment|DISEASE_ENTITY|hypertension|-rsb-|.	169958	1.0	10
DISEASE_ENTITY|motility|couple|decrease|cellular|concentration|COMPOUND_ENTITY|triphosphate|decline|oxygen|consumption|,|uncoupling|agent|immediately|destroy|motility|time|.	169982	0.0	11
-lsb-|COMPOUND_ENTITY|treatment|patient|DISEASE_ENTITY|ischemic|heart|disease|-rsb-|.	170090	1.0	11
Carbamazepine|,|diazepam|phenytoin|effective|block|DISEASE_ENTITY|cause|COMPOUND_ENTITY|-lrb-|delta9thc|-rrb-|.	170091	0.0	11
Carbamazepine|,|diazepam|phenytoin|effective|block|DISEASE_ENTITY|cause|delta9tetrahydrocannabinol|-lrb-|COMPOUND_ENTITY|-rrb-|.	170095	0.0	11
effect|COMPOUND_ENTITY|DISEASE_ENTITY|gastric|mucosa|examine|seven|healthy|volunteer|.	170173	0.0	10
COMPOUND_ENTITY|treatment|patient|DISEASE_ENTITY|hypertension|renal|functional|impairment|.	170240	1.0	10
analysis|urea|metabolism|oral|administration|aminoglycoside|antibiotic|demonstrate|nitrogen|derive|COMPOUND_ENTITY|use|DISEASE_ENTITY|uremic|patient|amino|acid|synthesis|.	170308	0.0	11
magnesium|deficiency|occur|congestive|heart|failure|,|diuresis|furoxemide|,|COMPOUND_ENTITY|acid|mercurial|,|digitalis|intoxication|,|DISEASE_ENTITY|diabetic|acidosis|,|acute|chronic|alcoholism|,|delerium|tremen|,|cirrhosis|,|malabsorption|syndrome|,|protracted|postoperative|case|,|open|heart|surgery|,|diuretic|phase|acute|tubular|necrosis|,|hypoparathyroidism|,|primary|aldosteronism|,|juxta-glomerular|hyperplasia|pancreatitis|.	170400	0.0	10
original|study|Patak|et|al.|1975|reveal|antihypertensive|natriuretic|effect|furosemide|markedly|blunt|abrogate|COMPOUND_ENTITY|normotensive|hypertensive|man|,|postulate|ameliorative|effect|furosemide|human|essential|DISEASE_ENTITY|hypertension|mediate|release|intrarenal|prostaglandin|.	170468	0.0	10
DISEASE_ENTITY|maturity|onset|diabetic|,|hand|,|ketone|body|disappearance|rate|remain|abnormally|low|treatment|COMPOUND_ENTITY|.	170569	0.0	11
moderate|DISEASE_ENTITY|:|treatment|guanethidine|COMPOUND_ENTITY|.	170736	1.0	10
additional|single-blind|study|patient|severe|DISEASE_ENTITY|,|dependent|COMPOUND_ENTITY|dose|20|25|mg/d|,|response|beclomethasone|variable|significant|-lrb-|p|<|0.01|-rrb-|.	170890	0.0	10
disodium|cromoglycate|dose|employ|greatly|inferior|COMPOUND_ENTITY|maintenance|treatment|prevention|relapse|DISEASE_ENTITY|ulcerative|colitis|.	170952	1.0	10
pathophysiology|antibiotic-associated|colitis|study|rabbit|severe|DISEASE_ENTITY|induce|oral|administration|COMPOUND_ENTITY|.	171305	0.0	10
-lsb-|double-blind|trial|:|COMPOUND_ENTITY|versus|phenylbutazone|DISEASE_ENTITY|acute|gouty|arthritis|-lrb-|author|transl|-rrb-|-rsb-|.	171369	0.0	11
gastrointestinal|bacterium|think|DISEASE_ENTITY|uremic|patient|provide|internal|source|nitrogen|degrade|COMPOUND_ENTITY|function|alternative|means|clear|waste|product|.	171383	0.0	11
effect|cytostatic|drug|use|treatment|DISEASE_ENTITY|disease|:|cerubidin|,|COMPOUND_ENTITY|.	171420	1.0	10
agent|active|NA|kcl|response|,|effective|na|COMPOUND_ENTITY|response|aortae|DISEASE_ENTITY|hypertensive|animal|.	171437	0.0	10
-lsb-|hemodynamic|change|induce|COMPOUND_ENTITY|basic|condition|pressor|test|essential|DISEASE_ENTITY|hypertension|-rsb-|.	171772	0.0	10
COMPOUND_ENTITY|DISEASE_ENTITY|amyotrophic|lateral|sclerosis|.	172002	0.0	10
activity|pituitary|hormone|-lrb-|acth|,|sth|,|tth|,|fsh|,|lh|-rrb-|,|adrenal|hormone|-lrb-|cortisol|,|aldosterone|-rrb-|,|kidney|hormone|-lrb-|renin|-rrb-|,|thyroid|hormone|-lrb-|thyroxine|tri-iodthyronine|-rrb-|,|thyroxine|binding|capacity|blood|protein|activity|hormone|pancreas|-lrb-|insulin|-rrb-|sex|gland|-lrb-|testosterone|,|COMPOUND_ENTITY|-rrb-|study|26|male|suffer|ischemic|heart|disease|verify|means|selective|coronarography|20|healthy|male|DISEASE_ENTITY|atherosclerosis|coronary|artery|heart|.	172157	0.0	11
forty-nine|DISEASE_ENTITY|outpatient|stabilize|oral|antipsychotic|medication|procyclidine|receive|12.5|mg|18.75|mg|COMPOUND_ENTITY|enanthate|fluphenazine|decanoate|examine|extrapyramidal|effect|week|later|.	172361	0.0	10
renal|COMPOUND_ENTITY|-lrb-|pah|-rrb-|clearance|predict|16|kidney|DISEASE_ENTITY|hypertensive|patient|renal|artery|stenosis|,|pyelonephritis|,|obstructive|nephropathy|,|individual|ureteral|catheterization|.	172421	0.0	10
higher|dose|pilocarpine|,|increase|COMPOUND_ENTITY|threshold|DISEASE_ENTITY|convulsion|induce|pilocarpine|treatment|.	172456	0.0	10
31|month|old|child|develop|DISEASE_ENTITY|30|minute|accidental|ingestion|toxic|quantity|COMPOUND_ENTITY|acid|.	172574	0.0	11
blockade|prostaglandin|synthesis|COMPOUND_ENTITY|-lrb-|1|-rrb-|induce|significant|change|blood|pressure|renal|circulation|renovascular|hypertensive|rabbit|normal|renal|blood|flow|;|-lrb-|2|-rrb-|induce|renal|insufficiency|aggravate|DISEASE_ENTITY|hypertension|hypertensive|rabbit|renal|blood|flow|normal|level|;|-lrb-|3|-rrb-|alter|reversal|renovascular|hypertension|produce|release|renal|arterial|constriction|;|-lrb-|4|-rrb-|induce|decrease|plasma|renin|activity|decrease|renin|release|.	172721	0.0	10
Methyldopate|,|ethyl|ester|hydrochloride|salt|COMPOUND_ENTITY|-lrb-|alpha-md|-rrb-|,|use|extensively|treatment|severe|DISEASE_ENTITY|hypertension|.	172736	1.0	10
non-blind|randomize|comparison|sotalol|hydrochloride|COMPOUND_ENTITY|essential|DISEASE_ENTITY|hypertension|,|drug|equivocal|effect|reach|preset|hypotensive|aim|,|maximum|decrease|baseline|mean|reduction|week|baseline|.	172773	0.0	10
DISEASE_ENTITY|cancer|treat|medroxyprogesterone|acetate|COMPOUND_ENTITY|propionate|,|little|success|.	172823	1.0	11
,|marked|contrast|previous|study|,|COMPOUND_ENTITY|gradient|ultracentrifugal|analysis|strongly|precipitate|serum|reveal|DISEASE_ENTITY|mcrf|precipitate|material|sedimenting|monomeric|igg|position|.	172833	0.0	10
series|26|patient|DISEASE_ENTITY|spondylitis|include|double-blind|cross-over|comparison|COMPOUND_ENTITY|200|mg|daily|phenylbutazone|300|mg|daily|,|drug|4|week|,|paracetamol|`|rescue|drug|'|.	172846	0.0	10
peripheral|blood|t|cell|patient|DISEASE_ENTITY|erythematosus|-lrb-|sle|-rrb-|age|-|sex-matched|control|study|flow|microfluorometry|use|sle|anti-cell|antibody|COMPOUND_ENTITY|conjugate|antibody|human|igm|.	172847	0.0	11
peripheral|blood|t|cell|patient|systemic|lupus|erythematosus|-lrb-|sle|-rrb-|age|-|sex-matched|control|study|flow|microfluorometry|use|DISEASE_ENTITY|anti-cell|antibody|COMPOUND_ENTITY|conjugate|antibody|human|igm|.	172858	0.0	11
cannabidiol|effective|block|DISEASE_ENTITY|concurrently|,|prior|COMPOUND_ENTITY|.	173020	0.0	11
20|mm|op|induce|small|DISEASE_ENTITY|contraction|amplitude|loss|wet|weight|10|%|similar|osmotic|effect|pentanoic|acid|COMPOUND_ENTITY|.	173065	0.0	10
June|19|,|1975|December|22|,|1976|,|twenty-seven|patient|advanced|DISEASE_ENTITY|disease|fail|MOPP|-lrb-|nitrogen|mustard|,|vincristine|,|procarbazine|prednisone|-rrb-|treat|adriamycin|,|bleomycin|,|COMPOUND_ENTITY|,|imidazole|carboxamide|,|-lrb-|abvd|-rrb-|.	173484	1.0	10
patient|DISEASE_ENTITY|disease|stage|iia|,|treat|COMPOUND_ENTITY|,|arterial|tone|pressure|decrease|,|venous|tone|significantly|increase|-lrb-|normalize|-rrb-|.	173722	1.0	10
COMPOUND_ENTITY|severe|DISEASE_ENTITY|hypertension|effect|blood|pressure|,|plasma|renin|activity|hypertensive|emergency|.	173777	0.0	10
effect|COMPOUND_ENTITY|patient|DISEASE_ENTITY|acute|myocardial|infarction|.	173804	0.0	10
plasma|COMPOUND_ENTITY|level|seven|untreated|manic-depressive|patient|DISEASE_ENTITY|manic|phase|compare|untreated|schizoaffective|patient|excited|phase|18|control|.	212364	0.0	10
erythroleukemia|follow|COMPOUND_ENTITY|therapy|multiple|DISEASE_ENTITY|myeloma|.	212513	1.0	10
antineoplastic|agent|propose|currently|use|human|brain|tumor|,|include|1,3-bis|-lrb-|2-chloroethyl|-rrb-|-1|-|nitrosourea|-lrb-|bcnu|-rrb-|,|COMPOUND_ENTITY|,|aziridinylbenzoquinone|-lrb-|azq|-rrb-|,|cis-platinum|,|acivicin|,|administer|intravenously|-lrb-|iv|-rrb-|,|intraperitoneally|-lrb-|ip|-rrb-|,|intracerebrally|-lrb-|ic|-rrb-|rat|burden|intracranial|9l|DISEASE_ENTITY|gliosarcoma|.	212531	0.0	10
-lsb-|effect|reserpine|,|octadine|COMPOUND_ENTITY|distribution|cardiac|output|DISEASE_ENTITY|hypertension|-rsb-|.	212650	0.0	10
activity|chronic|DISEASE_ENTITY|patient|:|comparison|pimozide|COMPOUND_ENTITY|double|blind|trial|.	212674	0.0	10
content|erythrocyte|2,3|diphosphoglycerate|COMPOUND_ENTITY|triphosphate|DISEASE_ENTITY|myelomatosis|leukaemia|.	212715	0.0	11
content|erythrocyte|2,3|diphosphoglycerate|COMPOUND_ENTITY|triphosphate|myelomatosis|DISEASE_ENTITY|leukaemia|.	212719	0.0	11
superficial|glomerulus|anesthetized|munich-wistar|rat|rapidly|fix|situ|drip|COMPOUND_ENTITY|renal|surface|,|igg|catalase|largely|confine|glomerular|capillary|lumen|,|small|lamina|rara|interna|immediately|beneath|endothelial|fenestrae|,|deeper|basement|membrane|-lrb-|DISEASE_ENTITY|gbm|-rrb-|urinary|space|.	212717	0.0	11
patient|moderate|severe|DISEASE_ENTITY|respond|particularly|polythiazide|add|prazosin|,|continue|receive|COMPOUND_ENTITY|comparable|period|improvement|.	212859	0.0	10
low|dose|COMPOUND_ENTITY|,|affect|respond|control|rat|,|significantly|DISEASE_ENTITY|depressed|respond|rat|brain|dopamine|reduce|.	213214	0.0	10
electrophysiological|effect|orally|administer|COMPOUND_ENTITY|-lrb-|600|mg|daily|8|day|-rrb-|evaluate|use|bundle|electrogram|,|extrastimulus|method|atrial|pacing|16|patient|proved|DISEASE_ENTITY|ischemic|heart|disease|.	213278	0.0	11
combination|dfd-py|weekly|effective|chemosuppressive|falciparum|vivax|parasitmia|,|cause|fourfold|reduction|falciparum|approximately|threefold|reduction|vivax|parasitemia|;|,|combination|efficacious|COMPOUND_ENTITY|chemosuppression|falciparum|DISEASE_ENTITY|malaria|.	213386	1.0	10
alpha-chloralose|,|50|mg/kg|,|inject|intraperitoneally|produce|model|stimulus-sensitive|myoclonus|COMPOUND_ENTITY|g|,|350,000|units/kg|,|inject|intramuscularly|produce|model|petit|DISEASE_ENTITY|mal|epilepsy|.	213462	0.0	10
Proceedings|:|inhale|corticosteroid|compare|oral|COMPOUND_ENTITY|DISEASE_ENTITY|asthmatic|patient|commence|regular|corticosteroid|.	213491	0.0	10
effect|timolol|COMPOUND_ENTITY|,|combine|fix|ratio|4:1|,|blood|pressure|,|plasma|renin|activity|,|plasma|potassium|concentration|,|investigate|normotensive|renal|hypertensive|dog|,|normotensive|spontaneously|DISEASE_ENTITY|hypertensive|rat|.	213562	0.0	10
serial|measurement|serum|COMPOUND_ENTITY|phosphokinase|-lrb-|cpk|-rrb-|alpha-hydroxybutyrate|dehydrogenase|-lrb-|hbd|-rrb-|activity|17|patient|DISEASE_ENTITY|acute|myocardial|infarction|.	213571	0.0	10
motility|normal|DISEASE_ENTITY|lymphocyte|decrease|cytochalasin|b|increase|colchicine|,|vincristine|,|COMPOUND_ENTITY|.	213704	0.0	10
fatal|pancytopenia|occur|patient|history|depression|hypomanic|rebound|,|admit|DISEASE_ENTITY|episode|treat|COMPOUND_ENTITY|,|diazepam|lithium|carbonate|.	213827	0.0	11
treatment|spasticity|DISEASE_ENTITY|sclerosis|:|comparison|COMPOUND_ENTITY|sodium|diazepam|.	214230	1.0	11
-lsb-|DISEASE_ENTITY|disease|malabsorption|COMPOUND_ENTITY|k|severe|gastrointestinal|hemorrhage|-rsb-|.	214241	0.0	11
effect|immunotherapy|DISEASE_ENTITY|asthma|:|treatment|mite|extract|absorb|COMPOUND_ENTITY|.	214597	0.0	11
standardized|test|renin|responsiveness|,|employ|dual|stimulus|upright|posture|loop|diuretic|furosemide|,|apply|19|DISEASE_ENTITY|patient|untreated|state|therapy|antihypertensive|agent|guanethidine|COMPOUND_ENTITY|.	214741	0.0	10
skin|lesion|patient|DISEASE_ENTITY|erythematosus|,|patient|discoid|lupus|erythematosus|,|patient|systemic|sclerosis|,|patient|localized|morphoea|control|examine|immunohistological|technique|use|COMPOUND_ENTITY|anti-human|igg|,|anti-human|c3|anti-human|renal|glomerulus|antisera|.	214749	0.0	11
experiment|cat|nembutal|anesthesia|lesion|medial|forebrain|bundle|-lrb-|mfb|-rrb-|partly|preoptic|region|local|penicillin|application|cerebral|cortex|-lrb-|g.|suprasylvius|medius|-rrb-|result|depression|DISEASE_ENTITY|activity|COMPOUND_ENTITY|focus|,|secondary|``|mirror|''|focus|,|appear|symmetrical|cortex|area|hemisphere|.	214779	0.0	10
chronic|treatment|age|4|16|week|hydrallazine|,|combination|COMPOUND_ENTITY|,|ad|libitum|drinking|water|,|prevent|development|DISEASE_ENTITY|hypertension|sh-rat|reduce|vascular|reactivity|na|5-ht|isolate|vessel|preparation|treat|compare|control|rat|.	215015	0.0	10
action|COMPOUND_ENTITY|DISEASE_ENTITY|acute|gouty|arthritis|.	215370	0.0	11
arginase|activity|erythrocyte|membrane|fragment|determine|normal|subject|group|DISEASE_ENTITY|patient|:|1|-rrb-|blood|COMPOUND_ENTITY|concentration|100|mgm/100|ml|higher|elevated|erythrocyte|sodium|concentration|2|-rrb-|patient|blood|urea|concentration|100|mgm/100|ml|higher|normal|erythrocyte|sodium|concentration|.	215509	0.0	11
arginase|activity|erythrocyte|membrane|fragment|determine|normal|subject|group|DISEASE_ENTITY|patient|:|1|-rrb-|blood|urea|concentration|100|mgm/100|ml|higher|elevated|erythrocyte|sodium|concentration|2|-rrb-|patient|blood|COMPOUND_ENTITY|concentration|100|mgm/100|ml|higher|normal|erythrocyte|sodium|concentration|.	215513	0.0	11
DISEASE_ENTITY|patient|airway|obstruction|improve|significantly|trial|COMPOUND_ENTITY|study|detail|.	215579	1.0	10
COMPOUND_ENTITY|,|procarbazine|,|cytosine|arabinoside|combination|reinduction|childhood|acute|DISEASE_ENTITY|myelocytic|leukemia|.	215763	1.0	10
COMPOUND_ENTITY|DISEASE_ENTITY|hypertension|:|present|status|.	215801	0.0	10
preparation|obtain|DISEASE_ENTITY|rat|,|response|higher|dose|noradrenaline|angiotensin|initially|greater|normotensive|rat|reduce|greater|extent|infusion|COMPOUND_ENTITY|,|abolish|release|prostaglandin|e-like|activity|.	216087	0.0	10
experience|neonate|disorder|circulatory|adjustment|birth|follow|prenatal|exposure|COMPOUND_ENTITY|indicate|indomethacin|interfere|adjustment|man|favor|development|oxygen|dependency|know|DISEASE_ENTITY|primary|pulmonary|hypertension|newborn|.	216149	0.0	10
experience|neonate|disorder|circulatory|adjustment|birth|follow|prenatal|exposure|indomethacin|indicate|COMPOUND_ENTITY|interfere|adjustment|man|favor|development|oxygen|dependency|know|DISEASE_ENTITY|primary|pulmonary|hypertension|newborn|.	216152	0.0	10
alp|isozyme|fl|cell|property|common|DISEASE_ENTITY|alp|regard|COMPOUND_ENTITY|sensitivity|,|inhibition|ethylenediaminetetraacetate|,|inactivation|urea|,|antigen|site|,|differ|electrophoretic|mobility|,|sensitivity|l-leucine|l-homoarginine|,|presence|antigen|site|.	216209	0.0	11
hemodynamic|effect|intravenous|administration|22|mg|free|base|imipramine|COMPOUND_ENTITY|investigate|12|patient|DISEASE_ENTITY|coronary|disease|.	216332	0.0	10
experience|COMPOUND_ENTITY|treatment|DISEASE_ENTITY|hypertension|.	216336	1.0	10
operative|death|--|DISEASE_ENTITY|infarction|operation|COMPOUND_ENTITY|hepatitis|.	216443	0.0	11
Proceedings|:|significance|serum|COMPOUND_ENTITY|phosphokinase|isoenzyme|acute|DISEASE_ENTITY|myocardial|infarction|atypical|enzyme|profile|.	216514	0.0	10
result|suggest|acute|DISEASE_ENTITY|,|COMPOUND_ENTITY|decanoate|appropriate|drug|elated|acutely|disturbed|patient|,|patient|lowered|mood|history|depression|,|flupenthixol|decanoate|appropriate|drug|.	216584	0.0	10
COMPOUND_ENTITY|acetate|treatment|DISEASE_ENTITY|advanced|breast|cancer|.	216616	1.0	11
serum|COMPOUND_ENTITY|phosphokinase|activity|acute|DISEASE_ENTITY|myocardial|infarction|.	216783	0.0	10
test|nicotine|,|anticonvulsant|agent|prevent|DISEASE_ENTITY|;|dph|fail|increase|latency|;|COMPOUND_ENTITY|dph|potent|pb|cdp|prevent|mortality|.	217047	0.0	11
COMPOUND_ENTITY|-lrb-|thc|-rrb-|compare|diphenylhydantoin|-lrb-|dph|-rrb-|,|phenobarbital|-lrb-|pb|-rrb-|chlordiazepoxide|-lrb-|cdp|-rrb-|use|standard|laboratory|procedure|determine|anticonvulsant|activity|mouse|,|i.e.|,|maximal|electroshock|test|-lrb-|mes|-rrb-|,|DISEASE_ENTITY|seizure|induce|pentylenetetrazol|,|strychnine|nicotine|.	217071	0.0	11
delta9-tetrahydrocannabinol|-lrb-|COMPOUND_ENTITY|-rrb-|compare|diphenylhydantoin|-lrb-|dph|-rrb-|,|phenobarbital|-lrb-|pb|-rrb-|chlordiazepoxide|-lrb-|cdp|-rrb-|use|standard|laboratory|procedure|determine|anticonvulsant|activity|mouse|,|i.e.|,|maximal|electroshock|test|-lrb-|mes|-rrb-|,|DISEASE_ENTITY|seizure|induce|pentylenetetrazol|,|strychnine|nicotine|.	217086	0.0	11
phytohaemagglutinin-induced|lymphocyte|transformation|study|19|patient|DISEASE_ENTITY|erythematosus|-lrb-|sle|-rrb-|relation|disease|activity|,|peripheral|blood|lymphocyte|count|,|serum|iron|COMPOUND_ENTITY|level|,|corticosteroid|treatment|.	217157	0.0	11
phytohaemagglutinin-induced|lymphocyte|transformation|study|19|patient|systemic|lupus|erythematosus|-lrb-|DISEASE_ENTITY|-rrb-|relation|disease|activity|,|peripheral|blood|lymphocyte|count|,|serum|iron|COMPOUND_ENTITY|level|,|corticosteroid|treatment|.	217163	0.0	11
addition|Visken|COMPOUND_ENTITY|therapy|DISEASE_ENTITY|hypertension|:|multicentre|study|.	217313	0.0	10
anticonvulsant|activity|COMPOUND_ENTITY|-lrb-|delta9-thc|-rrb-|determine|DISEASE_ENTITY|seizure|induce|epileptic|chicken|intermittent|photic|stimulation|-lrb-|ips|-rrb-|epileptic|nonepileptic|chicken|metrazol|.	217364	1.0	11
serial|measurement|mb|isoenzyme|creatine|kinase|,|total|COMPOUND_ENTITY|kinase|,|aspartate|mainotransferase|,|urea|stable|lactate|dehydrogenase|serum|series|139|patient|admit|diagnosis|suspect|DISEASE_ENTITY|myocardial|infarction|.	217466	0.0	10
factor|prolongation|anoxic|arrest|,|irritation|ventricular|septum|valvular|prosthesis|,|cardiac|irritation|thoracic|tube|,|psychologic|trauma|,|COMPOUND_ENTITY|anesthesia|DISEASE_ENTITY|coronary|arterial|disease|old|age|group|possible|predisposing|factor|patient|.	217690	0.0	11
DISEASE_ENTITY|appear|intraparenchymal|activation|zymogen|,|result|synergistic|action|COMPOUND_ENTITY|deficiency|basic|toxicity|ethionine|acinar|cell|pancreas|.	217698	0.0	11
longitudinal|,|blind|study|Gilles|de|la|DISEASE_ENTITY|disease|44|year|old|male|patient|nonresponsive|COMPOUND_ENTITY|therapy|indicate|dopamine|excretion|relate|clinical|response|.	218070	0.0	10
patient|severe|DISEASE_ENTITY|combination|COMPOUND_ENTITY|-lrb-|dopegyt|-rrb-|+|etacrynic|acid|-lrb-|uregyt|-rrb-|evoke|distinct|decrease|systolic|diastolic|blood|pressure|.	218133	0.0	10
try|tropical|therapy|sort|course|COMPOUND_ENTITY|,|tonsillectomy|consider|recur|,|DISEASE_ENTITY|refractory|psoriasis|vulgaris|child|adolescent|.	218184	0.0	11
COMPOUND_ENTITY|affect|incidence|metrazol-induced|DISEASE_ENTITY|seizure|epileptic|nonepileptic|chicken|.	218256	0.0	11
COMPOUND_ENTITY|affect|incidence|metrazol-induced|seizure|DISEASE_ENTITY|epileptic|nonepileptic|chicken|.	218261	0.0	11
order|ascertain|effect|tonsillectomy|treatment|child|adolescent|recur|psoriasis|vulgaris|,|refractory|topical|therapy|course|COMPOUND_ENTITY|,|trigger|infection|,|test|possible|correlation|tonsillitis|exacerbation|DISEASE_ENTITY|psoriasis|,|retrospective|study|course|psoriasis|tonsillectomy|,|use|chart|questionnaire|,|undertake|74|psoriatic|patient|.	218445	0.0	11
order|ascertain|effect|tonsillectomy|treatment|child|adolescent|recur|psoriasis|vulgaris|,|refractory|topical|therapy|course|COMPOUND_ENTITY|,|trigger|infection|,|test|possible|correlation|tonsillitis|exacerbation|psoriasis|,|retrospective|study|course|DISEASE_ENTITY|psoriasis|tonsillectomy|,|use|chart|questionnaire|,|undertake|74|psoriatic|patient|.	218451	0.0	11
COMPOUND_ENTITY|provocative|test|suspect|untreated|DISEASE_ENTITY|open-angle|glaucoma|.	218460	0.0	10
letter|:|treatment|spasticity|DISEASE_ENTITY|sclerosis|COMPOUND_ENTITY|.	218499	0.0	11
COMPOUND_ENTITY|phosphokinase|isoenzyme|DISEASE_ENTITY|myocardial|infarction|.	218742	0.0	10
contrast|,|DISEASE_ENTITY|patient|pretreat|COMPOUND_ENTITY|-lrb-|10|mg|-rrb-|sulpiride|-lrb-|100|mg|-rrb-|,|apomorphine|-lrb-|10|mg|-rrb-|markedly|diminish|tremor|rigidity|fail|produce|nausea|,|vomit|sleepiness|.	218786	0.0	10
Pressor|chronotropic|response|bilateral|carotid|occlusion|-lrb-|bco|-rrb-|tyramine|markedly|reduce|follow|treatment|COMPOUND_ENTITY|,|consistent|clinical|finding|chronic|methyldopa|treatment|DISEASE_ENTITY|hypertensive|patient|impair|cardiovascular|reflex|.	219036	0.0	10
COMPOUND_ENTITY|-lrb-|50|mg/kg|-rrb-|completely|abolish|DISEASE_ENTITY|seizure|single|injection|tolerance|develop|effect|protection|afford|6|daily|dose|.	219074	1.0	11
formation|COMPOUND_ENTITY|epileptogenic|zone|hippocamp|,|eeg|animal|exhibit|identical|type|focal|interseizure|discharge|electrographic|correlate|DISEASE_ENTITY|seizure|,|amplitude|epileptifiorm|discharge|eeg|increase|age|.	219618	0.0	10
cortical|unit|activity|generalize|DISEASE_ENTITY|induce|COMPOUND_ENTITY|.	219864	0.0	10
sulfhydryl|reagent|-lrb-|ethacrynic|acid|COMPOUND_ENTITY|-rrb-|cytochalasin|b|clearly|inhibit|AIB|transport|glia|cell|effect|DISEASE_ENTITY|glioma|cell|minimal|.	220025	0.0	11
COMPOUND_ENTITY|decrease|experimental|DISEASE_ENTITY|myocardial|ischemia|non-failing|canine|heart|.	220935	0.0	11
lack|DISEASE_ENTITY|disorder|reflect|different|relationship|beta41|beta|42|and/or|similarity|volume|hydrophobicity|tyrosine|COMPOUND_ENTITY|.	221232	0.0	10
perform|complete|ocular|examination|,|include|COMPOUND_ENTITY|angiography|fundus|,|50|ambulatory|patient|moderately|active|inactive|DISEASE_ENTITY|systemic|lupus|erythematosus|;|ocular|symptom|.	221237	0.0	11
comparison|cardiovascular|action|dihydralazine|,|phentolamine|,|COMPOUND_ENTITY|spontaneously|DISEASE_ENTITY|hypertensive|rat|.	221642	0.0	10
decrease|parallel|reduction|inhibitory|stimulatory|effect|COMPOUND_ENTITY|hydrolysis|liposome|DISEASE_ENTITY|pancreatic|Naja|naja|phospholipase|,|respectively|.	221646	1.0	11
try|topical|therapy|sort|course|COMPOUND_ENTITY|,|tonsillectomy|consideration|relapsing|,|recalcitrant|DISEASE_ENTITY|psoriasis|vulgaris|child|adolescent|.	221665	0.0	11
letter|:|COMPOUND_ENTITY|treatment|DISEASE_ENTITY|hypertension|.	221790	1.0	10
behavioral|DISEASE_ENTITY|decrease|severity|disappear|long-term|administration|COMPOUND_ENTITY|.	221795	0.0	11
identical|condition|,|evidence|ultrastructural|change|produce|COMPOUND_ENTITY|lymphocyte|DISEASE_ENTITY|chronic|lymphocytic|leukemic|patient|,|rpmi|1788|cell|line|.	222064	0.0	10
different|strength|seizure|focus|induce|COMPOUND_ENTITY|g|1000|,|3000|6000|U|inject|cortex|,|amygdala|intralaminal|thalamus|,|spread|DISEASE_ENTITY|epileptic|discharge|subcortex|surround|area|contralateral|area|follow|.	222119	0.0	10
trial|carry|18|DISEASE_ENTITY|patient|assess|effectiveness|vaccine|house|dust|mite|extract|-lrb-|dermatophagoides|pteronyssinus|-rrb-|absorb|COMPOUND_ENTITY|.	222160	0.0	11
degree|audiogenic|DISEASE_ENTITY|measure|dba/2j|-lrb-|COMPOUND_ENTITY|hydroxylase|deficient|-rrb-|mouse|function|dietary|phenylalanine|-lrb-|phe|-rrb-|inject|5-hydroxytryptophan|-lrb-|5-htp|-rrb-|,|precursor|serotonin|-lrb-|5-ht|-rrb-|.	222558	0.0	10
erythrocyte|reduce|COMPOUND_ENTITY|level|increase|onset|DISEASE_ENTITY|anemia|.	222727	0.0	10
effect|COMPOUND_ENTITY|rabbit|DISEASE_ENTITY|renovascular|hypertension|.	222783	0.0	10
physiologic|dose|COMPOUND_ENTITY|administer|,|DISEASE_ENTITY|hypertension|,|electrolyte|imbalance|,|abnormal|corticosteroid|secretion|correct|.	222858	0.0	10
letter|:|treatment|spasticity|DISEASE_ENTITY|sclerosis|COMPOUND_ENTITY|.	222872	0.0	11
effect|regular|use|neublized|COMPOUND_ENTITY|14|patient|symptomatic|DISEASE_ENTITY|chronic|obstructive|lung|disease|-lrb-|cold|-rrb-|evaluate|double-blind|crossover|16-week|study|.	222947	0.0	10
result|suggest|association|COMPOUND_ENTITY|px|DISEASE_ENTITY|deficiency|hemolytic|anemia|need|represent|cause-and-effect|relationship|.	222955	0.0	10
randomize|study|compare|response|patient|DISEASE_ENTITY|myeloma|chlorambucil|,|COMPOUND_ENTITY|,|azathioprine|.	223051	0.0	10
letter|:|COMPOUND_ENTITY|toxicity|DISEASE_ENTITY|anemia|.	223615	0.0	11
effect|acute|chronic|paleocerebellar|stimulation|experimental|model|DISEASE_ENTITY|cat|:|study|enflurane|,|pentylenetetrazol|,|COMPOUND_ENTITY|,|chloralose|.	223693	0.0	10
american|trial|small|significant|increase|liver|transaminase|,|3.8|%|COMPOUND_ENTITY|patient|vs|0.9|%|control|1|%|increase|DISEASE_ENTITY|anaemia|acarbose|group|.	223806	0.0	11
american|trial|small|significant|increase|liver|transaminase|,|3.8|%|acarbose-treated|patient|vs|0.9|%|control|1|%|increase|DISEASE_ENTITY|COMPOUND_ENTITY|group|.	223811	0.0	11
binding|capacity|plasma|testosterone-estradiol-binding|globulin|-lrb-|tebg|-rrb-|testosterone|-lrb-|t|-rrb-|level|measure|woman|proved|DISEASE_ENTITY|ovary|woman|clinical|diagnosis|polycystic|ovarian|disease|,|,|administration|norethindrone|,|2|mg.|,|COMPOUND_ENTITY|,|0.1|mg|.	223815	0.0	10
red|cell|COMPOUND_ENTITY|-lrb-|gsh-px|-rrb-|activity|9|normal|subject|compare|15|case|iron|deficiency|anaemia|13|case|heterozygous|beta-thalassemia|degree|DISEASE_ENTITY|anaemia|hypochromia|.	224390	0.0	10
datum|indicate|lysosomal|disruption|early|consequence|DISEASE_ENTITY|ischemia|treatment|COMPOUND_ENTITY|prevent|loss|myocardial|lysosomal|cellular|enzyme|reflect|normalization|ecg|plasma|cpk|activity|ischemic|cat|.	224400	1.0	10
enhance|,|,|DISEASE_ENTITY|effect|methydopa|,|hydrallazine|,|guanethidine|clonidine|,|,|lesser|extent|,|COMPOUND_ENTITY|hydrochlorothiazide|.	224418	0.0	10
ap5-sensitive|long|duration|component|dr-vrp|DISEASE_ENTITY|respective|maximal|level|23.2|+|/|-|1.4|%|-lrb-|n|=|7|-rrb-|,|18.8|+|/|-|3.8|%|-lrb-|n|=|4|-rrb-|47.6|+|/|-|1.6|%|-lrb-|n|=|5|-rrb-|control|-lrb-|100|%|-rrb-|level|COMPOUND_ENTITY|-lrb-|ec50|135|+|/|-|33|nm|-rrb-|,|clonidine|-lrb-|ec50|26.0|+|/|-|2.2|nm|-rrb-|diazepam|-lrb-|ec25|114|+|/|-|12|nm|,|n|=|4|-rrb-|.	453556	0.0	11
conclusion|,|postmenopausal|patient|DISEASE_ENTITY|treat|low|dose|COMPOUND_ENTITY|reduce|level|sex|hormone|osteocalcin|reduce|vertebral|bone|mass|.	453678	0.0	10
hl-60|human|DISEASE_ENTITY|leukemia|cell|induce|differentiate|granulocyte|COMPOUND_ENTITY|acid|dimethyl|sulfoxide|monocyte-macrophage|phorbol|ester|1,25-dihydroxyvitamin|d3|.	453682	0.0	10
result|indicate|glucose-tolerant|offspring|DISEASE_ENTITY|parent|characterize|hyperinsulinemia|manifest|metabolic|abnormality|characterize|fully|establish|diabetic|state|,|include|insulin|resistance|,|major|impairment|nonoxidative|glucose|disposal|,|quantitatively|important|defect|glucose|oxidation|,|diminish|insulin-mediated|suppression|lipid|oxidation|plasma|COMPOUND_ENTITY|concentration|.	453705	0.0	10
achieve|high|percentage|durable|complete|remission|-lrb-|cr|-rrb-|prolonged|survival|reduce|toxicity|patient|early-stage|intermediate-stage|DISEASE_ENTITY|disease|,|randomized|trial|cycle|mechlorethamine|,|vincristine|,|procarbazine|,|prednisone|-lrb-|mopp|-rrb-|versus|cycle|thiotepa|,|bleomycin|,|COMPOUND_ENTITY|-lrb-|tbv|-rrb-|combine|regional|radiation|therapy|-lrb-|rt|-rrb-|conduct|.	453756	0.0	10
light|clinical|observation|elevated|COMPOUND_ENTITY|level|DISEASE_ENTITY|alzheimer|patient|,|result|explain|limited|number|patient|respond|therapy|memory|enhancer|.	453801	0.0	11
case|spinal|cord|compression|DISEASE_ENTITY|haemopoiesis|thalassaemic|patient|:|putative|role|COMPOUND_ENTITY|?	454138	0.0	10
long-term|interferon|alpha-2b|-lrb-|ifn|-rrb-|therapy|Philadelphia|chromosome-positive|chronic|myelogenous|leukemia|-lrb-|DISEASE_ENTITY|-rrb-|patient|,|short-term|effect|tumor|necrosis|factor|alpha|-lrb-|tnf|-rrb-|peripheral|leukocyte|count|,|COMPOUND_ENTITY|corticotropin|-lrb-|acth|-rrb-|release|study|.	454318	0.0	10
remission|induction|DISEASE_ENTITY|leukemia|COMPOUND_ENTITY|acid|:|molecular|evidence|restoration|normal|hematopoiesis|differentiation|subsequent|extinction|leukemic|clone|.	454375	0.0	10
ophthalmoscopy|COMPOUND_ENTITY|angiography|reveal|typical|aspect|DISEASE_ENTITY|sle-associated|vaso-occlusive|retinopathy|eye|marked|ischemia|macula|.	454435	0.0	11
influence|COMPOUND_ENTITY|cerebral|low-flow|region|DISEASE_ENTITY|migraine|--|interictal|99mtc-hmpao|spect|study|.	454537	0.0	10
investigate|issue|concordant|heterotopic|cardiac|xenograft|model|develop|conjunction|COMPOUND_ENTITY|and/or|DISEASE_ENTITY|total-lymphoid|irradiation|.	454584	0.0	10
identify|COMPOUND_ENTITY|acid|,|1,3-dithiolan-2-ylidenehydrazide|;|pyruvic|acid|,|1,3-dithiolan-2-ylidenehydrazide|;|benzoic|acid|hippuric|acid|uv|DISEASE_ENTITY|MS.|confirm|chemical|synthesis|.	454841	0.0	11
case|malignant|neoplasm|,|pneumonitis|,|DISEASE_ENTITY|treatment|low-dose|COMPOUND_ENTITY|.	454879	0.0	11
accord|logistic|regression|analysis|,|relationship|plasma|COMPOUND_ENTITY|concentration|response|,|reflect|number|DISEASE_ENTITY|panic|attack|report|,|phobia|rating|,|physician|'|patient|'|rating|global|improvement|,|emergence|effect|,|significant|.	454978	0.0	10
study|mechanism|-lrb-|s|-rrb-|polyunsaturated-fatty-acid-mediated|increase|intracellular|COMPOUND_ENTITY|formation|n1e-115|DISEASE_ENTITY|neuroblastoma|cell|.	455168	0.0	10
evidence|presence|pineal|calcification|-lrb-|pc|-rrb-|relate|,|factor|,|disturbance|COMPOUND_ENTITY|secretion|,|I|investigate|23|chronic|institutionalized|DISEASE_ENTITY|schizophrenic|patient|relationship|pc|size|ct|scan|mode|onset|schizophrenia|carry|developmental|prognostic|significance|.	455328	0.0	11
study|conduct|drug|previously|review|Journal|1984|confirm|comparable|efficacy|equal|dose|budesonide|beclomethasone|dipropionate|,|ability|COMPOUND_ENTITY|reduce|oral|maintenance|corticosteroid|requirement|,|demonstrate|potential|first-line|treatment|mild|moderate|DISEASE_ENTITY|asthma|.	455462	1.0	10
finding|demonstrate|COMPOUND_ENTITY|bambuterol|reduce|nocturnal|airway|responsiveness|DISEASE_ENTITY|asthma|symptom|suggest|relationship|degree|airway|responsiveness|presence|nocturnal|symptom|asthma|.	455536	0.0	10
prostaglandin|e2|-lrb-|COMPOUND_ENTITY|-rrb-|-|6-keto-pgf1|alpha-like|immunoactivity|measure|incubate|DISEASE_ENTITY|forestomach|gastric|corpus|mucosa|-lrb-|-rrb-|unoperated|rat|,|-lrb-|b|-rrb-|rat|sham-operation|kidney|-lrb-|c|-rrb-|rat|bilateral|nephrectomy|.	455558	0.0	10
effect|safety|ephedrine/caffeine|compound|compare|COMPOUND_ENTITY|,|caffeine|placebo|DISEASE_ENTITY|obese|subject|energy|restricted|diet|.	455565	0.0	10
patient|-lrb-|female|,|18|male|,|mean|age|57|+|/|-|11|year|-rrb-|severe|heart|failure|nyha|iv|-lrb-|7|DISEASE_ENTITY|disease|,|13|congestive|cardiomyopathy|-rrb-|treat|8.8|+|/|-|1.7|micrograms.kg-1|x|min-1|COMPOUND_ENTITY|.	455596	1.0	10
tissue|serum|ratio|COMPOUND_ENTITY|DISEASE_ENTITY|hypothalamus|,|hippocampus|,|striatum|,|midbrain|cortex|smaller|morphine|tolerant|non-tolerant|rat|.	456043	0.0	10
forty-one|dsm-iii-r|DISEASE_ENTITY|subject|constant|,|low-dose|maintenance|neuroleptic|drug|therapy|-lrb-|5-10|mg|COMPOUND_ENTITY|decanoate|intramuscularly|2|week|-rrb-|randomly|assign|structured|modularized|skill|training|supportive|group|psychotherapy|.	456087	1.0	10
patient|active|DISEASE_ENTITY|leukemia|-lrb-|aml|-rrb-|receive|13|cis|COMPOUND_ENTITY|acid|-lrb-|ra|-rrb-|+|alpha|interferon|-lrb-|ifn|-rrb-|recombinant|human|granulocyte-macrophage|colony-stimulating|factor|-lrb-|rhgm-csf|-rrb-|3|day|.	456275	0.0	10
combination|COMPOUND_ENTITY|acid|interferon|gamma|effective|reduce|cfu-l|recover|-lrb-|8|responsive/15|DISEASE_ENTITY|aml|case|-rrb-|,|g-csf|m-csf|display|inhibitory|stimulatory|activity|different|aml|case|.	456611	0.0	10
model|generate|5|hz|oscillation|record|carbachol|following|condition|:|-lrb-|-rrb-|excitatory|synaptic|conductance|limited|range|;|-lrb-|b|-rrb-|blockade|fast|slow|ipsp|-lrb-|consistent|experimental|lack|effect|bicuculline|phaclofen|carbachol|oscillation|known|DISEASE_ENTITY|ipsp|acetylcholine|-rrb-|;|-lrb-|c|-rrb-|hyperpolarization|-lrb-|ahp|-rrb-|conductance|reduce|-lrb-|consistent|known|pharmacology|COMPOUND_ENTITY|-rrb-|;|-lrb-|d|-rrb-|apical|dendrite|pyramidal|cell|depolarize|,|suggest|carbachol-induced|depolarization|pyramidal|neurone|.	456860	0.0	10
preliminary|study|patient|rat|DISEASE_ENTITY|disease|hypertensive|,|insulin|resistant|COMPOUND_ENTITY|deficient|hyperparathyroidism|;|parenteral|administration|pharmacological|dose|1,25-dihydroxycholecalciferol|lead|reversal|hypertension|insulin|resistance|significant|change|serum|calcium|parathyroid|hormone|concentration|.	457019	0.0	11
preliminary|study|patient|rat|DISEASE_ENTITY|disease|hypertensive|,|insulin|resistant|1,25-dihydroxycholecalciferol|deficient|hyperparathyroidism|;|parenteral|administration|pharmacological|dose|COMPOUND_ENTITY|lead|reversal|hypertension|insulin|resistance|significant|change|serum|calcium|parathyroid|hormone|concentration|.	457035	0.0	11
double-blind|study|,|455|patient|DISEASE_ENTITY|randomly|assign|receive|combination|arthrotec|,|50|mg|diclofenac|200|microgram|COMPOUND_ENTITY|,|50|mg|diclofenac|;|drug|time|daily|4|week|.	457032	1.0	11
hypothesis|:|etiology|atherosclerosis|DISEASE_ENTITY|:|imbalance|COMPOUND_ENTITY|endocrine|system|implicate|?	457051	0.0	11
preliminary|study|moderately|severe|DISEASE_ENTITY|,|30|gambian|child|randomise|pair|receive|intramuscular|COMPOUND_ENTITY|-lrb-|4|mg/kg|load|dose|follow|2|mg/kg|daily|-rrb-|intramuscular|chloroquine|-lrb-|`|nivaquine|'|-rrb-|3.5|mg|base/kg|6|h.|drug|tolerate|rapidly|effective|.	457193	1.0	10
comparison|COMPOUND_ENTITY|chloroquine|severe|DISEASE_ENTITY|malaria|gambian|child|.	457363	0.0	10
thermogenic|combination|COMPOUND_ENTITY|caffeine|newer|selective|beta|3-agonist|assess|treatment|DISEASE_ENTITY|obesity|.	457375	1.0	10
COMPOUND_ENTITY|acid|follow|intensive|chemotherapy|high|complete|remission|rate|prolong|remission|newly|diagnose|DISEASE_ENTITY|acute|promyelocytic|leukemia|:|pilot|study|26|case|.	457485	0.0	10
use|real-time|st|segment|trend|analysis|-lrb-|lead|v5|ii|-rrb-|IMI|-lrb-|halothane|39|%|,|isoflurane|38|%|-rrb-|,|DISEASE_ENTITY|-lrb-|halothane|1.3|%|,|isoflurane|1.5|%|-rrb-|cd|-lrb-|COMPOUND_ENTITY|0.4|%|,|isoflurane|0.7|%|-rrb-|differ|significantly|group|.	457613	0.0	11
describe|case|acute|nonlymphocytic|leukemia|inversion|chromosome|16|patient|DISEASE_ENTITY|erythematosus|treat|immunosuppressive|agent|include|COMPOUND_ENTITY|cyclophosphamide|.	457628	1.0	10
-lsb-|effect|neurotropin|DISEASE_ENTITY|activity|COMPOUND_ENTITY|kindling|-rsb-|.	457727	0.0	10
tau|pathology|case|DISEASE_ENTITY|disease|valine|COMPOUND_ENTITY|mutation|position|717|amyloid|precursor|protein|.	457766	0.0	10
tinted|COMPOUND_ENTITY|hyaluronate|-lrb-|Healon|Yellow|-rrb-|use|posterior|segment|surgery|mainly|dissection|epiretinal|membrane|case|proliferative|diabetic|retinopathy|DISEASE_ENTITY|macular|pucker|.	457823	0.0	10
multivariate|analysis|stepwise|logistic|regression|identify|Q|-|wave|DISEASE_ENTITY|infarct|,|age|,|delay|hospital|admission|,|peak|mb|COMPOUND_ENTITY|kinase|location|infarct|independent|predictive|variable|pericarditis|occurrence|.	458168	0.0	10
lhrh|analogue|DISEASE_ENTITY|disease|:|validity|use|COMPOUND_ENTITY|depot|treatment|disease|.	458228	1.0	11
molecular|monitoring|COMPOUND_ENTITY|acid|receptor-alpha|fusion|gene|DISEASE_ENTITY|acute|promyelocytic|leukemia|polymerase|chain|reaction|.	458311	0.0	10
objective|:|investigate|correlation|joint|disease|composition|chondroitin|COMPOUND_ENTITY|joint|fluid|,|unsaturated|disaccharide|isomer|chondroitin|4-sulfate|-lrb-|delta|di-4s|-rrb-|chondroitin|6-sulfate|-lrb-|delta|di-6s|-rrb-|measure|joint|fluid|obtain|patient|osteoarthritis|-lrb-|oa|-rrb-|,|rheumatoid|arthritis|-lrb-|DISEASE_ENTITY|ra|-rrb-|,|traumatic|arthritis|-lrb-|TA|-rrb-|.	458362	0.0	11
pretreatment|10|-lrb-|-5|-rrb-|m|COMPOUND_ENTITY|partially|inhibit|endothelin-1-evoked|DISEASE_ENTITY|increase|pd|scc|.	458375	1.0	10
-lsb-|experimental|study|tumor|direct|therapy|DISEASE_ENTITY|cancer|monoclonal|antibody-mitomycin|conjugate|combine|COMPOUND_ENTITY|angiotensin|ii|-rsb-|.	458564	0.0	11
current|randomize|study|86|adult|DISEASE_ENTITY|treat|chemotherapy|bone|marrow|transplantation|assess|potential|role|chlorhexidine|,|COMPOUND_ENTITY|,|saline|solution|rinse|reduce|finding|oral|mucositis|,|gingivitis|,|oral|infection|.	458578	1.0	10
interest|retinoid|therapeutic|agent|develop|result|observation|remission|induction|COMPOUND_ENTITY|acid|-lrb-|tra|-rrb-|patient|acute|promyelocytic|leukemia|-lrb-|DISEASE_ENTITY|apl|-rrb-|,|high|objective|response|rate|note|combination|cis-retinoic|acid|-lrb-|cra|-rrb-|interferon-alpha|squamous|cell|carcinoma|skin|cervix|.	458725	1.0	10
effect|COMPOUND_ENTITY|,|Ranitidine|,|Omeprazole|gastric|hepatic|DISEASE_ENTITY|alcohol-dehydrogenase|-lrb-|adh|-rrb-|activity|study|rat|.	458814	0.0	10
weight-reducing|effect|ephedrine-caffeine|combination|superior|placebo|treatment|24|wk|energy|restriction|DISEASE_ENTITY|woman|,|caffeine|COMPOUND_ENTITY|separately|effect|.	458864	0.0	10
oral|COMPOUND_ENTITY|consider|alternative|drug|multiple-drug-resistant|DISEASE_ENTITY|falciparum|malaria|.	458869	1.0	10
8-base|pair|sequence|,|tgattcac|,|position|-255|,|resemble|consensus|sequence|12-o-tetradecanoylphorbol-13-acetate-responsive|element|-lrb-|tre|-rrb-|,|enhance|expression|COMPOUND_ENTITY|acetyltransferase|gene|macrophage|-lrb-|ahins-b3|-rrb-|non-macrophage|-lrb-|DISEASE_ENTITY|glioblastoma|g203|myeloma|ns1|-rrb-|cell|.	459025	0.0	11
nontolerant|tolerant|dog|,|,|COMPOUND_ENTITY|alter|dose-response|large|DISEASE_ENTITY|epicardial|artery|dilation|intravenous|gtn|challenge|modify|nitrate|tolerance|low|pressure|system|dog|.	459169	0.0	11
bzr|ligand|COMPOUND_ENTITY|,|diazepam|,|ro|19-8022|-lrb-|benzoquinolizinone|-rrb-|bretazenil|-lrb-|ro|16-6028|,|imidazobenzodiazepinone|-rrb-|pharmacologically|characterize|neurological|behavioral|paradigm|mouse|:|anticonvulsant|test|-lrb-|prevention|audiogenic|pentylenetetrazol-induced|DISEASE_ENTITY|seizure|-rrb-|,|conflict|test|reveal|anxiolytic|sedative|property|test|mainly|measure|motor|impairment|-lrb-|rotarod|horizontal|wire|test|-rrb-|.	459462	0.0	11
comment|disease|ck-bb|fraction|elevated|,|discuss|laboratory|method|determination|creatine|kinase|isoenzyme|,|revise|,|briefly|,|property|new|immunoassay|,|measure|mass|concentration|COMPOUND_ENTITY|kinase|mb|,|diagnosis|DISEASE_ENTITY|acute|myocardial|infarction|.	459512	0.0	10
objective|study|evaluate|effect|sulphydryl|-lrb-|sh|-rrb-|compound|,|n-acetylcysteine|-lrb-|nac|-rrb-|,|cysteine|-lrb-|COMPOUND_ENTITY|-rrb-|cystamine|,|functional|recovery|ventricular|arrhythmia|-lrb-|VF|-rrb-|stunned|DISEASE_ENTITY|myocardium|isolate|perfused|heart|rat|.	459624	0.0	10
forty-three-year-old|man|schizophrenia|,|diagnose|chronic|myelogenous|leukemia|-lrb-|DISEASE_ENTITY|-rrb-|treat|COMPOUND_ENTITY|3|month|,|develop|blastic|crisis|.	459627	1.0	10
investigate|effect|COMPOUND_ENTITY|,|enflurane|,|isoflurane|central|hemodynamic|leave|ventricular|global|regional|function|use|control|intraoperative|hypertension|39|patient|DISEASE_ENTITY|coronary|artery|disease|.	459706	0.0	11
thirty-two|patient|advanced|non-hodgkin|lymphoma|-lrb-|DISEASE_ENTITY|-rrb-|aggressive|histologic|finding|treat|cyclophosphamide|,|doxorubicin|,|methotrexate|leucovorin|rescue|,|bleomycin|,|vincristine|,|etoposide|,|COMPOUND_ENTITY|,|prednisolone|-lrb-|cambo-vip|-rrb-|,|presumably|non-cross-resistant|myelosuppressive|nonmyelosuppressive|agent|administer|alternate|week|12|week|.	459745	1.0	11
deacetyl-thymosin|alpha|1|analogue|contain|COMPOUND_ENTITY|phe|-lrb-|4f|-rrb-|position|21|synthesize|manual|solid-phase|method|immunological|effect|low|e-rosette-forming|lymphocyte|DISEASE_ENTITY|uremic|patient|study|.	460040	0.0	10
deacetyl-thymosin|alpha|1|analogue|contain|phe|COMPOUND_ENTITY|-lrb-|4f|-rrb-|position|21|synthesize|manual|solid-phase|method|immunological|effect|low|e-rosette-forming|lymphocyte|DISEASE_ENTITY|uremic|patient|study|.	460044	0.0	10
increase|serum|level|mb|isoenzyme|COMPOUND_ENTITY|kinase|-lrb-|ck-mb|-rrb-|useful|marker|acute|DISEASE_ENTITY|myocardial|infarction|.	460523	0.0	10
serum|concentration|antigenic|keratan|COMPOUND_ENTITY|determine|enzyme|linked|immunosorbent|assay|-lrb-|elisa|-rrb-|monoclonal|antibody|study|patient|DISEASE_ENTITY|rheumatoid|arthritis|-lrb-|ra|-rrb-|,|osteoarthritis|,|ankylose|spondylitis|,|inflammatory|disease|,|large|control|group|woman|arthritis|.	460587	0.0	11
prospective|study|,|51|patient|suffer|DISEASE_ENTITY|ichthyosis|treat|COMPOUND_ENTITY|2|year|.	460675	1.0	10
model|accurately|predict|experimentally-known|value|different|age|DISEASE_ENTITY|volume|,|alveolar|number|,|volume|average|alveolus|,|gas-exchange|surface|area|,|alveolar|volume|distribution|normal|rat|rat|septation|inhibit|treatment|COMPOUND_ENTITY|hypoxia|early|postnatal|week|life|.	461037	1.0	10
group|10|receive|fish|oil|contain|COMPOUND_ENTITY|acid|-lrb-|4.1|g/day|-rrb-|docosahexaenoic|acid|-lrb-|3.6|g/day|-rrb-|,|mean|percentage|replicative|``|s|''|-|phase|cell|upper|colonic|crypt|-lrb-|consider|reliable|marker|DISEASE_ENTITY|colon|cancer|risk|-rrb-|significantly|drop|baseline|level|2|week|treatment|remain|lower|study|period|;|change|upper-crypt|labeling|observe|10|placebo|patient|.	461101	0.0	10
clinical|laboratory|evaluation|myeloprotective|effect|COMPOUND_ENTITY|acetate|DISEASE_ENTITY|head|neck|cancer|.	461189	0.0	11
conclusion|:|COMPOUND_ENTITY|decrease|placental|vascular|resistance|mild|preeclamptic|chronic|DISEASE_ENTITY|hypertensive|woman|.	461311	1.0	10
neuroblastoma|x|DISEASE_ENTITY|hybrid|ng108-15|cell|mouse|neuroblastoma|n18tg-2|n1e-115|cell|transiently|transfect|sense|cdna|code|rat|COMPOUND_ENTITY|acetyltransferase|-lrb-|chat|-rrb-|.	461434	0.0	10
confirm|selective|capacity|medium|George|et|al.|-lrb-|1979|-rrb-|use|``|DISEASE_ENTITY|''|selective|agent|cycloserine|d|COMPOUND_ENTITY|.	461478	0.0	10
COMPOUND_ENTITY|oxide|production|measure|indirectly|nitrite|serum|synovial|fluid|sample|patient|rheumatoid|arthritis|-lrb-|DISEASE_ENTITY|ra|-rrb-|osteoarthritis|-lrb-|oa|-rrb-|serum|sample|healthy|volunteer|match|age|sex|.	461545	0.0	11
control|-lrb-|100|%|-rrb-|synaptic|response|rat|superior|cervical|ganglion|preparation|DISEASE_ENTITY|respectively|near|maximal|level|60.0|+|/|-|5.2|%|-lrb-|n|=|4|-rrb-|60.7|+|/|-|5.6|%|-lrb-|n|=|5|-rrb-|clonidine|-lrb-|0.5|jam|,|ec25|15.3|+|/|-|3.0|nm|-rrb-|COMPOUND_ENTITY|-lrb-|1|jam|,|ec25|227|+|/|-|83|nm|-rrb-|.	461594	0.0	11
effect|lisinopril|low-dose|COMPOUND_ENTITY|lipoprotein|metabolism|patient|mild|moderate|DISEASE_ENTITY|hypertension|.	461894	0.0	10
datum|increase|COMPOUND_ENTITY|oxide|production|DISEASE_ENTITY|ra|oa|suggest|role|nitric|oxide|inflammatory|mediator|rheumatic|disease|.	461897	0.0	11
canine|experiment|COMPOUND_ENTITY|use|course|therapy|DISEASE_ENTITY|pulmonary|hypertension|abolition|heart|overload|substantially|enhance|myocardial|contractility|relaxing|property|ventricle|improve|cardiac|pump|function|.	462228	1.0	10
DISEASE_ENTITY|disease|,|COMPOUND_ENTITY|single|agent|demonstrate|high|activity|,|overall|response|range|34|90|%|.	462271	0.0	10
-lsb-|serum|triiodothyronine|COMPOUND_ENTITY|level|child|DISEASE_ENTITY|celiac|disease|-rsb-|.	462780	0.0	10
older|group|subject|,|COMPOUND_ENTITY|produce|aspect|cognitive|impairment|occur|DISEASE_ENTITY|ad|test|episodic|memory|learning|,|vigilance-attention|,|category|retrieval|,|digit|span|,|number|intrusion|.	462884	0.0	11
accord|animal|experiment|COMPOUND_ENTITY|inhibit|xanthine|oxidase|induce|DISEASE_ENTITY|pulmonary|hypertension|piglet|.	462936	1.0	11
mechanism|DISEASE_ENTITY|associate|neuronal|remain|open|,|vitro|vivo|datum|provide|evidence|facilitate|pi|signalling|increase|free|intracellular|COMPOUND_ENTITY|+|important|role|event|.	463008	0.0	10
COMPOUND_ENTITY|acid|receptor|-lrb-|rar|alpha|-rrb-|express|virtually|hematopoietic|lineage|,|role|transcription|factor|regulate|growth|differentiation|DISEASE_ENTITY|hematopoietic|progenitor|unknown|.	463271	0.0	10
objective|study|relate|regional|wall|motion|abnormality|assess|COMPOUND_ENTITY|dipyridamole|stress|echocardiography|quantitative|measurement|DISEASE_ENTITY|coronary|artery|stenosis|consecutive|patient|refer|coronary|angiography|,|compare|haemodynamic|effect|complication|relate|agent|.	463376	0.0	10
Verapamil|COMPOUND_ENTITY|clinically|achievable|dose|1|microgram/ml|produce|significant|chemosensitisation|normal|leukaemic|specimen|,|sensitisation|ratio|greater|equal|2|minority|specimen|,|case|sensitisation|vincristine|majority|DISEASE_ENTITY|cll|specimen|.	463529	0.0	10
experiment|freely|male|Wistar|rat|model|COMPOUND_ENTITY|focal|DISEASE_ENTITY|epileptic|activity|-lrb-|ea|-rrb-|-lrb-|application|sensorimotor|cortex|filter|paper|soak|benzylpenicillin|sodium|salt|solution|-rrb-|addition|mgso4|-lrb-|series|1|-rrb-|nicl2|-lrb-|series|2|-rrb-|solution|penicillin|significantly|weaken|ea|.	463550	0.0	10
method|:|multicenter|prospective|controlled|study|previously|untreated|minimally|treat|chronic|phase|ph|+|DISEASE_ENTITY|employ|:|322|patient|recruit|1986|1988|assign|treatment|human|recombinant|alpha-ifn|-lrb-|roferon-a|-rrb-|COMPOUND_ENTITY|,|randomization|ratio|2:1|.	463688	0.0	10
DISEASE_ENTITY|tremor|induce|combined|application|COMPOUND_ENTITY|pentobarbitone|cat|left-paw|preference|.	464075	0.0	11
COMPOUND_ENTITY|know|exert|protective|effect|development|DISEASE_ENTITY|atherosclerosis|,|mechanism|hormonal|action|unknown|.	464154	1.0	11
approach|explanation|differentiating|effect|COMPOUND_ENTITY|acid|DISEASE_ENTITY|acute|promyelocytic|leukemia|.	464378	0.0	10
combine|therapy|COMPOUND_ENTITY|acid|high-dose|chemotherapy|patient|hyperleukocytic|DISEASE_ENTITY|acute|promyelocytic|leukemia|severe|visceral|hemorrhage|.	464607	0.0	10
performance|44|DISEASE_ENTITY|patient|33|control|examine|test|previously|find|differentially|affect|COMPOUND_ENTITY|administration|.	464798	0.0	11
purpose|investigation|test|hypothesis|chronic|exposure|COMPOUND_ENTITY|accelerate|Alzheimer|disease|-lrb-|ad|-rrb-|,|independently|add|receptor|loss|accelerate|DISEASE_ENTITY|ad|disease|process|.	464868	0.0	10
COMPOUND_ENTITY|,|new|anticonvulsant|effective|maximal|electroshock|-lrb-|mes|-rrb-|DISEASE_ENTITY|seizure|mouse|reduce|t-type|ca2|+|current|dose-dependent|manner|.	464884	1.0	11
effect|COMPOUND_ENTITY|accelerate|DISEASE_ENTITY|atherosclerosis|rabbit|heterotopic|aortic|allograft|.	465147	0.0	11
report|describe|efficacy|toxicity|pave|-lrb-|procarbazine|,|Alkeran|,|COMPOUND_ENTITY|-rrb-|irradiation|-lrb-|rt|-rrb-|management|159|patient|locally|extensive|advanced|stage|hodgkin|disease|-lrb-|DISEASE_ENTITY|hd|-rrb-|Stanford|University|.	465269	0.0	10
study|investigate|effect|gamma-linolenic|acid|-lrb-|gla|-rrb-|,|eicosapentaenoic|acid|-lrb-|COMPOUND_ENTITY|-rrb-|prostaglandin|-lrb-|pg|-rrb-|e1|proliferation|metabolism|human|DISEASE_ENTITY|colon|cancer|cell|line|:|ht|29|,|HRT|18|,|CACO|2|.	465290	0.0	10
,|patient|DISEASE_ENTITY|disease|receive|mean|total|dose|84|mg|COMPOUND_ENTITY|.	465358	0.0	10
dog|4-week-old|anterior|wall|DISEASE_ENTITY|infarction|,|chronic|indwelling|intramyocardial|electrode|inducible|sustained|ventricular|tachycardia|baseline|,|study|closed-chest|state|baseline|-lrb-|control|-rrb-|intravenous|infusion|COMPOUND_ENTITY|10|micrograms/kg/min|.	465562	0.0	10
conclude|intravenous|COMPOUND_ENTITY|depress|rest|ventilation|,|spinal|anesthesia|stimulate|rest|ventilation|,|combination|modest|synergistic|effect|DISEASE_ENTITY|depressing|rest|ventilation|.	465582	0.0	11
forty-four|patient|high|risk|primary|DISEASE_ENTITY|syndrome|excess|marrow|blast|treat|combination|low-dose|ara-c|,|COMPOUND_ENTITY|acid|vitamin|d3|.	465734	1.0	10
sixty-two|patient|chronically|ingest|ibuprofen|,|piroxicam|,|naproxen|DISEASE_ENTITY|,|abdominal|pain|endoscopically|prove|gastric|ulcer|evaluate|week|randomize|,|double-blind|trial|compare|COMPOUND_ENTITY|-lrb-|200|microgram|time|daily|meal|bedtime|-rrb-|-lrb-|n|=|77|-rrb-|placebo|-lrb-|n|=|85|-rrb-|.	466563	0.0	11
COMPOUND_ENTITY|ketoconazole|treatment|oral|esophageal|candidiasis|DISEASE_ENTITY|aids|patient|.	466677	1.0	10
study|suggest|asacol|effective|COMPOUND_ENTITY|maintain|remission|DISEASE_ENTITY|ulcerative|colitis|patient|crohn|disease|ileal|involvement|.	466695	1.0	10
patient|hematologic|relapse|DISEASE_ENTITY|leukemia|-lrb-|cml|-rrb-|follow|allogeneic|bmt|treat|abrupt|discontinuation|COMPOUND_ENTITY|.	466699	0.0	10
report|21-month-old|girl|present|lethargy|generalize|DISEASE_ENTITY|12|hour|ingestion|unknown|number|COMPOUND_ENTITY|pill|.	466814	0.0	11
COMPOUND_ENTITY|E.|Neurochemistry|implication|neurodegeneration|DISEASE_ENTITY|Parkinson|disease|.	467256	0.0	11
result|clearly|significant|increase|urinary|level|hva|VMA|,|derive|respectively|dopamine|norepinephrine|COMPOUND_ENTITY|characterize|onset|progressive|active|phase|DISEASE_ENTITY|vitiligo|,|irrespective|type|distribution|.	467292	0.0	10
total|25|patient|DISEASE_ENTITY|cancer|treat|phase|ii|protocol|5|day|continuous-infusion|COMPOUND_ENTITY|-lrb-|fudr|-rrb-|,|-lrb-|0.1|mg/kg|daily|-rrb-|high-dose|oral|leucovorin|-lrb-|100|mg|4|h|-rrb-|daily|x6|high-dose|interferon-alpha|2b|-lrb-|30|x|10|-lrb-|6|-rrb-|iu/m2|-rrb-|.	467304	1.0	11
recently|develop|antifungal|agent|itraconazole|COMPOUND_ENTITY|evaluate|primary|maintenance|therapy|mycose|patient|DISEASE_ENTITY|acquire|immune|deficiency|syndrome|-lrb-|aids|-rrb-|comparative|non-comparative|trial|.	467368	1.0	10
effect|inotropic|agent|differ|ancillary|property|-lsb-|cardiac|glycoside|-lrb-|digoxin|-rrb-|,|combined|alpha|-|beta-adrenergic|agonist|-lrb-|COMPOUND_ENTITY|-rrb-|,|beta-adrenergic|agonist|-lrb-|prenalterol|-rrb-|,|phosphodiesterase|inhibitor|-lrb-|amrinone|-rrb-|-rsb-|subsequent|addition|isosorbide|dinitrate|compare|48|consecutive|DISEASE_ENTITY|acute|myocardial|infarction|patient|radiographic|haemodynamic|-lrb-|pulmonary|artery|occluded|pressure|greater|18|mm|hg|-rrb-|leave|ventricular|failure|.	467382	0.0	10
DISEASE_ENTITY|tumor|locus|chromosome|11p13|contain|tumor|suppressor|gene|,|wt1|,|encode|dna|binding|protein|-lrb-|wt1|-rrb-|zinc|finger|COMPOUND_ENTITY|n|terminus|function|repressor|transcription|.	467417	0.0	11
-lsb-|DISEASE_ENTITY|depression|intravenous|perfusion|COMPOUND_ENTITY|-rsb-|.	467450	0.0	11
study|COMPOUND_ENTITY|acid|efficacy|DISEASE_ENTITY|aml3|leukemia|,|retinoic|acid-binding|protein|study|cytosol|extract|hematopoietic|cell|.	467516	0.0	10
decline|COMPOUND_ENTITY|production|increase|year|diagnosis|-lrb-|5.7|%|/|yr|-rrb-|observe|exclusively|insulin-taking|DISEASE_ENTITY|niddm|participant|.	467909	0.0	11
analysis|clonal|extinction|bm|blast|cell|response|trans|COMPOUND_ENTITY|acid|-lrb-|ra|-rrb-|,|1|alpha|,25|-lrb-|oh|-rrb-|2d3|,|colony|stimulating|factor|-lrb-|pha-lcm|-rrb-|,|combination|,|reveal|individual|pattern|response|case|mdps|DISEASE_ENTITY|aml|.	467998	0.0	10
lack|tata|caat|box|contain|g+c|-|rich|region|,|demonstrate|function|strong|promoter|neuronal|cell|line|-lrb-|ng108-15|mouse|neuroblastoma|x|rat|glioma|hybrid|cell|n1e115|mouse|neuroblastoma|cell|-rrb-|,|nonneuronal|cell|line|-lrb-|c6|rat|DISEASE_ENTITY|l-m|mouse|fibroblastoid|cell|-rrb-|transient|COMPOUND_ENTITY|acetyltransferase|expression|assay|.	468191	0.0	11
coadministration|COMPOUND_ENTITY|nsaid|patient|DISEASE_ENTITY|osteoarthritis|rheumatoid|arthritis|prevent|development|gastric|duodenal|ulcer|.	468194	0.0	11
method|:|response|intravenous|hydrocortisone|50|mg|-lrb-|low|dose|-rrb-|,|100|mg|-lrb-|medium|dose|-rrb-|,|500|mg|-lrb-|high|dose|-rrb-|,|administer|hour|48|hour|follow|oral|COMPOUND_ENTITY|,|compare|patient|acute|DISEASE_ENTITY|asthma|double|blind|randomised|study|.	468448	0.0	10
report|52-yr-old|man|DISEASE_ENTITY|colitis|develop|COMPOUND_ENTITY|pulmonary|infiltration|eosinophilia|-lrb-|pie|syndrome|-rrb-|,|resolve|completely|withdrawal|drug|.	468457	0.0	10
study|plasma|tissue|concentration|COMPOUND_ENTITY|follow|intramuscular|application/pharmacokinetics|etofenamate|flutenamic|acid|plasma|,|synovia|tissue|patient|chronic|polyarthritis|application|oily|etofenamat|solution|pharmacokinetic|etofenamate|-lrb-|eto|,|CAS|30544-47-9|;|Rheumon|i.m.|-rrb-|flufenamic|acid|-lrb-|flu|,|CAS|530-78-9|-rrb-|investigate|plasma|,|synovial|fluid|,|tissue|single|intramuscular|application|etofenamate|patient|DISEASE_ENTITY|rheumatoid|arthritis|.	468463	0.0	10
study|plasma|tissue|concentration|etofenamate|follow|intramuscular|application/pharmacokinetics|COMPOUND_ENTITY|flutenamic|acid|plasma|,|synovia|tissue|patient|chronic|polyarthritis|application|oily|etofenamat|solution|pharmacokinetic|etofenamate|-lrb-|eto|,|CAS|30544-47-9|;|Rheumon|i.m.|-rrb-|flufenamic|acid|-lrb-|flu|,|CAS|530-78-9|-rrb-|investigate|plasma|,|synovial|fluid|,|tissue|single|intramuscular|application|etofenamate|patient|DISEASE_ENTITY|rheumatoid|arthritis|.	468467	0.0	10
study|plasma|tissue|concentration|etofenamate|follow|intramuscular|application/pharmacokinetics|etofenamate|flutenamic|acid|plasma|,|synovia|tissue|patient|chronic|polyarthritis|application|oily|etofenamat|solution|pharmacokinetic|COMPOUND_ENTITY|-lrb-|eto|,|CAS|30544-47-9|;|Rheumon|i.m.|-rrb-|flufenamic|acid|-lrb-|flu|,|CAS|530-78-9|-rrb-|investigate|plasma|,|synovial|fluid|,|tissue|single|intramuscular|application|etofenamate|patient|DISEASE_ENTITY|rheumatoid|arthritis|.	468471	0.0	10
human|DISEASE_ENTITY|drug-resistant/sensitive|cell|line|pair|evaluate|;|drug-resistant|sub-line|include|select|primary|resistance|adriamycin|,|etoposide|,|teniposide|,|vincristine|,|COMPOUND_ENTITY|.	468641	0.0	10
evaluate|effect|dialysate|buffer|immune|cell|activation|,|release|interleukin-1|-lrb-|il-1|-rrb-|,|tumor|necrosis|factor|-lrb-|tnf|-rrb-|,|prostaglandin|e2|-lrb-|COMPOUND_ENTITY|-rrb-|,|leukotriene|b4|-lrb-|ltb4|-rrb-|peripheral|blood|monocyte|study|12|DISEASE_ENTITY|uremic|patient|hdf|polyacrylonitrile|membrane|-lrb-|filtral|12|,|Hospal|Laboratories|,|Bologna|,|Italy|-rrb-|consecutive|dialysis|acetate|,|bicarbonate|,|AFB|.	468729	0.0	10
conclude|COMPOUND_ENTITY|dipyridamole|stress|echocardiography|similar|sensitivity|specificity|detection|myocardial|ischaemia|DISEASE_ENTITY|coronary|artery|disease|haemodynamic|effect|agent|different|.	468888	0.0	10
tonic-clonic|seizure|observe|3|postnatal|week|suppress|solvent|-lsb-|include|COMPOUND_ENTITY|-lrb-|peg|-rrb-|,|ethanol|,|water|-rsb-|;|effect|DISEASE_ENTITY|aed|tonic-clonic|seizure|proconvulsant|instead|.	469262	0.0	10
knowledge|,|report|COMPOUND_ENTITY|induce|DISEASE_ENTITY|sle|.	469340	0.0	10
measure|metabolic|pattern|gluconeogenic|substrate|alanine|,|predominantly|produce|muscle|,|COMPOUND_ENTITY|oral|glucose|load|normal|subject|eighteen|non-insulin|dependent|diabetes|mellitus|-lrb-|DISEASE_ENTITY|niddm|-rrb-|subject|.	469426	0.0	10
topical|COMPOUND_ENTITY|enkephalin|,|leucine|enkephalin|,|dynorphin|-lrb-|10|-lrb-|-6|-rrb-|m|-rrb-|previously|observe|produce|prominent|DISEASE_ENTITY|pial|arteriolar|dilation|.	469594	0.0	11
DISEASE_ENTITY|use|trimethoprim|COMPOUND_ENTITY|.	469745	0.0	11
effect|recombinant|human|g-csf|-lrb-|rhg-csf|-rrb-|COMPOUND_ENTITY|acid|-lrb-|ra|-rrb-|study|proliferation|differentiation|hl-60|cell|human|DISEASE_ENTITY|acute|myeloid|leukemic|cell|.	469831	0.0	10
distribution|COMPOUND_ENTITY|,|new|antiepileptic|drug|,|erythrocyte|brain|study|clarify|factor|influence|distribution|DISEASE_ENTITY|epileptic|patient|.	469974	0.0	11
effective|concentration|zonisamide|serum|compare|blood|refractory|DISEASE_ENTITY|patient|COMPOUND_ENTITY|chronically|,|variation|effective|serum|concentration|significantly|larger|blood|concentration|.	469987	0.0	11
COMPOUND_ENTITY|acid|-lrb-|ra|-rrb-|inducer|terminal|differentiation|leukemia|cell|line|vitro|clinical|trial|produce|high|percentage|remission|patient|DISEASE_ENTITY|acute|promyelocytic|leukemia|.	470215	0.0	10
distribution|dna|cleavage|induce|COMPOUND_ENTITY|neocarzinostatin|define|sequence|rat|DISEASE_ENTITY|glioma|cell|.	470461	0.0	10
associate|pharmacological|study|semi-quantitative|evaluation|p-glycoprotein|-lrb-|s|-rrb-|expression|,|establish|classical|multidrug|resistance|-lrb-|mdr|-rrb-|account|complete|resistance|phenotype|exhibit|progressively|COMPOUND_ENTITY|rat|DISEASE_ENTITY|glioblastoma|cell|.	471006	0.0	10
DISEASE_ENTITY|treat|diazepam|,|COMPOUND_ENTITY|administer|.	471187	0.0	10
rat|tuftsin|use|DISEASE_ENTITY|activity|develop|behaviour|analogical|COMPOUND_ENTITY|animal|.	471197	0.0	10
fluorination|p-position|COMPOUND_ENTITY|result|marked|restorative|effect|low|e-rosette-forming|lymphocyte|DISEASE_ENTITY|uremic|patient|compare|-lsb-|phe21|-rsb-|deacetyl-thymosin|alpha|1|.	471407	0.0	10
primary|cause|symptom|excess|acetylcholine|follow|acetylcholinesterase|-lrb-|ache|-rrb-|inhibition|,|centrally|act|muscarinic|blocker|,|COMPOUND_ENTITY|,|alleviate|,|block|,|DISEASE_ENTITY|convulsive|action|soman|.	471447	0.0	10
effect|COMPOUND_ENTITY|effective|refractory|period|-lrb-|erp|-rrb-|ventricular|activation|examine|canine|DISEASE_ENTITY|myocardial|infarction|model|,|compare|propranolol|.	471540	0.0	11
conclude|COMPOUND_ENTITY|associate|significantly|gastroduodenal|damage|diclofenac|,|whilst|effective|diclofenac|treatment|DISEASE_ENTITY|osteoarthritis|.	471663	0.0	11
patient|DISEASE_ENTITY|asthmaticus|-lrb-|30-year-old|female|48-year-old|male|-rrb-|develop|flaccid|quadriplegia|sensory|impairment|glove|stock|type|treatment|halothane|,|muscle|relaxant|-lrb-|COMPOUND_ENTITY|vecuronium|-rrb-|steroid|describe|.	471811	0.0	10
1986|1988|,|81|patient|high|grade|malignant|DISEASE_ENTITY|lymphoma|accord|Kiel|classification|treat|vim-bleo/chop-regimen|:|etoposide|100|mg/m2|intravenously|day|1-3|,|COMPOUND_ENTITY|1.5|g/m2|intravenously|day|1-5|mesna|prophylaxis|cystitis|,|methotrexate|30|mg/m2|intravenously|day|3|,|bleomycin|10|mg|intravenously|day|8|15|,|cyclophosphamide|750|mg/m2|day|22|,|doxorubicin|50|mg/m2|day|22|,|vincristine|1.4|mg/m2|day|22|,|prednisolone|100|mg|postoperatively|day|1-5|22-26|.	471832	1.0	11
study|effect|MT|disrupt|drug|,|colchicine|-lrb-|coln|-rrb-|vincristine|-lrb-|VCR|-rrb-|,|maturation|process|,|hl-60|DISEASE_ENTITY|cell|pretreat|coln|VCR|1|h|expose|COMPOUND_ENTITY|acid|-lrb-|ra|-rrb-|dimethyl|sulfoxide|-lrb-|dmso|-rrb-|.	472597	0.0	10
anti-proliferative|activity|human|interferon|-lrb-|huifn|-rrb-|enhance|COMPOUND_ENTITY|,|2,6-bis|-|-lrb-|diethanolamino|-rrb-|-4,8|-|dipiperidinopyrimido|-|-lsb-|5,4-d|-rsb-|-|py|rimidine|,|test|human|tumor|cell|line|,|include|KT|-lrb-|DISEASE_ENTITY|breast|carcinoma|-rrb-|,|plc/prf/5|-lrb-|hepatoma|-rrb-|,|mgc-i|,|u251-sp|t98|-lrb-|glioma|-rrb-|,|hac-2|shin-3|-lrb-|ovarian|carcinoma|-rrb-|,|mm-icb|-lrb-|melanoma|-rrb-|.	472600	0.0	11
-lsb-|overdosage|COMPOUND_ENTITY|present|lethargy|DISEASE_ENTITY|seizure|child|-rsb-|.	473065	0.0	11
methylate|analog|COMPOUND_ENTITY|,|ineffective|DISEASE_ENTITY|MES|seizure|mouse|,|test|concentration|500|microm|,|reduce|t-type|l-type|ca2|+|current|.	473406	0.0	11
DISEASE_ENTITY|arthritis|:|clinical|response|effect|COMPOUND_ENTITY|therapy|.	473579	1.0	10
combination|methotrexate|folic|COMPOUND_ENTITY|acid|use|limit|effect|methotrexate|therapy|psoriasis|DISEASE_ENTITY|psoriatic|arthropathy|.	473771	0.0	10
sulfasalazine-induced|lung|disorder|extremely|rare|entity|consider|DISEASE_ENTITY|colitis|patient|COMPOUND_ENTITY|therapy|,|despite|absence|pulmonary|symptomatology|.	473816	0.0	10
effect|quinidine|COMPOUND_ENTITY|blood|pressure|rapid|ventricular|pacing|DISEASE_ENTITY|coronary|artery|disease|.	473977	0.0	11
observation|conclude|:|1|-rrb-|glucose|ingest|post-absorptive|condition|,|plasma|alanine|level|change|concurrently|COMPOUND_ENTITY|increase|,|muscle|tissue|play|predominant|role|glucose|disposal|2|-rrb-|oral|glucose|load|,|pattern|gluconeogenic|precursor|-lrb-|alanine|lactate|-rrb-|similar|normal|niddm|subject|3|-rrb-|main|cause|fasting|post-prandial|hyperglycemia|DISEASE_ENTITY|NIDDM|subject|overproduction|alanine|lactate|.	474108	0.0	10
observation|conclude|:|1|-rrb-|glucose|ingest|post-absorptive|condition|,|plasma|alanine|level|change|concurrently|lactate|increase|,|muscle|tissue|play|predominant|role|glucose|disposal|2|-rrb-|oral|glucose|load|,|pattern|gluconeogenic|precursor|-lrb-|alanine|lactate|-rrb-|similar|normal|DISEASE_ENTITY|subject|3|-rrb-|main|cause|fasting|post-prandial|hyperglycemia|NIDDM|subject|overproduction|alanine|COMPOUND_ENTITY|.	474124	0.0	10
DISEASE_ENTITY|cancer|:|role|difluoromethylornithine|-lrb-|COMPOUND_ENTITY|-rrb-|.	474155	0.0	10
recent|three-month|,|placebo-controlled|study|establish|efficacy|COMPOUND_ENTITY|200|microgram|qid|prevention|nsaid-induced|duodenal|ulcer|429|patient|osteoarthritis|-lrb-|DISEASE_ENTITY|oa|-rrb-|,|rheumatoid|arthritis|-lrb-|ra|-rrb-|,|rheumatic|disease|,|receive|daily|treatment|nsaid|.	474754	0.0	11
child|-lrb-|age|1.2|9.4|year|-rrb-|advanced|DISEASE_ENTITY|treat|myelosuppressive|chemotherapy|-lrb-|cyclophosphamide|,|COMPOUND_ENTITY|,|doxorubicin|-rrb-|follow|5|-lrb-|n|=|5|-rrb-|,|10|-lrb-|n|=|5|-rrb-|,|15|-lrb-|n|=|5|-rrb-|micrograms/kg|recombinant|granulocyte|colony-stimulating|factor|-lrb-|rg-csf|-rrb-|subcutaneously|-lrb-|sc|-rrb-|daily|10|day|,|start|day|chemotherapy|.	475339	0.0	10
forty-seven|patient|uncomplicated|falciparum|DISEASE_ENTITY|randomly|assign|receive|COMPOUND_ENTITY|-lrb-|n|=|24|-rrb-|,|9.6|mg/kg|body|weight|intramuscularly|day|chloroquine|-lrb-|n|=|23|-rrb-|,|25|mg/kg|body|weight|orally|.	475353	0.0	10
clinical|response|treatment|COMPOUND_ENTITY|observe|ovarian|cancer|,|DISEASE_ENTITY|breast|,|lung|cancer|melanoma|.	475532	0.0	10
aging|brain|COMPOUND_ENTITY|E.|use|recently-developed|membrane|lipid|peroxidation|-lrb-|mlp|-rrb-|system|,|demonstrate|important|role|vitamin|e|prevention|MLP|possible|relationship|MLP|pathogenesis|DISEASE_ENTITY|Parkinson|disease|.	475544	0.0	11
finding|suggest|effect|COMPOUND_ENTITY|DISEASE_ENTITY|MES|seizure|occur|reduction|t-type|ca2|+|current|.	475619	0.0	11
serum|level|alpha-tocopherol|-lrb-|COMPOUND_ENTITY|-rrb-|DISEASE_ENTITY|Parkinson|disease|.	650464	0.0	11
result|suggest|serum|COMPOUND_ENTITY|e|concentration|play|role|pathogenesis|DISEASE_ENTITY|pd|.	650588	0.0	11
two-dimensional|echocardiography|detect|regional|wall|motion|abnormality|result|DISEASE_ENTITY|ischemia|produce|COMPOUND_ENTITY|infusion|.	650620	0.0	10
DISEASE_ENTITY|strongly|associate|specific|blood|flow|abnormality|parietotemporal|cortex|;|previously|,|despite|induction|dementia-like|state|,|COMPOUND_ENTITY|produce|blood|flow|change|.	650673	0.0	11
postoperative|result|comparable|hemodynamic|,|inotropic|requirement|-lrb-|10/50|ice|versus|8/50|saline|versus|5/50|cooling|-rrb-|,|DISEASE_ENTITY|infarction|-lrb-|1/50|versus|2/50|versus|2/50|-rrb-|,|enzyme|-lrb-|aspartate|aminotransferase|myocardial|band|COMPOUND_ENTITY|kinase|-rrb-|.	650760	0.0	10
contrast|,|COMPOUND_ENTITY|greater|effect|delta|compare|c|fibre|reflex|;|delta|reflex|abolish|total|dose|3|mg|midazolam|,|c|fibre|reflex|DISEASE_ENTITY|depress|50|%|.	650804	0.0	11
contrast|,|midazolam|greater|effect|delta|compare|c|fibre|reflex|;|delta|reflex|abolish|total|dose|3|mg|COMPOUND_ENTITY|,|c|fibre|reflex|DISEASE_ENTITY|depress|50|%|.	650808	0.0	11
synergism|detect|production|antinociception|-lrb-|tail|flick|test|-rrb-|test|ability|flurazepam|delay|onset|clonic|DISEASE_ENTITY|induce|intravenous|infusion|pentylenetetrazole|compare|presence|absence|COMPOUND_ENTITY|cannabidiol|.	651016	0.0	11
Dichloromethotrexate|,|infusional|cisplatin|,|infusional|COMPOUND_ENTITY|locally|advance|metastatic|DISEASE_ENTITY|non-small|cell|lung|cancer|.	651501	0.0	10
DISEASE_ENTITY|depression|COMPOUND_ENTITY|.	651519	0.0	11
July|2|,|1987|,|August|21|,|1987|,|cancer|DISEASE_ENTITY|Group|b|-lrb-|calgb|-rrb-|conduct|phase|ii|evaluation|carboplatin|-lrb-|cbdca|-rrb-|COMPOUND_ENTITY|-lrb-|vbl|-rrb-|advanced|non-small-cell|lung|cancer|.	651556	0.0	10
tamoxifen|inhibit|estrogen-deficiency|bone|loss|COMPOUND_ENTITY|rat|DISEASE_ENTITY|depress|hypoestrogenic|action|lhrh-agonist|,|suggest|use|tamoxifen|protect|skeleton|lhrh-agonist|therapy|young|woman|explore|.	651576	0.0	11
result|consistent|hypothesis|antiepileptic|drug|dph|,|COMPOUND_ENTITY|pnt|block|axonal|conduction|DISEASE_ENTITY|epileptic|focus|neighbouring|area|brain|.	652114	0.0	10
study|demonstrate|tenoxicam|20|mg|od|COMPOUND_ENTITY|20|mg|od|similar|efficacy|safety|patient|active|DISEASE_ENTITY|ra|.	652404	1.0	11
myocardial|circulatory|metabolic|effect|COMPOUND_ENTITY|use|control|intraoperative|hypertension|patient|DISEASE_ENTITY|coronary|artery|disease|.	652561	0.0	11
study|conduct|series|11|patient|-lrb-|previous|DISEASE_ENTITY|infarction|normal|left|ventricular|function|-rrb-|examine|baseline|i.v.|COMPOUND_ENTITY|infusion|,|dose|know|increase|peak|ejection|fill|rate|.	652823	0.0	10
serum|level|COMPOUND_ENTITY|e|vitamin|e/cholesterol|ratio|correlate|age|,|age|onset|,|score|Unified|DISEASE_ENTITY|Parkinson|disease|Rating|Scale|Hoehn|Yahr|staging|pd|group|.	652852	0.0	11
serum|level|vitamin|e|COMPOUND_ENTITY|e/cholesterol|ratio|correlate|age|,|age|onset|,|score|Unified|DISEASE_ENTITY|Parkinson|disease|Rating|Scale|Hoehn|Yahr|staging|pd|group|.	652862	0.0	11
serum|level|vitamin|e|COMPOUND_ENTITY|e/cholesterol|ratio|correlate|age|,|age|onset|,|score|Unified|Parkinson|disease|Rating|Scale|Hoehn|Yahr|staging|DISEASE_ENTITY|pd|group|.	652868	0.0	11
year|,|37|patient|high|grade|DISEASE_ENTITY|glioma|undergo|246|treatment|procedure|combination|methotrexate|,|COMPOUND_ENTITY|,|procarbazine|association|hyperosmolar|mannitol-induced|transient|breakdown|blood-brain|barrier|.	652874	1.0	11
methodological|requirement|clinical|trial|DISEASE_ENTITY|--|experience|COMPOUND_ENTITY|.	652972	0.0	11
blood|sample|obtain|20.00|,|22.00|,|24.00|,|01.00|,|02.00|,|06.00|,|08.00|12.00|h.|light|turn|21.00|07.00|h.|compare|normal|control|,|circadian|rhythm|plasma|COMPOUND_ENTITY|absent|paranoid|DISEASE_ENTITY|schizophrenic|-lrb-|f7|.84|=|7.30|,|p|0.0001|;|two-way|ANOVA|repeat|measure|-rrb-|24-h|profile|plasma|cortisol|preserve|,|slightly|higher|level|-lrb-|f1|.12|=|26.810|,|p|0.0002|-rrb-|.	653056	0.0	11
previous|work|consistent|fall|COMPOUND_ENTITY|-lrb-|sam|-rrb-|liver|diethylnitrosamine-initiated|rat|,|development|preneoplastic|lesion|,|persistent|nodule|-lrb-|pn|-rrb-|,|DISEASE_ENTITY|hepatocellular|carcinoma|.	653165	0.0	11
extracellular|level|aspartate|-lrb-|asp|-rrb-|,|glutamate|-lrb-|glu|-rrb-|,|serine|-lrb-|ser|-rrb-|,|asparagine|-lrb-|asn|-rrb-|,|glycine|-lrb-|gly|-rrb-|,|threonine|-lrb-|thr|-rrb-|,|arginine|-lrb-|arg|-rrb-|,|alanine|-lrb-|ala|-rrb-|,|taurine|-lrb-|tau|-rrb-|,|tyrosine|-lrb-|tyr|-rrb-|,|COMPOUND_ENTITY|-lrb-|phe|-rrb-|,|isoleucine|-lrb-|ileu|-rrb-|,|leucine|-lrb-|leu|-rrb-|monitor|use|intracerebral|microdialysis|seven|patient|medically|intractable|epilepsy|,|undergo|DISEASE_ENTITY|epilepsy|surgery|.	653168	0.0	10
effect|COMPOUND_ENTITY|self-renewal|capacity|leukemic|progenitor|DISEASE_ENTITY|acute|myeloblastic|leukemia|.	653207	0.0	10
Motor|evoke|potential|-lrb-|mep|-rrb-|record|23|patient|definite|relapsing|DISEASE_ENTITY|sclerosis|treatment|short|course|high|dose|COMPOUND_ENTITY|.	653411	0.0	10
total|30|consecutive|patient|refractory|relapsing|DISEASE_ENTITY|lymphoma|-lrb-|nhl|-rrb-|treat|combination|dexamethasone|,|etoposide|-lrb-|vp-16|-rrb-|,|COMPOUND_ENTITY|,|cisplatin|-lrb-|dvip|-rrb-|.	653479	1.0	11
COMPOUND_ENTITY|use|year|management|DISEASE_ENTITY|ulcerative|colitis|.	653635	0.0	10
,|lower|dopamine|level|neostriatum|nucleus|accumben|septi|El|mouse|compare|ddy|mouse|improve|DISEASE_ENTITY|IVT|administration|COMPOUND_ENTITY|.	653724	0.0	10
synthetic|glucocorticoid|COMPOUND_ENTITY|-lrb-|1|microm|1|pm|-rrb-|strongly|-lrb-|maximum|greater|80|%|-rrb-|inhibit|proliferation|a549|human|DISEASE_ENTITY|lung|adenocarcinoma|line|-lrb-|ec50|greater|1|nm|-rrb-|lead|appearance|,|increase|-lrb-|approximately|3-fold|-rrb-|expression|cell|surface|,|calcium|phospholipid|binding|protein|lipocortin|-lrb-|annexin|-rrb-|1|.	653733	0.0	10
cerebrospinal|fluid|-lrb-|csf|-rrb-|level|corticotropin-releasing|hormone|-lrb-|crh|-rrb-|acth|,|plasma|level|CRH|,|acth|COMPOUND_ENTITY|determine|sample|simultaneously|28|patient|dementia|include|senile|dementia|DISEASE_ENTITY|alzheimer|type|-lrb-|sdat|-rrb-|,|multi-infarct|dementia|-lrb-|mid|-rrb-|,|dementia|follow|cerebrovascular|accident|-lrb-|cvd|-rrb-|,|borderline-to-normal|state|.	653818	0.0	11
abortive|DISEASE_ENTITY|therapy|oral|naproxen|sodium|plus|metoclopramide|plus|ergotamine|tartrate|COMPOUND_ENTITY|.	653843	1.0	11
datum|suggest|basal|COMPOUND_ENTITY|formation|artery|reflect|basal|release|edrf|reduce|older|shr|associate|development|hypertension|,|stimulate|release|edrf|associate|development|DISEASE_ENTITY|hypertension|.	654194	0.0	10
Rolipram|,|selective|inhibitor|cgmp-noninhibited|COMPOUND_ENTITY|phosphodiesterase|,|small|effect|DISEASE_ENTITY|coronary|lung|artery|,|produce|slightly|pronounced|relaxation|renal|artery|man|rat|.	654340	0.0	10
significant|difference|val|,|Leu|,|Leu|,|COMPOUND_ENTITY|,|Tyr|,|Met|Fischer|ratio|DISEASE_ENTITY|HCC|surround|tissue|.	654371	0.0	11
datum|derive|multi-center|randomize|double-blind|study|comparative|effect|antihypertensive|therapy|-lrb-|captopril|,|COMPOUND_ENTITY|propranolol|-rrb-|quality|life|620|DISEASE_ENTITY|hypertensive|man|.	654519	1.0	10
voltage|clamp|condition|,|current|evoke|transferrin|similar|COMPOUND_ENTITY|display|DISEASE_ENTITY|non-linear|voltage|dependence|.	654543	0.0	10
determine|beneficial|effect|low-dose|COMPOUND_ENTITY|survival|patient|complex|ventricular|arrhythmia|DISEASE_ENTITY|myocardial|infarction|dependent|left|ventricular|-lrb-|lv|-rrb-|function|,|result|Basel|Antiarrhythmic|Study|Infarct|Survival|analyze|.	654643	0.0	11
case|blood|eosinophilia|pulmonary|infiltrate|associate|COMPOUND_ENTITY|therapy|patient|DISEASE_ENTITY|ulcerative|colitis|describe|.	654676	0.0	10
explore|effect|repeat|episode|hypercortisolemia|DISEASE_ENTITY|axis|regulation|,|study|plasma|acth|COMPOUND_ENTITY|-lrb-|cort|-rrb-|response|100|microgram|human|crh|-lrb-|hcrh|-rrb-|10|dexamethasone|-lrb-|1.5|mg|-rrb-|-|pretreat|elderly|endurance|athlete|abstain|physical|activity|48|h|testing|13|sedentary|age-matched|control|.	655053	0.0	10
study|serum|thromboxane|-lrb-|txb2|-rrb-|,|prostacyclin|metabolite|,|6-keto-pgf1|-lrb-|6kpgf1|-rrb-|glucose|,|insulin|,|lipid/lipoprotein|profile|27|patient|non-insulin-dependent|diabetes|mellitus|-lrb-|DISEASE_ENTITY|-rrb-|switch|therapy|glibenclamide|-lrb-|glb|-rrb-|-lrb-|-lsb-|glbh|-rsb-|COMPOUND_ENTITY|-rrb-|gliclazide|3|month|.	655863	0.0	10
chromosome|observation|DISEASE_ENTITY|leukemia|treat|COMPOUND_ENTITY|acid|.	655948	0.0	10
stress|echocardiography|COMPOUND_ENTITY|infusion|detection|DISEASE_ENTITY|coronary|artery|disease|potential|alternative|exercise|stress|testing|theoretic|advantage|.	656019	0.0	10
direct|addition|COMPOUND_ENTITY|emulsion|t-cell|proliferation|assay|system|suppress|DISEASE_ENTITY|apc|function|.	656216	0.0	11
present|study|,|calcium|acetate|use|mean|11|month|serum|phosphate|control|30|DISEASE_ENTITY|patient|previously|treat|aluminum|and/or|COMPOUND_ENTITY|carbonate|.	656226	1.0	10
value|l-alanine|COMPOUND_ENTITY|transport|2-fold|higher|preparation|DISEASE_ENTITY|obese|rat|.	656294	0.0	11
hypocomplementemic|urticarial|vasculitic|syndrome|,|DISEASE_ENTITY|anaphylactic|reaction|COMPOUND_ENTITY|.	656299	0.0	10
comparison|wall|motion|analysis|,|12-lead|electrocardiogram|COMPOUND_ENTITY|infusion|reveal|ischemic|change|17|%|patient|DISEASE_ENTITY|cad|.	656430	0.0	10
long-term|follow-up|controlled|trial|compare|combination|methotrexate|plus|COMPOUND_ENTITY|cyclosporine|prophylaxis|graft-versus-host|disease|patient|administer|hla-identical|marrow|graft|DISEASE_ENTITY|leukemia|.	656544	0.0	10
successful|uncomplicated|angioplasty|-lrb-|ptca|-rrb-|,|study|effect|short|lasting|DISEASE_ENTITY|ischemia|plasma|creatine|kinase|,|COMPOUND_ENTITY|kinase|mb-activity|,|creatine|kinase|mm-isoform|-lrb-|mm1|,|mm2|,|mm3|-rrb-|23|patient|.	656691	0.0	10
successful|uncomplicated|angioplasty|-lrb-|ptca|-rrb-|,|study|effect|short|lasting|DISEASE_ENTITY|ischemia|plasma|creatine|kinase|,|creatine|kinase|mb-activity|,|COMPOUND_ENTITY|kinase|mm-isoform|-lrb-|mm1|,|mm2|,|mm3|-rrb-|23|patient|.	656697	0.0	10
conclusion|:|population|high|prevalence|-lrb-|85|%|-rrb-|DISEASE_ENTITY|disease|,|COMPOUND_ENTITY|stress|echocardiography|high|sensitivity|positive|predictive|value|coronary|disease|detection|particularly|patient|left|anterior|descend|vessel|disease|.	657022	0.0	10
16|patient|significant|DISEASE_ENTITY|disease|,|COMPOUND_ENTITY|stress|identify|15|patient|correctly|,|12|abnormal|exercise|response|.	657139	0.0	10
randomize|clinical|trial|,|author|compare|use|postoperative|subconjunctival|injection|5-fluorouracil|-lrb-|5-fu|-rrb-|19|eye|single|intraoperative|application|subconjunctival|mitomycin|-lrb-|COMPOUND_ENTITY|-rrb-|filter|site|20|eye|high|risk|failure|DISEASE_ENTITY|glaucoma|filter|surgery|.	657247	0.0	10
evaluate|role|mm|COMPOUND_ENTITY|kinase|isoform|detect|infarct|vessel|patency|84|patient|DISEASE_ENTITY|acute|myocardial|infarction|,|total|creatine|kinase|,|mb|creatine|kinase|,|mm|isoform|determine|start|thrombolytic|therapy|30|,|60|,|120|minute|later|.	657373	0.0	10
19|patient|locally|advance|cutaneous|DISEASE_ENTITY|cancer|treat|topical|vitamin|d|analogue|COMPOUND_ENTITY|100|microgram|daily|.	657558	1.0	11
major|finding|study|patient|DISEASE_ENTITY|experience|lactic|acidosis|exercise|achieve|physiologic|training|response|program|endurance|training|training|work|rate|engender|high|level|blood|COMPOUND_ENTITY|effective|work|rate|elicit|low|lactate|level|.	657654	0.0	11
topical|COMPOUND_ENTITY|treatment|advanced|DISEASE_ENTITY|breast|cancer|.	657915	1.0	11
induction|skin|DISEASE_ENTITY|tumor|male|rat|n-methyl-n-nitrosourea|sequential|treatment|COMPOUND_ENTITY|acetate|testosterone|propionate|:|effect|castration|,|rat|strain|time|carcinogen|injection|.	657987	1.0	11
summary|,|portal|DISEASE_ENTITY|accompany|significant|vitro|hyporeactivity|splanchnic|vessel|norepinephrine|,|arginine-vasopressin|,|COMPOUND_ENTITY|chloride|,|secretion|nitric|oxide|preparation|responsible|blunt|response|.	658234	0.0	10
DISEASE_ENTITY|patient|,|significant|positive|linear|correlation|-lrb-|r|=|.821|,|p|.001|-rrb-|find|serum|COMPOUND_ENTITY|guanidinosuccinic|acid|level|significant|positive|linear|correlation|find|serum|urea|level|urinary|guanidinosuccinic|acid|level|-lrb-|r|=|.828|,|p|.001|-rrb-|,|serum|arginine|level|urinary|guanidinosuccinic|acid|level|hyperargininemic|patient|.	658282	0.0	11
DISEASE_ENTITY|patient|,|significant|positive|linear|correlation|-lrb-|r|=|.821|,|p|.001|-rrb-|find|serum|urea|guanidinosuccinic|acid|level|significant|positive|linear|correlation|find|serum|COMPOUND_ENTITY|level|urinary|guanidinosuccinic|acid|level|-lrb-|r|=|.828|,|p|.001|-rrb-|,|serum|arginine|level|urinary|guanidinosuccinic|acid|level|hyperargininemic|patient|.	658287	0.0	11
slight|efficacy|COMPOUND_ENTITY|e|detect|DISEASE_ENTITY|atopic|dermatitis|child|.	658297	1.0	11
DISEASE_ENTITY|patient|undergo|course|ECT|,|receive|COMPOUND_ENTITY|thiopental|anaesthesia|alternatively|.	658359	1.0	11
human|tumour-associated|macrophage|-lrb-|tam|-rrb-|isolate|DISEASE_ENTITY|carcinoma|incubate|bone|slice|form|resorption|lacuna|14|day|co-culture|mouse|marrow-derived|stromal|cell|line|-lrb-|st2|-rrb-|add|1|alpha|,|25-dihydroxy|vitamin|d3|COMPOUND_ENTITY|.	658451	0.0	10
basal|activity|DISEASE_ENTITY|axis|estimate|determination|24-h|urinary|free|cortisol-excretion|,|evening|basal|plasma|total|free|COMPOUND_ENTITY|concentration|,|cortisol|binding|globulin-binding|capacity|.	658724	0.0	10
demonstrate|vitro|ige|synthesis|peripheral|blood|mononuclear|cell|culture|patient|DISEASE_ENTITY|dermatitis|suppress|addition|COMPOUND_ENTITY|pge2|.	658866	0.0	11
examine|effect|COMPOUND_ENTITY|pulsed-doppler|left|ventricular|ejection|dynamics|utility|evaluation|coronary|disease|-lrb-|DISEASE_ENTITY|cad|-rrb-|study|10|patient|normal|coronary|-lrb-|group|1|-rrb-|24|patient|significant|cad|-lrb-|greater|equal|70|%|diameter|stenosis|-rrb-|use|grade|stress|infusion|-lrb-|5|20|micrograms.kg-1|.	658883	0.0	10
phase|ii|clinical|trial|,|combination|COMPOUND_ENTITY|ara-c|produce|43|%|response|rate|patient|refractory|DISEASE_ENTITY|malignant|lymphoma|.	658951	0.0	10
DISEASE_ENTITY|arthritis|treat|prednisone|COMPOUND_ENTITY|.	659565	1.0	11
Weekend|attack|DISEASE_ENTITY|patient|:|cause|COMPOUND_ENTITY|withdrawal|?	659627	0.0	11
COMPOUND_ENTITY|kinase|mb|isoform|early|diagnosis|monitoring|DISEASE_ENTITY|acute|myocardial|infarction|.	659714	0.0	10
ketamine|,|midazolam|COMPOUND_ENTITY|infusion|use|total|intravenous|anesthesia|patient|syndrome|,|ventricular|septal|defect|DISEASE_ENTITY|pulmonary|hypertension|.	659799	0.0	10
Fluoxetine|COMPOUND_ENTITY|treatment|DISEASE_ENTITY|bipolar|disorder|,|type|ii|,|associate|gad|.	659978	1.0	10
better|understand|biosynthesis|guanidinosuccinic|acid|,|determine|COMPOUND_ENTITY|,|arginine|,|guanidinosuccinic|acid|level|nondialyzed|DISEASE_ENTITY|uremic|hyperargininemic|patient|.	660097	0.0	11
COMPOUND_ENTITY|prednisone|therapy|pure|red|cell|aplasia|patient|DISEASE_ENTITY|chronic|lymphocytic|leukemia|.	660154	1.0	10
COMPOUND_ENTITY|safely|combine|mitoxantrone|dose|previously|treat|patient|DISEASE_ENTITY|non-hodgkin|lymphoma|.	660382	1.0	11
content|COMPOUND_ENTITY|acid|red|blood|cell|,|plasma|,|DISEASE_ENTITY|Ehrlich|ascite|tumor|cell|measure|gas-liquid|chromatography|use|column|terephtalic|acid|support|coat|polyethylene|glycol-6000|.	660434	0.0	10
common|pharmacological|treatment|DISEASE_ENTITY|agoraphobia|-lrb-|pda|-rrb-|include|use|imipramine|COMPOUND_ENTITY|common|behavior|therapy|use|grade|vivo|exposure|.	660690	1.0	10
68-yr-old|male|severe|psoriasis|develop|DISEASE_ENTITY|anemia|folate|deficiency|3|month|cessation|low-dose|COMPOUND_ENTITY|therapy|.	661139	1.0	11
compare|COMPOUND_ENTITY|acid|-lrb-|gd-dtpa|-rrb-|enhance|t1-weighted|image|-lrb-|t1-gd|-rrb-|histopathological|finding|13|patient|DISEASE_ENTITY|bone|soft|tissue|sarcoma|.	661555	0.0	11
basal|acth|COMPOUND_ENTITY|secretion|study|dexamethasone|suppression|test|patient|early|stage|clinically|probable|DISEASE_ENTITY|alzheimer|disease|control|,|result|normal|.	661847	0.0	11
measurement|result|:|35|patient|-lrb-|26|%|;|95|%|ci|,|9|%|52|%|-rrb-|DISEASE_ENTITY|leukemia|treat|COMPOUND_ENTITY|acid|develop|syndrome|consist|primarily|fever|respiratory|distress|.	662221	1.0	10
COMPOUND_ENTITY|deficiency|,|significant|feature|senile|dementia|alzheimer|type|DISEASE_ENTITY|aids-related|dementia|complex|,|result|concomitant|slow|synthesis|dna|SAM|.	662272	0.0	10
patient|receive|triple|intrathecal|chemotherapy|-lrb-|COMPOUND_ENTITY|,|ara-c|,|methotrexate|-rrb-|prevention|DISEASE_ENTITY|cns|leukemia|.	662529	1.0	10
patient|DISEASE_ENTITY|respond|administration|COMPOUND_ENTITY|acid|.	662627	0.0	10
clinical|immunohistological|characteristic|DISEASE_ENTITY|lymphoma|describe|etiopathological|mechanism|,|especially|role|COMPOUND_ENTITY|,|development|lymphoproliferative|disorder|,|discuss|.	662868	0.0	10
study|perform|elucidate|role|bacterial|infection|acute|DISEASE_ENTITY|young|female|mouse|feed|COMPOUND_ENTITY|diet|supplement|0.5|%|dl-ethionine|-lrb-|cde|diet|-rrb-|.	662971	0.0	11
find|treatment|COMPOUND_ENTITY|beneficial|DISEASE_ENTITY|multiple|sclerosis|-lrb-|ms|-rrb-|,|70|patient|definite|ms|enter|randomize|,|double-blind|,|placebo-controlled|,|cross-over|trial|treat|4-aminopyridine|placebo|12|week|-lrb-|maximum|dose|,|0.5|mg/kg|body|weight|-rrb-|.	663303	0.0	10
find|treatment|4-aminopyridine|beneficial|multiple|sclerosis|-lrb-|DISEASE_ENTITY|-rrb-|,|70|patient|definite|ms|enter|randomize|,|double-blind|,|placebo-controlled|,|cross-over|trial|treat|COMPOUND_ENTITY|placebo|12|week|-lrb-|maximum|dose|,|0.5|mg/kg|body|weight|-rrb-|.	663325	0.0	10
,|iv|administration|COMPOUND_ENTITY|,|practical|patient|DISEASE_ENTITY|end-stage|renal|disease|-lrb-|esrd|-rrb-|maintain|continuous|ambulatory|peritoneal|dialysis|-lrb-|capd|-rrb-|.	663433	0.0	11
,|iv|administration|COMPOUND_ENTITY|,|practical|patient|end-stage|renal|disease|-lrb-|DISEASE_ENTITY|esrd|-rrb-|maintain|continuous|ambulatory|peritoneal|dialysis|-lrb-|capd|-rrb-|.	663437	0.0	11
paper|report|author|'|experience|effect|therapy|methotrexate|-lrb-|COMPOUND_ENTITY|-rrb-|18|patient|DISEASE_ENTITY|invalidant|psoriatic|arthritis|-lrb-|pa|-rrb-|.	663458	0.0	10
-lsb-|effect|COMPOUND_ENTITY|prostacyclin|,|thromboxane|pancreatic|blood|flow|rat|experimental|acute|DISEASE_ENTITY|pancreatitis|-rsb-|.	663636	0.0	10
factor|influence|serum|concentration|COMPOUND_ENTITY|DISEASE_ENTITY|epileptic|patient|.	663890	0.0	11
study|effect|COMPOUND_ENTITY|verapamil|modulation|vincristine|daunorubicin|resistance|multidrug-resistant|subline|human|t-cell|DISEASE_ENTITY|acute|lymphatic|leukemia|gm3639|.	663921	0.0	10
two-kidney|,|one-clip|DISEASE_ENTITY|preparation|,|COMPOUND_ENTITY|normalize|endothelium-dependent|relaxation|.	663952	0.0	10
DISEASE_ENTITY|COMPOUND_ENTITY|renal|transplant|recipient|.	663991	0.0	10
present|analytical|finding|DISEASE_ENTITY|hyperargininemic|patient|clearly|demonstrate|metabolic|relationship|COMPOUND_ENTITY|guanidinosuccinic|acid|.	664181	0.0	11
guideline|clinical|evaluation|antiepileptic|drug|-lrb-|aed|-rrb-|,|propose|International|League|DISEASE_ENTITY|1989|,|scrutinize|clinical|experience|COMPOUND_ENTITY|.	664250	0.0	11
study|objective|:|study|test|hypothesis|serial|COMPOUND_ENTITY|phosphokinase|-lrb-|ck|-rrb-|-|mb|sampling|emergency|department|identify|acute|myocardial|infarction|-lrb-|DISEASE_ENTITY|AMI|-rrb-|patient|present|ed|chest|pain|nondiagnostic|ecg|.	664350	0.0	10
compare|in-vitro|activity|COMPOUND_ENTITY|,|itraconazole|ketoconazole|evaluate|minimal|inhibitory|concentration|-lrb-|mic|-rrb-|100|fungal|strain|isolate|different|biological|specimen|DISEASE_ENTITY|arc/aids|patient|.	664385	0.0	10
Tenoxicam|20|mg|od|compare|COMPOUND_ENTITY|20|mg|od|patient|DISEASE_ENTITY|rheumatoid|arthritis|-lrb-|ra|-rrb-|.	664573	0.0	11
prospective|study|8|child|receive|tmp-smz|chemotherapy|DISEASE_ENTITY|leukemia|reveal|lower|serum|COMPOUND_ENTITY|concentration|higher|urine|ph|follow|dose|tmp-smz|paired|value|obtain|3|day|dose|.	664589	0.0	10
patient|DISEASE_ENTITY|infarction|asymptomatic|complex|arrhythmia|randomly|assign|receive|COMPOUND_ENTITY|200|mg/day|control|group|follow|1|year|.	664620	0.0	11
basis|present|result|,|previous|observation|COMPOUND_ENTITY|transiently|inactivate|neuron|nucleus|locus|coeruleus|,|propose|reflex|DISEASE_ENTITY|depression|cause|removal|descend|noradrenergic|facilitation|exert|spinal|reflex|transmission|.	664664	0.0	11
agent|active|DISEASE_ENTITY|-lrb-|e.g.|mk-801|,|imipramine|,|COMPOUND_ENTITY|-rrb-|unaffected|regimen|.	664704	0.0	11
circulate|acth|COMPOUND_ENTITY|similar|patient|control|normal|inhibition|plasma|cortisol|dexamethasone|observe|13/14|DISEASE_ENTITY|ad|12/14|pd|patient|.	664810	0.0	11
circulate|acth|cortisol|similar|patient|control|normal|inhibition|plasma|COMPOUND_ENTITY|dexamethasone|observe|13/14|DISEASE_ENTITY|ad|12/14|pd|patient|.	664820	0.0	11
phase|ii|trial|COMPOUND_ENTITY|mitoxantrone|previously|treat|patient|DISEASE_ENTITY|non-hodgkin|lymphoma|:|cancer|leukemia|group|b|study|8753|.	665113	1.0	11
localization|cellular|COMPOUND_ENTITY|acid|binding|protein|-lrb-|crabp|-rrb-|gene|relative|DISEASE_ENTITY|acute|promyelocytic|leukemia-associated|breakpoint|human|chromosome|15|.	665427	0.0	10
COMPOUND_ENTITY|significantly|effective|panic|anxiety|variable|DISEASE_ENTITY|PDA|,|exposure|significantly|effective|phobia|variable|.	665448	1.0	10
COMPOUND_ENTITY|cyclic|amp|accumulation|cell|prepare|DISEASE_ENTITY|obese|subject|compare|normal-weight|subject|,|sensitive|inhibition|adenosine|agonist|n6|-|-lrb-|phenylisopropyl|-rrb-|adenosine|-lrb-|pia|-rrb-|-lrb-|p|=|0.047|-rrb-|.	665710	0.0	10
comparison|tenoxicam|COMPOUND_ENTITY|treatment|DISEASE_ENTITY|rheumatoid|arthritis|.	665725	1.0	11
purpose|:|recent|report|dramatic|antitumor|effect|COMPOUND_ENTITY|acid|-lrb-|ra|-rrb-|patient|DISEASE_ENTITY|acute|promyelocytic|leukemia|-lrb-|apl|-rrb-|generate|renew|enthusiasm|clinical|study|retinoid|oncologic|therapeutic|indication|.	665728	0.0	10
55-year-old|patient|DISEASE_ENTITY|infarction|treat|effectively|ventricular|tachycardia|high-dose|oral|COMPOUND_ENTITY|load|regimen|-lrb-|5|g|16|hour|-rrb-|.	666027	0.0	11
method|:|pulmonary|effect|examine|sample|61|symptomless|patient|-lrb-|mean|-lrb-|sd|-rrb-|age|55|-lrb-|7|-rrb-|year|-rrb-|long|term|treatment|COMPOUND_ENTITY|-lrb-|daily|maintenance|dose|400|mg|-rrb-|,|select|482|man|attend|University|Barcelona|DISEASE_ENTITY|myocardial|infarction|project|.	666035	1.0	11
elucidate|possible|role|COMPOUND_ENTITY|e|pathogenesis|DISEASE_ENTITY|Parkinson|disease|-lrb-|pd|-rrb-|,|compare|serum|level|alpha-tocopherol|-lrb-|vitamin|e|-rrb-|,|measure|high-performance|liquid|chromatography|,|vitamin|e/cholesterol|ratio|42|Parkinson|disease|-lrb-|pd|-rrb-|patient|use|spouse|control|group|.	666185	0.0	11
elucidate|possible|role|COMPOUND_ENTITY|e|pathogenesis|Parkinson|disease|-lrb-|pd|-rrb-|,|compare|serum|level|alpha-tocopherol|-lrb-|vitamin|e|-rrb-|,|measure|high-performance|liquid|chromatography|,|vitamin|e/cholesterol|ratio|42|DISEASE_ENTITY|Parkinson|disease|-lrb-|pd|-rrb-|patient|use|spouse|control|group|.	666194	0.0	11
elucidate|possible|role|vitamin|e|pathogenesis|Parkinson|disease|-lrb-|DISEASE_ENTITY|-rrb-|,|compare|serum|level|alpha-tocopherol|-lrb-|COMPOUND_ENTITY|-rrb-|,|measure|high-performance|liquid|chromatography|,|vitamin|e/cholesterol|ratio|42|Parkinson|disease|-lrb-|pd|-rrb-|patient|use|spouse|control|group|.	666207	0.0	11
elucidate|possible|role|vitamin|e|pathogenesis|Parkinson|disease|-lrb-|pd|-rrb-|,|compare|serum|level|alpha-tocopherol|-lrb-|COMPOUND_ENTITY|-rrb-|,|measure|high-performance|liquid|chromatography|,|vitamin|e/cholesterol|ratio|42|DISEASE_ENTITY|Parkinson|disease|-lrb-|pd|-rrb-|patient|use|spouse|control|group|.	666212	0.0	11
elucidate|possible|role|vitamin|e|pathogenesis|Parkinson|disease|-lrb-|DISEASE_ENTITY|-rrb-|,|compare|serum|level|alpha-tocopherol|-lrb-|vitamin|e|-rrb-|,|measure|high-performance|liquid|chromatography|,|COMPOUND_ENTITY|e/cholesterol|ratio|42|Parkinson|disease|-lrb-|pd|-rrb-|patient|use|spouse|control|group|.	666227	0.0	11
conclusion|:|echocardiography|combine|COMPOUND_ENTITY|infusion|safe|accurate|method|detect|DISEASE_ENTITY|coronary|artery|disease|predict|extent|disease|localized|rest|wall|motion|abnormality|.	666338	0.0	10
depressed|nocturnal|plasma|COMPOUND_ENTITY|level|drug-free|paranoid|DISEASE_ENTITY|schizophrenic|.	666513	0.0	11
study|na|-lrb-|+|-rrb-|-|dependent|uptake|l-alanine|COMPOUND_ENTITY|plasma-membrane|vesicle|isolate|DISEASE_ENTITY|obese|-|lean-rat|liver|.	666606	0.0	11
DATA|SYNTHESIS|:|case|clinical|manifestation|concomitant|COMPOUND_ENTITY|nsaid|administration|,|include|acute|renal|failure|DISEASE_ENTITY|pancytopenia|,|report|.	666859	0.0	11
DISEASE_ENTITY|population|respond|form|retinoic|acid|,|nb4|cell|sensitive|COMPOUND_ENTITY|acid|compare|cis-retinoic|acid|.	666935	0.0	10
nineteen|nonsteroid-dependent|DISEASE_ENTITY|child|COMPOUND_ENTITY|orally|medication|constant|.	667161	1.0	10
investigate|COMPOUND_ENTITY|-lrb-|alp|-rrb-|coprescription|early|imipramine|-lrb-|imi|-rrb-|treatment|DISEASE_ENTITY|panic|disorder|improve|overall|treatment|response|IMI|,|48|panic|disorder|patient|randomly|assign|receive|IMI|plus|placebo|imi|plus|alp|4-6|week|,|follow|2|week|IMI|plus|placebo-alp|taper|2|week|IMI|.	667421	0.0	10
attempt|elucidate|possible|mechanism|responsible|synergistic|interaction|hyperthermia|melphalan|observe|DISEASE_ENTITY|cell|,|investigate|effect|heat|formation|removal|COMPOUND_ENTITY|dna|interstrand|cross-link|-lrb-|dna|isc|-rrb-|.	667851	0.0	10
selective|adrenergic|alpha|1|blocker|,|COMPOUND_ENTITY|,|alpha|2|blocker|,|yohimbine|,|non-selective|beta-blocker|,|propranolol|,|significant|effect|gastric|relaxation|follow|DISEASE_ENTITY|colonic|distension|.	667930	0.0	10
describe|pediatric|patient|acute|promyelocytic|leukemia|-lrb-|DISEASE_ENTITY|-rrb-|successfully|induce|complete|remission|COMPOUND_ENTITY|acid|-lrb-|atra|,|45|mg/m2|day|-rrb-|fail|conventional|chemotherapy|.	668257	1.0	10
cardiac|event|occur|30|postoperative|day|:|cardiac|death|-lrb-|5|%|-rrb-|,|nonfatal|myocardial|infarction|-lrb-|10|%|-rrb-|,|patient|DISEASE_ENTITY|angina|-lrb-|3.3|%|-rrb-|,|patient|asymptomatic|elevation|COMPOUND_ENTITY|phosphokinase|mb|isoenzyme|electrocardiographic|change|-lrb-|1.7|%|-rrb-|.	668270	0.0	10
ability|13c|aminopyrine|breath|test|-lrb-|apbt|-rrb-|reflect|hepatocellular|metabolic|capacity|predict|COMPOUND_ENTITY|removal|follow|incremental|exercise|male|DISEASE_ENTITY|copd|patient|evaluate|.	668416	0.0	11
high-resolution|1h|nmr|spectroscopy|use|measure|concentration|metabolite|-lrb-|alanine|,|n-acetylaspartate|,|gamma-aminobutyric|acid|,|glutamate|,|glutamine|,|aspartate|,|taurine|,|COMPOUND_ENTITY|,|succinate|,|creatine|,|choline|,|inositol|,|glucose|-rrb-|perchloric|acid|extract|human|epileptic|cortex|DISEASE_ENTITY|brain|tumor|.	668430	0.0	11
COMPOUND_ENTITY|cytotoxic|agent|DISEASE_ENTITY|cholangiocarcinoma|:|preliminary|report|seven|case|.	668468	0.0	10
COMPOUND_ENTITY|DISEASE_ENTITY|hypertension|preterm|infant|.	668577	0.0	10
sr|DISEASE_ENTITY|define|failure|improve|morning|prebronchodilator|fev1|greater|60|%|predict|2-week|course|oral|COMPOUND_ENTITY|-lrb-|mean|dose|,|45|mg/day|-rrb-|.	668835	0.0	10
effect|cafeteria|diet-induced|DISEASE_ENTITY|vitro|uptake|l-alanine|,|glycine|,|l-lysine|,|COMPOUND_ENTITY|,|l-glutamic|acid|,|l-phenylalanine|l-leucine|isolate|rat|erythrocyte|study|.	668871	0.0	11
potentially|fatal|arrhythmia|encounter|patient|previous|DISEASE_ENTITY|infarction|,|resistant|treatment|lidocaine|,|COMPOUND_ENTITY|electric|defibrillation|.	669012	1.0	11
24-h|profile|plasma|COMPOUND_ENTITY|cortisol|evaluate|7|drug-free|male|paranoid|DISEASE_ENTITY|schizophrenic|7|healthy|subject|match|patient|age|,|sex|,|body|weight|,|height|season|testing|.	669230	0.0	11
rapid|relapse|cryptococcal|meningitis|termination|maintenance|COMPOUND_ENTITY|DISEASE_ENTITY|AIDS|.	669284	0.0	10
-lsb-|treatment|congestive|heart|failure|COMPOUND_ENTITY|nitroprusside|infusion|association|DISEASE_ENTITY|chronic|obstructive|lung|disease|postinfarct|cardiosclerosis|-rsb-|.	669373	0.0	11
COMPOUND_ENTITY|acid-induced|granulocytic|differentiation|hl60|human|DISEASE_ENTITY|promyelocytic|leukemia|cell|precede|downregulation|autonomous|generation|inositol|lipid-derived|second|messenger|.	670143	0.0	10
examine|role|COMPOUND_ENTITY|acid|-lrb-|ra|-rrb-|,|biologically|active|metabolite|vitamin|,|expression|il-1|beta|gene|human|DISEASE_ENTITY|myeloid|leukemia|cell|line|thp-1|human|monocyte|.	670586	0.0	10
study|infusional|cisplatin|infusional|COMPOUND_ENTITY|locally|advance|metastatic|DISEASE_ENTITY|non-small-cell|lung|cancer|:|Mid-Atlantic|Oncology|Program|study|.	670668	0.0	10
serum|level|COMPOUND_ENTITY|e|differ|significantly|group|-lrb-|13.84|+|/|-|0.56|micrograms/ml|DISEASE_ENTITY|pd|14.80|+|/|-|0.57|micrograms/ml|control|-rrb-|,|vitamin|e/cholesterol|ratio|-lrb-|0.64|+|/|-|0.03|group|-rrb-|.	670733	0.0	11
triple-drug|immunosuppression|-lrb-|cyclosporine|,|azathioprine|,|COMPOUND_ENTITY|-rrb-|reduce|incidence|acute|rejection|pediatric|cardiac|transplantation|,|effect|development|DISEASE_ENTITY|coronary|artery|disease|,|major|determinant|long-term|survival|patient|,|define|.	670749	0.0	10
allow|confounding|effect|DISEASE_ENTITY|disease|tobacco|history|lung|function|,|46|patient|COMPOUND_ENTITY|year|match|control|group|population|.	671166	0.0	11
tail-pinch|potential|ipsilateral|slow|vrp|DISEASE_ENTITY|application|spinal|cord|COMPOUND_ENTITY|-lrb-|2-3|microm|-rrb-|,|diazepam|-lrb-|2|microm|-rrb-|eperisone|-lrb-|100-200|microm|-rrb-|.	671234	0.0	11
analysis|publication|devote|point|indicate|drug|actually|consider|potent|disinhibitor|-lrb-|i.e.|active|negative|symptom|DISEASE_ENTITY|-rrb-|:|phenothiazine|:|controlled|study|itil|-lrb-|1971|-rrb-|,|poirier-littr|-lrb-|1988|-rrb-|,|COMPOUND_ENTITY|pipotiazine|improve|bprs|anergia|factor|sans|score|.	671276	0.0	10
wide|variety|agent|undergo|preliminary|testing|regard|include|natural|substance|homoherringtonine|,|drug|demonstrate|modest|complete|remission|rate|disease|COMPOUND_ENTITY|acid|,|compound|revolutionize|treatment|DISEASE_ENTITY|acute|promyelocytic|leukemia|.	671564	1.0	10
increase|cytoplasmic|COMPOUND_ENTITY|+|stimulation|calcitonin|secretion|human|DISEASE_ENTITY|medullary|thyroid|carcinoma|cell|gastrin-releasing|peptide|.	672076	0.0	10
salvage|therapy|DISEASE_ENTITY|lymphoma|combination|dexamethasone|,|etoposide|,|COMPOUND_ENTITY|,|cisplatin|.	672085	1.0	11
bullae|cure|administration|corticosteroid|and/or|COMPOUND_ENTITY|course|parallel|DISEASE_ENTITY|ulcerative|colitis|.	672449	0.0	10
COMPOUND_ENTITY|resistant|candida|DISEASE_ENTITY|AIDS|.	876047	0.0	10
Monotherapy|childhood|DISEASE_ENTITY|COMPOUND_ENTITY|.	876137	1.0	11
efficacy|safety|COMPOUND_ENTITY|,|imipramine|placebo|treat|DISEASE_ENTITY|panic|disorder|.	876160	1.0	10
molecular|evaluation|response|COMPOUND_ENTITY|acid|therapy|patient|DISEASE_ENTITY|acute|promyelocytic|leukemia|.	876276	0.0	10
patient|steal-prone|coronary|anatomy|,|incidence|DISEASE_ENTITY|ischemia|primary|anesthetic|24.0|%|enflurane|,|34.4|%|COMPOUND_ENTITY|,|32.1|%|isoflurane|,|38.2|%|sufentanil|.	876334	0.0	11
COMPOUND_ENTITY|produce|marked|DISEASE_ENTITY|increase|blood|pressure|rabbit|pretreat|tranylcypromine|affect|significantly|heart|rate|.	876387	0.0	10
initial|step|understand|rapid|growth|small|cell|lung|cancer|-lrb-|sclc|-rrb-|,|complementary|dna|library|prepare|DISEASE_ENTITY|cell|line|screen|viral|oncogene|probe|encode|COMPOUND_ENTITY|kinase|,|know|play|important|role|regulation|cell|growth|.	876468	0.0	10
aspirin|potentiate|effect|COMPOUND_ENTITY|thermogenic|response|meal|DISEASE_ENTITY|obese|lean|woman|.	876655	0.0	10
effect|DPI|201-106|,|novel|cardiotonic|agent|,|hemodynamic|,|cardiac|electrophysiology|arrhythmia|induce|program|ventricular|stimulation|dog|subacute|DISEASE_ENTITY|infarction|:|comparative|study|COMPOUND_ENTITY|.	876851	0.0	10
stabilize|DISEASE_ENTITY|patient|,|receive|low|dose|schizophrenic|patient|,|receive|low|dose|COMPOUND_ENTITY|decanoate|-lrb-|5|10|mg|2|week|-rrb-|monitor|weekly|evaluation|determine|meet|criterion|nonpsychotic|prodromal|episode|.	876884	0.0	10
datum|,|conclude|2|week|intermittent|dobutamine|therapy|conscious|rat|heal|DISEASE_ENTITY|infarct|improve|cardiac|performance|restore|inotropic|response|acute|COMPOUND_ENTITY|administration|.	877020	0.0	10
COMPOUND_ENTITY|treatment|high-grade|recurrent|DISEASE_ENTITY|non-hodgkin|lymphoma|.	877057	1.0	11
Randomized|,|double-blind|trial|deflazacort|versus|COMPOUND_ENTITY|juvenile|chronic|-lrb-|DISEASE_ENTITY|rheumatoid|-rrb-|arthritis|:|relatively|bone-sparing|effect|deflazacort|.	877178	0.0	10
COMPOUND_ENTITY|,|isotretinoin|acitretin|examine|capacity|modulate|proliferation|cell|line|:|hl-60|-lrb-|DISEASE_ENTITY|acute|promyelocytic|leukemia|-rrb-|,|mcf7|-lrb-|mammary|carcinoma|-rrb-|,|scc4|,|scc15|a431|-lrb-|squamous|cell|carcinoma|-rrb-|.	877375	0.0	10
patient|DISEASE_ENTITY|arthritis|-lrb-|ra|-rrb-|reduce|capacity|s-oxidation|formation|drug|COMPOUND_ENTITY|conjugate|.	877454	0.0	11
patient|rheumatoid|arthritis|-lrb-|DISEASE_ENTITY|-rrb-|reduce|capacity|s-oxidation|formation|drug|COMPOUND_ENTITY|conjugate|.	877458	0.0	11
additional|depressive|effect|contractility|active|relaxation|result|10|mg|COMPOUND_ENTITY|administer|dog|DISEASE_ENTITY|myocardial|infarction|effect|sufficient|worsen|acute|myocardial|infarction-induced|heart|failure|.	877496	0.0	11
effect|monotherapy|angiotensin|convert|enzyme|inhibitor|COMPOUND_ENTITY|-lrb-|10|mg|daily|-rrb-|cardiovascular|baroreceptor|reflex|determine|10|patient|essential|DISEASE_ENTITY|hypertension|use|randomize|,|double-blind|,|placebo-controlled|,|cross-over|protocol|.	878040	0.0	10
absence|arterial|DISEASE_ENTITY|prognosis-positive|factor|treatment|urinary|syndrome|COMPOUND_ENTITY|.	878185	0.0	10
COMPOUND_ENTITY|acid|alpha|receptor|gene|frequently|disrupt|5|'|chinese|patient|DISEASE_ENTITY|acute|promyelocytic|leukemia|.	878323	0.0	10
flexibility|efficacy|automatic|continuous|COMPOUND_ENTITY|infusion|metastase|DISEASE_ENTITY|renal|cell|carcinoma|.	878544	1.0	11
20|dog|critical|DISEASE_ENTITY|artery|-lrb-|lad|-rrb-|stenosis|,|atrial|pacing|rate|100|160|beats/min|achieve|,|end-tidal|COMPOUND_ENTITY|0.7|%|-lrb-|lowh|-rrb-|1.1|%|-lrb-|highh|-rrb-|,|end-tidal|isoflurane|1.1|%|-lrb-|lowi|-rrb-|1.5|%|-lrb-|highi|-rrb-|,|continuous|fentanyl|plus|midazolam|-lrb-|fm|-rrb-|infusion|anesthesia|.	878623	0.0	11
compare|effect|dietary|treatment|-lrb-|d|-rrb-|diet|plus|COMPOUND_ENTITY|-lrb-|dpg|-rrb-|,|3|week|,|glycemia|,|insulin|secretion|action|2|group|DISEASE_ENTITY|non-obese|patient|niddm|match|fast|plasma|glucose|level|.	878919	0.0	11
study|group|asthmatic|patient|inhale|average|326|micrograms/day|beclomethasone|dipropionate|equivalent|50|month|-lrb-|range|36|62|month|-rrb-|control|group|DISEASE_ENTITY|patient|ocs|,|use|12.5|mg|COMPOUND_ENTITY|equivalent|daily|average|57|month|-lrb-|range|22|120|month|-rrb-|.	879021	0.0	10
assess|low|dose|COMPOUND_ENTITY|produce|generalize|alteration|skeletal|homeostasis|rheumatoid|arthritis|-lrb-|DISEASE_ENTITY|ra|-rrb-|,|index|calcium|metabolism|bone|mineral|density|-lrb-|bmd|-rrb-|measure|22|woman|ra|treat|prednisone|-lrb-|6.6|mg|daily|-rrb-|.	879330	0.0	10
effect|acute|alcohol|administration|prostaglandin|e2|-lrb-|COMPOUND_ENTITY|-rrb-|f2|alpha|-lrb-|pgf2|alpha|-rrb-|synthesis|histological|damage|human|DISEASE_ENTITY|gastric|mucosa|.	879383	0.0	10
COMPOUND_ENTITY|treatment|persistent|cryptococcus|neoforman|prostatic|infection|DISEASE_ENTITY|AIDS|.	879435	1.0	10
aspirin|-lrb-|COMPOUND_ENTITY|-rrb-|effective|reduce|vascular|outcome|event|patient|DISEASE_ENTITY|atherosclerosis|:|relative|risk|reduction|30|%|stroke|,|22|%|stroke|death|,|15|%|vascular|mortality|.	880142	0.0	10
DISEASE_ENTITY|spondylarthritis|manifest|silent|intestinal|inflammation|COMPOUND_ENTITY|acid|drug|choice|.	880391	1.0	11
investigate|effect|prior|therapy|-lrb-|busulfan|COMPOUND_ENTITY|-rrb-|DISEASE_ENTITY|cml|hematopoiesis|maintain|long-term|culture|.	880692	0.0	10
twenty-one|psychiatrically|hospitalize|boy|study|psychoactive|medication|determine|DISEASE_ENTITY|disorder|,|solitary|type|,|abuse|neglect|experience|correlate|low|level|COMPOUND_ENTITY|-lrb-|dbh|-rrb-|activity|.	880722	0.0	11
growth|stimulation|differential|regulation|transform|growth|factor-beta|1|-lrb-|tgf|beta|1|-rrb-|,|tgf|beta|2|,|tgf|beta|3|messenger|rna|level|COMPOUND_ENTITY|mcf-7|human|DISEASE_ENTITY|breast|cancer|cell|.	881243	0.0	11
,|DISEASE_ENTITY|correct|epoetin|alfa|,|use|COMPOUND_ENTITY|measure|dialysis|effectiveness|adequate|.	881320	0.0	11
COMPOUND_ENTITY|prevention|early|relapse|treatment|acute|DISEASE_ENTITY|asthma|.	881493	1.0	10
result|confirm|delay|DISEASE_ENTITY|emptying|solid|liquid|diabetic|patient|autonomic|neuropathy|,|indicate|COMPOUND_ENTITY|test|propose|simple|,|safe|noninvasive|test|quantitative|assessment|gastric|emptying|diabetic|patient|.	881574	0.0	10
use|tao|COMPOUND_ENTITY|treatment|severe|DISEASE_ENTITY|asthma|.	881754	0.0	10
evaluate|effect|COMPOUND_ENTITY|-lrb-|combination|estrogen|commonly|use|oral|contraceptive|-rrb-|progestin|-lsb-|medioxyprogesterone|acetate|-lrb-|mpa|-rrb-|r5020|,|use|oral|contraceptive|-rsb-|cell|growth|expression|tgf|beta|1|,|tgf|beta|2|,|tgf|beta|3|mrna|mcf-7|human|DISEASE_ENTITY|breast|cancer|cell|.	881769	0.0	11
use|COMPOUND_ENTITY|DISEASE_ENTITY|acute|gouty|arthritis|date|ancient|time|.	882041	1.0	11
,|largest|trial|early|use|COMPOUND_ENTITY|woman|mild|chronic|hypertension|,|clearly|treatment|prevent|superimposition|DISEASE_ENTITY|preeclampsia|.	882106	0.0	10
-lsb-|effect|COMPOUND_ENTITY|presurgical|treatment|vascularity|sub-serosal|interstitial|tissue|uterus|operative|blood|loss|hysterectomy|woman|DISEASE_ENTITY|uterine|leiomyoma|adenomyosis|-rsb-|.	882135	0.0	11
double|blind|,|placebo|control|trial|cytoprotective|effect|COMPOUND_ENTITY|subject|rheumatoid|arthritis|,|DISEASE_ENTITY|osteoarthritis|seronegative|spondarthropathy|nsaid|.	882184	0.0	11
24|DISEASE_ENTITY|patient|treat|high|dose|intravenous|COMPOUND_ENTITY|acute|relapse|progressive|disease|clinical|improvement|-lrb-|measure|Kurtzke|expand|disability|status|scale|-rrb-|compare|paraclinical|parameter|,|i.e.|visual|evoke|potential|-lrb-|vep|-rrb-|registration|saccadic|smooth|pursuit|eye|movement|.	882228	0.0	10
kinetics|aminoglycoside|-lrb-|amikacin|,|netilmycin|,|COMPOUND_ENTITY|,|tobramycin|-rrb-|investigate|patient|DISEASE_ENTITY|end-stage|renal|disease|systemic|hemodialysis|.	882302	0.0	11
assess|therapeutical|efficacy|antidepressant|-lrb-|amineptine|,|COMPOUND_ENTITY|clomipramine|-rrb-|patient|affect|DISEASE_ENTITY|retard|depression|.	882314	1.0	10
,|COMPOUND_ENTITY|hydrochloride|expect|suppress|cardiac|hypertrophy|patient|DISEASE_ENTITY|hypertension|.	882353	1.0	10
level|COMPOUND_ENTITY|195.2|+|/|-|57.1|micrograms/gm|-lrb-|mean|+|/|-|standard|deviation|-rrb-|DISEASE_ENTITY|glioblastoma|multiforme|,|444.1|+|/|-|105.1|micrograms/gm|normal|brain|tissue|,|614.4|+|/|-|237.4|micrograms/gm|meningioma|.	882510	0.0	10
COMPOUND_ENTITY|,|use|treatment|DISEASE_ENTITY|ulcerative|colitis|,|cleave|colon|metabolic|action|colonic|bacterium|diazo|bond|release|5-aminosalicylic|acid|-lrb-|5-asa|-rrb-|sulpharidine|.	882932	1.0	10
study|carry|compare|efficacy|tolerability|etodolac|COMPOUND_ENTITY|patient|DISEASE_ENTITY|rheumatoid|arthritis|.	883093	0.0	11
determine|urea|distribution|ratio|measure|,|blood|plasma|,|water|COMPOUND_ENTITY|concentration|DISEASE_ENTITY|uremic|inflow|outflow|blood|sample|dialysis|.	883104	0.0	11
change|histology|steroid|hormone|binding|capacity|uterine|DISEASE_ENTITY|treat|;|gnrh|agonist|-lrb-|gnrha|COMPOUND_ENTITY|acetate|,|900|micrograms/day|16|week|-rrb-|investigate|.	883125	0.0	11
COMPOUND_ENTITY|culture|protect|blast|cell|DISEASE_ENTITY|acute|myeloblastic|leukemia|lethal|effect|cytosine|arabinoside|.	883225	0.0	10
ifosfamide|-lrb-|1.25|g/m2|intravenously/day|x|5|-rrb-|mesna|-lrb-|20|cent|ifosfamide|dose|x|dose|day|COMPOUND_ENTITY|therapy|-rrb-|administer|46|previously|treat|patient|DISEASE_ENTITY|non-hodgkin|lymphoma|31|eligible|evaluable|.	883314	0.0	11
anomalous|response|COMPOUND_ENTITY|early|neonatal|rat|relate|paradoxical|behavioral|effect|human|child|afflict|DISEASE_ENTITY|attention|deficit|disorder|.	883412	0.0	10
biopsy|sample|culture|cell|derive|obtain|39|patient|DISEASE_ENTITY|glioma|analyze|1|-rrb-|COMPOUND_ENTITY|-lrb-|gsh|-rrb-|content|;|2|-rrb-|sensitivity|1,3-bis|-lrb-|2-chloroethyl|-rrb-|-1|-|nitrosourea|-lrb-|bcnu|-rrb-|and/or|nitrogen|mustard|-lrb-|hn2|-rrb-|treatment|3|-rrb-|effect|buthionine|sulfoximine|-lrb-|bso|-rrb-|treatment|bcnu|and/or|hn2|cytotoxicity|.	883614	0.0	10
preliminary|datum|class|iii|antiarrhythmic|agent|suggest|agent|,|especially|COMPOUND_ENTITY|,|similarly|beta|blocker|,|potential|reduce|mortality|survivor|DISEASE_ENTITY|MI|.	883851	1.0	11
summary|,|oral|administration|enoximone|patient|DISEASE_ENTITY|disease|lead|favorable|acute|hemodynamic|antiischemic|effect|sufficiently|high|plasma|level|COMPOUND_ENTITY|sulfoxide|metabolite|.	883874	0.0	10
early|detection|DISEASE_ENTITY|infarction|measurement|mass|concentration|COMPOUND_ENTITY|kinase-mb|.	883882	0.0	10
small|number|comparative|study|,|DISEASE_ENTITY|efficacy|COMPOUND_ENTITY|appear|equivalent|captopril|,|enalapril|,|hydrochlorothiazide|,|nifedipine|,|nitrendipine|propranolol|usual|therapeutic|dose|.	884221	1.0	10
strategy|prevention|early|,|moderate|,|DISEASE_ENTITY|failure|review|discuss|particular|reference|dietary|phosphorus|restriction|,|use|gut|phosphorus|binder|,|control|acidosis|,|calcium|supplementation|,|use|oral|intravenous|COMPOUND_ENTITY|,|use|synthetic|analogue|1,25-dihydroxyvitamin|d3|.	884228	0.0	11
strategy|prevention|early|,|moderate|,|DISEASE_ENTITY|failure|review|discuss|particular|reference|dietary|phosphorus|restriction|,|use|gut|phosphorus|binder|,|control|acidosis|,|calcium|supplementation|,|use|oral|intravenous|calcitriol|,|use|synthetic|analogue|COMPOUND_ENTITY|d3|.	884232	0.0	11
antiarrhythmic|effect|chronic|oral|COMPOUND_ENTITY|treatment|dog|DISEASE_ENTITY|myocardial|infarction|reproducibly|inducible|sustained|ventricular|arrhythmia|.	884471	1.0	11
method|result|:|seventy-seven|patient|acute|DISEASE_ENTITY|infarction|previous|6-30|day|10|vpds/hr|run|ventricular|tachycardia|24-hour|electrocardiographic|recording|randomize|double-blind|fashion|2:1|COMPOUND_ENTITY|ratio|.	884570	0.0	11
rat|,|classical|antihistamine|block|DISEASE_ENTITY|seizure|,|,|h2-blocker|,|cimetidine|,|COMPOUND_ENTITY|,|ineffective|.	884651	0.0	10
hemorrhagic|pancreatitis|induce|feed|COMPOUND_ENTITY|,|ethionine-supplemented|-lrb-|cde|-rrb-|diet|mouse|66|h.|DISEASE_ENTITY|Edematous|pancreatitis|induce|7-h|subcutaneous|injection|50|micrograms/kg|cerulein|mouse|.	884961	0.0	11
antiarrhythmic|effect|8-week|oral|COMPOUND_ENTITY|regimen|study|dog|1-week-old|DISEASE_ENTITY|myocardial|infarction|reproducibly|inducible|sustained|ventricular|tachycardia|-lrb-|vt|-rrb-|ventricular|fibrillation|-lrb-|VF|-rrb-|.	884962	0.0	11
recipient|treat|group|:|-lrb-|1|-rrb-|cyclosporine|steroid|-lrb-|control|-rrb-|,|-lrb-|2|-rrb-|COMPOUND_ENTITY|steroid|plus|tli|20|gy|,|-lrb-|3|-rrb-|cyclosporine|,|steroid|,|antithymocyte|globulin|,|DISEASE_ENTITY|tli|6|gy|.	885046	0.0	10
peak|acth|COMPOUND_ENTITY|level|significantly|elevated|mentally|healthy|elderly|,|DISEASE_ENTITY|senile|demented|patient|rise|comparable|young|subject|.	885336	0.0	11
report|demonstrate|COMPOUND_ENTITY|stimulate|estrogen-responsive|human|DISEASE_ENTITY|breast|cancer|cell|growth|inhibit|expression|tgf|beta|2|tgf|beta|3|mrna|.	885383	0.0	11
DISEASE_ENTITY|anemia|observe|alteration|rbc|COMPOUND_ENTITY|methemoglobin|.	885446	0.0	10
,|acute|DISEASE_ENTITY|induce|caerulein|injection|,|feed|COMPOUND_ENTITY|,|ethionine-supplemented|-lrb-|cde|-rrb-|diet|.	885604	0.0	11
study|objective|:|determine|risk|liver|toxicity|long-term|administration|COMPOUND_ENTITY|patient|rheumatoid|arthritis|DISEASE_ENTITY|psoriatic|arthritis|.	885663	0.0	10
examine|194|case|DISEASE_ENTITY|leiomyoma|adenomyosis|receive|total|abdominal|hysterectomy|,|order|compare|effect|presurgical|medical|treatment|COMPOUND_ENTITY|,|danazol|pill|,|operative|blood|loss|non-treated|group|.	885700	0.0	11
man|,|central|cholinergic|blockade|COMPOUND_ENTITY|administration|impair|attention|,|information|processing|,|memory|new|information|,|secondary|memory|impairment|resemble|patient|DISEASE_ENTITY|alzheimer|disease|-lrb-|ad|-rrb-|.	885775	0.0	11
young|man|-lrb-|aged|21-24|yr|-rrb-|,|15|mentally|healthy|elderly|-lrb-|aged|65-90|yr|-rrb-|,|12|patient|DISEASE_ENTITY|-lrb-|aged|60-84|yr|-rrb-|receive|iv|bolus|injection|contain|50|microgram|CRH|0.5|iu|lysine|vasopressin|baseline|period|2|h.|acth|,|COMPOUND_ENTITY|,|dehydroepiandrosterone|secretion|monitor|period|2|h|injection|.	885972	0.0	11
effect|COMPOUND_ENTITY|DISEASE_ENTITY|convulsion|induce|pentylenetetrazol|.	885986	0.0	11
use|COMPOUND_ENTITY|DISEASE_ENTITY|chronic|myeloid|leukemia|pregnancy|:|case|report|.	886137	0.0	10
Physostigmine|,|know|enhance|memory|DISEASE_ENTITY|,|produce|marked|widespread|antagonism|COMPOUND_ENTITY|impairment|,|indicate|sensitivity|model|establish|relevance|clinical|situation|.	886138	0.0	11
extensive|clinical|trial|devise|determine|accuracy|effect|COMPOUND_ENTITY|mortality|patient|survive|DISEASE_ENTITY|myocardial|infarction|present|heart|failure|.	886379	1.0	11
Photochemotherapy|severe|DISEASE_ENTITY|combination|COMPOUND_ENTITY|:|randomize|,|double-blind|comparison|study|.	886472	0.0	10
standard|remission|induction|therapy|childhood|DISEASE_ENTITY|leukemia|include|L-asparaginase|,|leukemic|cell|lack|asparagine|synthetase|-lrb-|-rrb-|activity|require|exogenous|COMPOUND_ENTITY|.	887066	0.0	10
,|regimen|COMPOUND_ENTITY|treatment|consistently|attenuate|bronchial|responsiveness|DISEASE_ENTITY|asthmatic|subject|effect|man|;|larger|longer|trial|require|establish|subgroup|smoker|favorable|response|.	887142	0.0	10
emiat|randomize|,|double-blind|trial|versus|placebo|,|design|evaluate|efficacy|COMPOUND_ENTITY|prevention|total|mortality|patient|left|ventricular|ejection|fraction|40|%|DISEASE_ENTITY|myocardial|infarction|.	887201	0.0	11
test|sensitivity|convulsant|action|gabaergic|antagonist|,|COMPOUND_ENTITY|produce|seizure|lower|dose|CBA|compare|NMRI|c57|mouse|,|difference|strain|DISEASE_ENTITY|seizure|activity|produce|specific|gaba|receptor|antagonist|bicuculline|.	887211	0.0	10
agent|-lrb-|catalase|,|superoxide|dismutase|,|polyethylene|glycol-superoxide|dismutase|,|dimethylsulfoxide|,|allopurinol|-rrb-|evaluate|use|COMPOUND_ENTITY|ethionine-supplemented|diet-induced|model|acute|hemorrhagic|pancreatic|necrosis|supramaximal|caerulein|stimulation|model|acute|DISEASE_ENTITY|interstitial|edematous|pancreatitis|.	887321	0.0	11
baclofen|-lrb-|2|microm|-rrb-|add|picrotoxin|contain|medium|,|DISEASE_ENTITY|occur|entorhinal|cortex|area|ca3|,|suggest|inhibition|inhibitory|interneuron|COMPOUND_ENTITY|overcome|``|filter|''|project|activity|entorhinal|cortex|hippocampus|.	887512	0.0	11
-lsb-|result|comparative|study|nadolol|,|propranolol|,|COMPOUND_ENTITY|hydrochlorothiazide|patient|arterial|DISEASE_ENTITY|hypertension|12-month|stepped-plan|treatment|-lrb-|cooperative|research|-rrb-|.	887548	0.0	10
COMPOUND_ENTITY|dose|response|DISEASE_ENTITY|depression|.	887590	0.0	10
report|successful|use|mithramycin|COMPOUND_ENTITY|myeloid|blast|phase|DISEASE_ENTITY|chronic|granulocytic|leukemia|,|treat|patient|accord|protocol|devise|Koller|Miller|-lrb-|1986|-rrb-|.	887645	0.0	10
randomized|trial|cisplatin|,|COMPOUND_ENTITY|,|bleomycin|versus|vinblastine|,|cisplatin|,|etoposide|treatment|advanced|DISEASE_ENTITY|germ|cell|tumor|testis|:|Southwest|Oncology|Group|study|.	887680	0.0	10
combination|interleukin-6|COMPOUND_ENTITY|acid|reduce|dose|all-trans|retinoic|acid|require|induce|differentiation|hl-60|cell|single|agent|1.7|-|4.8-fold|;|,|efficacy|all-trans|retinoic|acid|induce|differentiation|human|DISEASE_ENTITY|myeloid|leukaemia|hl-60|cell|increase|4.8|time|combination|interleukin-6|.	887848	0.0	10
bwtg3|DISEASE_ENTITY|cell|acquire|COMPOUND_ENTITY|hydroxylase|,|cystathionine|synthase|cps-i|genetic|manipulation|,|activation|silent|OTC|gene|require|cell|fusion|hepatocyte|.	887952	0.0	11
program|develop|leukemogenic|chemotherapy|regimen|treatment|favorable|prognosis|hodgkin|disease|,|phase|i-ii|trial|mitoxantrone|,|etoposide|,|mitoguazone|,|COMPOUND_ENTITY|use|treat|patient|relapse|refractory|DISEASE_ENTITY|malignant|lymphoma|hodgkin|disease|.	888103	1.0	10
mechanism|resistance|etoposide|COMPOUND_ENTITY|acquire|resistant|human|DISEASE_ENTITY|colon|lung|carcinoma|cell|line|.	888196	0.0	10
rearrangement|COMPOUND_ENTITY|acid|receptor|gene|DISEASE_ENTITY|acute|promyelocytic|leukemia|.	888241	0.0	10
patient|type|iii|antiarrhythmic|drug|,|COMPOUND_ENTITY|,|place|,|fact|,|Basel|Antiarrhythmic|Study|Infarct|Survival|,|prospective|,|controlled|,|randomized|trial|use|low-dose|amiodarone|antiarrhythmic|agent|,|demonstrate|60|%|reduction|sudden|death|rate|74|%|reduction|arrhythmic|event|incidence|year|DISEASE_ENTITY|myocardial|infarction|.	888286	0.0	11
gradation|DISEASE_ENTITY|angina|base|sensitive|immunoassay|serum|COMPOUND_ENTITY|kinase|mb|.	888372	0.0	10
conflict|report|clinical|synergy|,|use|tetrazolium-based|colorimetric|-lrb-|mtt|-rrb-|assay|test|vitro|combination|effect|methotrexate|-lrb-|mtx|-rrb-|plus|COMPOUND_ENTITY|-lrb-|fura|-rrb-|4|schedule|2|human|non-small-cell|lung|cancer|cell|line|-lrb-|adenocarcinoma|,|nc1-h23|;|DISEASE_ENTITY|bronchio-alveolar-cell|carcinoma|,|nc1-h358|-rrb-|,|1|human|colorectal|adenocarcinoma|cell|line|-lrb-|snu-c1|-rrb-|.	888396	0.0	10
total|42|patient|DISEASE_ENTITY|carcinoma|receive|COMPOUND_ENTITY|infusion|14|day|monthly|interval|.	888617	1.0	11
study|design|compare|result|treatment|uvb|combine|COMPOUND_ENTITY|-lrb-|50|mg/day|-rrb-|placebo|determine|DISEASE_ENTITY|psoriasis|respond|faster|cumulative|exposure|uvb|acitretin|.	888622	0.0	10
COMPOUND_ENTITY|cellular|response|acnu-resistant|rat|DISEASE_ENTITY|glioma|subline|drug|radiation|.	888677	0.0	10
child|advanced|DISEASE_ENTITY|,|serum|concentration|COMPOUND_ENTITY|storage|protein|ferritin|correlate|inversely|prognosis|.	888685	0.0	11
incidence|late|potential|remain|largely|constant|COMPOUND_ENTITY|;|10|patient|constant|late|potential|,|12|patient|late|potential|,|patient|DISEASE_ENTITY|coronary|heart|disease|develop|new|late|potential|.	888800	0.0	11
incidence|DISEASE_ENTITY|death|strychnine|death|COMPOUND_ENTITY|enhance|treatment|ges|,|latency|pentetrazole-induced|tonic|extensor|prolong|.	888806	0.0	10
multiple|myeloma|coexistent|DISEASE_ENTITY|:|improvement|myelofibrosis|follow|recovery|multiple|myeloma|treatment|COMPOUND_ENTITY|prednisolone|.	888899	0.0	10
therapeutic|effect|CV|3611|,|new|synthetic|free|radical|scavenger|prepare|ascorbic|acid|derivative|,|COMPOUND_ENTITY|deficient|,|ethionine|enriched|-lrb-|cde|-rrb-|diet|induce|acute|DISEASE_ENTITY|pancreatitis|mouse|evaluate|compare|superoxide|dismutase|.	889510	0.0	11
multicentre|phase|iii|trial|146|previously|untreated|patient|high|grade|DISEASE_ENTITY|lymphoma|stage|ii-iv|randomize|receive|cycle|choep|-lrb-|cyclophosphamide|750|mg/m2|iv|d|1|,|doxorubicin|50|mg/m2|iv|d|1|,|vincristine|2|mg|iv|d|1|,|etoposide|100|mg/m2|iv|d|3-5|,|prednisolone|100|mg|po|d|1-5|-rrb-|-lrb-|treatment|arm|-rrb-|,|cycle|chemotherapy|hchop|-lrb-|cyclophosphamide|1200|mg/m2|iv|d|1|,|doxorubicin|40|mg/m2|iv|d|1|+|2|,|vincristine|2|mg|iv|d|1|,|prednisolone|100|mg|po|d|1-5|-rrb-|alternate|ivep|-lrb-|COMPOUND_ENTITY|1500|mg/m2|iv|d|1-5|,|vindesine|3|mg/m2|iv|d|1|,|etoposide|120|mg/m2|iv|d|3-5|,|prednisolone|100|mg|po|d|1-5|-rrb-|-lrb-|treatment|arm|b|-rrb-|.	889538	0.0	11
multicentre|phase|iii|trial|146|previously|untreated|patient|high|grade|DISEASE_ENTITY|lymphoma|stage|ii-iv|randomize|receive|cycle|choep|-lrb-|cyclophosphamide|750|mg/m2|iv|d|1|,|doxorubicin|50|mg/m2|iv|d|1|,|vincristine|2|mg|iv|d|1|,|etoposide|100|mg/m2|iv|d|3-5|,|prednisolone|100|mg|po|d|1-5|-rrb-|-lrb-|treatment|arm|-rrb-|,|cycle|chemotherapy|hchop|-lrb-|cyclophosphamide|1200|mg/m2|iv|d|1|,|doxorubicin|40|mg/m2|iv|d|1|+|2|,|vincristine|2|mg|iv|d|1|,|prednisolone|100|mg|po|d|1-5|-rrb-|alternate|ivep|-lrb-|ifosfamide|1500|mg/m2|iv|d|1-5|,|vindesine|3|mg/m2|iv|d|1|,|etoposide|120|mg/m2|iv|d|3-5|,|COMPOUND_ENTITY|100|mg|po|d|1-5|-rrb-|-lrb-|treatment|arm|b|-rrb-|.	889564	0.0	10
steady-state|pharmacokinetic|hydroxychloroquine|-lrb-|hc|-rrb-|COMPOUND_ENTITY|-lrb-|plaquenil|-rrb-|study|volunteer|DISEASE_ENTITY|rheumatoid|arthritis|6|mg/kg/d|drug|month|.	889682	0.0	11
transfection|-3986|/|+374|chloramphenicol|acetyltransferase|plasmid|human|u251mg|DISEASE_ENTITY|cell|ht1080|fibrosarcoma|cell|result|COMPOUND_ENTITY|acetyltransferase|expression|,|consistent|observe|synthesis|cytotactin|protein|u251mg|cell|line|.	889887	0.0	11
twin-track|study|COMPOUND_ENTITY|mitoxantrone|-lrb-|i-m|-rrb-|recurrent|high|grade|DISEASE_ENTITY|non-hodgkin|lymphoma|hodgkin|disease|.	889941	0.0	11
use|rapid|serial|sampling|COMPOUND_ENTITY|kinase|mb|early|detection|DISEASE_ENTITY|myocardial|infarction|patient|acute|chest|pain|.	890190	0.0	10
double-blind|comparison|etodolac|COMPOUND_ENTITY|patient|DISEASE_ENTITY|rheumatoid|arthritis|.	890218	0.0	11
COMPOUND_ENTITY|acid|turn|form|DISEASE_ENTITY|leukemia|.	890332	1.0	10
order|study|connection|diastolic|activity|smooth|muscle|blood|vessel|development|DISEASE_ENTITY|,|plasma|camp|,|COMPOUND_ENTITY|,|txb2|,|6-k-pgf1|alpha|,|anp|,|sp|determine|radioimmunoassay|,|173|hypertension|patient|liver|yang|exuberance|-lrb-|lye|-rrb-|91|case|,|Yin|deficiency|yang|exuberance|-lrb-|ydye|-rrb-|82|case|.	890634	0.0	10
disease|characterize|fever|,|purpura|,|headache|abdominal|pain|,|arterial|hypertension|,|microangiopathic|DISEASE_ENTITY|anemia|,|thrombocytopenia|,|increase|blood|COMPOUND_ENTITY|serum|creatinine|,|micro-haematuria|proteinuria|.	891429	0.0	11
determine|change|parathyroid|hormone|secretion|target|organ|response|cause|acute|DISEASE_ENTITY|development|systemic|toxic|condition|,|experimental|acute|pancreatitis|induce|rat|COMPOUND_ENTITY|,|ethionine-supplemented|diet|.	891442	0.0	11
determine|change|parathyroid|hormone|secretion|target|organ|response|cause|acute|pancreatitis|development|systemic|toxic|condition|,|experimental|acute|DISEASE_ENTITY|induce|rat|COMPOUND_ENTITY|,|ethionine-supplemented|diet|.	891446	0.0	11
group|34|consecutive|patient|DISEASE_ENTITY|disease|-lrb-|n|=|29|-rrb-|dilated|cardiomyopathy|-lrb-|n|=|5|-rrb-|-lrb-|3|woman|,|31|man|,|age|38-80|yr|-rrb-|severely|impaired|left|ventricular|function|-lrb-|left|ventricular|ejection|fraction|equal|40|%|-rrb-|high-grade|ventricular|ectopic|activity|-lrb-|sustained|nonsustained|ventricular|tachycardia|ventricular|fibrillation|-rrb-|treat|COMPOUND_ENTITY|-lrb-|mean|dose|:|206|mg/d|-rrb-|follow|1-117|-lrb-|mean|:|49|-rrb-|month|.	891514	1.0	11
enhancement|anti-proliferative|effect|human|interferon|-lrb-|huifn|-rrb-|preparation|-lrb-|alpha|,|beta|gamma|-rrb-|COMPOUND_ENTITY|detect|human|DISEASE_ENTITY|malignant|melanoma|cell|line|,|mm-icb|,|originally|establish|.	891791	0.0	10
review|611|hospitalised|patient|COMPOUND_ENTITY|,|353|patient|drug|prescribe|,|52-month|period|60-bed|department|,|note|amiodarone|prescribe|53|%|patient|arrhythmia|47|%|patient|DISEASE_ENTITY|coronary|insufficiency|.	891814	0.0	11
review|611|hospitalised|patient|amiodarone|,|353|patient|drug|prescribe|,|52-month|period|60-bed|department|,|note|COMPOUND_ENTITY|prescribe|53|%|patient|arrhythmia|47|%|patient|DISEASE_ENTITY|coronary|insufficiency|.	891819	1.0	11
mean|onset|time|-lrb-|time|maximum|twitch|DISEASE_ENTITY|-rrb-|drug|COMPOUND_ENTITY|-lrb-|group|3|4|-rrb-|significantly|shorter|-lrb-|1.4|+|/|-|0.4|1.6|+|/|-|0.1|min|,|respectively|-rrb-|.	891875	0.0	10
vitro|differentiation|culture|primary|bone|marrow|cell|patient|DISEASE_ENTITY|leukemia|-lrb-|m3|-rrb-|chronic|myelocytic|leukemia|-lrb-|cml|-rrb-|induce|COMPOUND_ENTITY|acid|-lrb-|ra|-rrb-|tpa|study|.	892063	0.0	10
phase|ii|trial|COMPOUND_ENTITY|mesna|previously|treat|patient|DISEASE_ENTITY|non-hodgkin|lymphoma|:|Cancer|Leukemia|Group|b|study|8552|.	892075	1.0	11
quantitation|confirmation|COMPOUND_ENTITY|residue|swine|muscle|liver|lc|DISEASE_ENTITY|gc/ms|.	892274	0.0	10
electrophysiological|antiarrhythmic|effect|acute|-lrb-|2|10|mg/kg|i.v.|-rrb-|chronic|-lrb-|400|mg/day|p.o.|28|day|-rrb-|COMPOUND_ENTITY|-lrb-|AM|-rrb-|treatment|compare|anaesthetised|dog|5-6-day-old|DISEASE_ENTITY|myocardial|infarct|.	892719	0.0	11
purpose|,|23|patient|angiographically|confirm|dilated|cardiomyopathy|DISEASE_ENTITY|disease|high-grade|ventricular|arrhythmia|,|average|class|antiarrhythmic|drug|prove|ineffective|,|stabilize|COMPOUND_ENTITY|.	893002	1.0	11
increase|dna|synthesis|time|dependent|,|associate|DISEASE_ENTITY|osteoblast|,|block|COMPOUND_ENTITY|.	893209	0.0	10
report|15-year-old|boy|,|administration|100|mg|i.v.|COMPOUND_ENTITY|,|present|acute|dystonic|reaction|consist|DISEASE_ENTITY|oculogyric|crisis|,|retrocollis|,|opysthotonus|,|dystonic|posture|left|arm|hand|.	893613	0.0	11
mechanism|propose|account|action|COMPOUND_ENTITY|DISEASE_ENTITY|acute|gouty|arthritis|,|interaction|cellular|membrane|cyclic|3|'|,5|'|-|adenosine|monophosphate|,|action|amyloidosis|.	893968	0.0	11
comparative|effect|diet|COMPOUND_ENTITY|insulin|secretion|action|DISEASE_ENTITY|non-obese|NIDDM|.	894008	0.0	11
author|suggest|new|method|choice|drug|-lrb-|quinidine|COMPOUND_ENTITY|-rrb-|maintenance|antiarrhythmic|therapy|sinus|rhythm|recovery|patient|permanent|atrial|fibrillation|,|patient|rheumatic|heart|disease|DISEASE_ENTITY|coronary|heart|disease|.	894351	1.0	11
COMPOUND_ENTITY|,|single|agent|,|produce|remission|limited|duration|DISEASE_ENTITY|non-hodgkin|lymphoma|patient|second|relapse|.	894734	1.0	11
circulate|level|dehydroepiandrosterone|sulfate|-lrb-|dheas|-rrb-|COMPOUND_ENTITY|study|86|patient|dementia|;|45|DISEASE_ENTITY|alzheimer|disease|41|multi-infarct|dementia|.	895257	0.0	11
COMPOUND_ENTITY|produce|satisfactory|model|attentional|secondary|memory|deficit|alzheimer|disease|-lrb-|DISEASE_ENTITY|ad|-rrb-|use|screen|compound|potential|therapeutic|usefulness|.	895862	0.0	11
cdna|clone|human|catechol-o-methyltransferase|-lrb-|hcomt|;|COMPOUND_ENTITY|:|catechol|o-methyltransferase|;|EC|2.1.1.6|-rrb-|isolate|human|DISEASE_ENTITY|hepatoma|cell|line|-lrb-|hep|g2|-rrb-|cdna|library|hybridization|screening|porcine|cdna|probe|.	896003	0.0	11
-lsb-|comparison|incidence|bleeding|2|anesthetic|technic|midazolam-alfentanil|versus|COMPOUND_ENTITY|treatment|DISEASE_ENTITY|otospongiosis|-rsb-|.	1046135	1.0	11
DISEASE_ENTITY|patient|carbamoylation|protein|endogenous|COMPOUND_ENTITY|cyanate|occur|epsilon-amino|group|lysine|residue|.	1046324	0.0	11
imply|pattern|secretion|pomc-derived|peptide|underlie|increase|COMPOUND_ENTITY|secretion|different|DISEASE_ENTITY|atd|depression|.	1046730	0.0	11
dopamine|increase|,|COMPOUND_ENTITY|thyroid|hormone|decrease|drug-free|DISEASE_ENTITY|schizophrenic|patient|compare|healthy|subject|.	1046829	0.0	11
-lsb-|DISEASE_ENTITY|opportunistic|infection|rheumatoid|arthritis|treat|COMPOUND_ENTITY|-rsb-|.	1047182	1.0	11
relationship|serum|beta|2-microglobulin|age|,|serum|COMPOUND_ENTITY|serum|creatinine|,|severity|DISEASE_ENTITY|anaemia|,|serum|albumin|,|sedimentation|rate|red|cell|,|degree|infiltration|bone|marrow|myeloma|plasmocyte|stage|disease|,|evaluate|system|Durie-Salmon|Medical|Research|Council|,|find|.	1047651	0.0	11
indomethacin|-lrb-|5|mg/kg|i.v.|-rrb-|block|COMPOUND_ENTITY|leucine|enkephalin|dynorphin-induced|DISEASE_ENTITY|pial|arteriolar|dilation|,|potentiate|beta-endorphin-induced|constriction|constriction|cause|dynorphin|hypotensive|piglet|.	1047658	0.0	11
low|dose|COMPOUND_ENTITY|therapy|rheumatoid|arthritis|complicate|DISEASE_ENTITY|pancytopenia|pneumocystis|carinius|pneumonia|.	1047712	0.0	11
drug|induce|significantly|parkinsonism|placebo|,|differently|:|COMPOUND_ENTITY|induce|type|DISEASE_ENTITY|parkinsonism|hypo|-|hyper-kinetic|symptom|,|remoxipride|induce|hyperkinetic|symptom|.	1047867	0.0	11
failure|COMPOUND_ENTITY|insulin|treatment|decrease|leucine|flux|DISEASE_ENTITY|obese|type|ii|diabetic|patient|.	1048030	0.0	11
codon|146|mutation|substitute|threonine|-lrb-|aca|-rrb-|COMPOUND_ENTITY|-lrb-|gca|-rrb-|detect|tumor|tissue|patient|DISEASE_ENTITY|colon|cancer|detect|normal|tissue|patient|.	1048108	0.0	11
serum|COMPOUND_ENTITY|level|DISEASE_ENTITY|schizophrenic|schizoaffective|hospitalize|patient|.	1048547	0.0	11
severe|DISEASE_ENTITY|patient|low|dose|COMPOUND_ENTITY|probenecid|.	1048838	0.0	11
COMPOUND_ENTITY|reduce|serum|parathyroid|hormone|level|DISEASE_ENTITY|uremic|patient|.	1049216	1.0	11
study|,|effect|isoflurane|COMPOUND_ENTITY|global|regional|myocardial|blood|flow|metabolism|compare|,|relationship|steal-induced|DISEASE_ENTITY|myocardial|ischemia|administer|volatile|anesthetic|investigate|40|patient|steal-prone|coronary|anatomy|undergo|elective|coronary|artery|bypass|operation|.	1049224	0.0	11
ascorbic|acid|enhance|effect|6-hydroxydopamine|h2o2|COMPOUND_ENTITY|dna|strand|break|related|process|DISEASE_ENTITY|neuroblastoma|cell|line|sk-n-sh|.	1049490	0.0	11
COMPOUND_ENTITY|induce|significant|DISEASE_ENTITY|depression|respiration|.	1049653	0.0	11
investigate|relationship|COMPOUND_ENTITY|secretion|td|,|I|evaluate|score|subtype|td|ct|scan|measurement|pineal|calcification|-lrb-|pc|-rrb-|size|77|chronic|institutionalized|DISEASE_ENTITY|schizophrenic|bipolar|patient|.	1050238	0.0	11
little|datum|exist|effect|adjunctive|therapy|COMPOUND_ENTITY|acetate|-lrb-|LA|-rrb-|luteal|phase|woman|DISEASE_ENTITY|polycystic|ovary|syndrome|-lrb-|pcos|-rrb-|undergo|ovulation|induction|human|menopausal|gonadotropin|-lrb-|hmg|-rrb-|.	1050542	1.0	11
little|datum|exist|effect|adjunctive|therapy|COMPOUND_ENTITY|acetate|-lrb-|LA|-rrb-|luteal|phase|woman|polycystic|ovary|syndrome|-lrb-|DISEASE_ENTITY|pcos|-rrb-|undergo|ovulation|induction|human|menopausal|gonadotropin|-lrb-|hmg|-rrb-|.	1050549	1.0	11
present|datum|evidence|worsen|DISEASE_ENTITY|ischemia|isoflurane|COMPOUND_ENTITY|.	1050581	1.0	11
histological|study|reveal|drug|significantly|decrease|severity|DISEASE_ENTITY|structural|change|cartilage|femoral|condyle|tibial|plateau|,|response|COMPOUND_ENTITY|pronounced|.	1051639	1.0	11
-lsb-|effect|COMPOUND_ENTITY|disopyramide|result|electrocardiographic|exercise|stress|testing|patient|DISEASE_ENTITY|coronary|disease|-rsb-|.	1051836	0.0	11
oral|parenteral|COMPOUND_ENTITY|management|DISEASE_ENTITY|end-stage|renal|disease|.	1051993	1.0	11
lower|ve|requirement|perform|exercise|proportion|lower|lactate|level|,|VE|decrease|decrease|COMPOUND_ENTITY|smaller|normal|subject|-lrb-|7.2|l/min/meq|/|l|-rrb-|,|apparently|patient|DISEASE_ENTITY|copd|fall|hyperventilate|response|lactic|acidosis|-lrb-|paco2|drop|-rrb-|.	1052078	0.0	11
effect|sevoflurane|-lrb-|sev|-rrb-|,|isoflurane|-lrb-|iso|-rrb-|,|COMPOUND_ENTITY|-lrb-|Hal|-rrb-|coronary|circulation|study|30|dog|acute|DISEASE_ENTITY|coronary|arterial|stenosis|.	1052139	0.0	11
brain|level|glutathione|,|glutathione|disulfide|,|COMPOUND_ENTITY|E.|Human|brain|level|glutathione|-lrb-|gsh|-rrb-|,|glutathione|disulfide|-lrb-|gssg|-rrb-|,|vitamin|e|measure|neurologically|normal|control|patient|group|patient|neurodegeneration|:|alzheimer|disease|-lrb-|ad|-rrb-|,|ad|feature|DISEASE_ENTITY|Parkinson|disease|-lrb-|ad-pd|-rrb-|.	1052273	0.0	11
brain|level|glutathione|,|glutathione|disulfide|,|vitamin|E.|Human|brain|level|glutathione|-lrb-|gsh|-rrb-|,|glutathione|disulfide|-lrb-|gssg|-rrb-|,|COMPOUND_ENTITY|e|measure|neurologically|normal|control|patient|group|patient|neurodegeneration|:|alzheimer|disease|-lrb-|ad|-rrb-|,|ad|feature|DISEASE_ENTITY|Parkinson|disease|-lrb-|ad-pd|-rrb-|.	1052297	0.0	11
urine|sample|b16|DISEASE_ENTITY|mouse|contain|COMPOUND_ENTITY|conjugate|ester|glucuronide|conjugate|.	1052827	0.0	11
dog|excitable|initial|dose|COMPOUND_ENTITY|develop|DISEASE_ENTITY|seizure|end|hmba|infusion|.	1052890	0.0	11
comparison|effect|DISEASE_ENTITY|disease|,|normal|aging|COMPOUND_ENTITY|human|transient|visual|evoke|potential|.	1053064	0.0	11
conclude|patient|steal-prone|coronary|anatomy|anesthetized|fentanyl|,|isoflurane|COMPOUND_ENTITY|administer|concentration|use|current|study|likely|cause|DISEASE_ENTITY|myocardial|ischemia|coronary|steal|mechanism|.	1053157	0.0	11
patient|undergo|surgery|DISEASE_ENTITY|aneurysm|frequently|receive|nimodipine|,|author|determine|MAC|isoflurane|dog|infusion|dose|COMPOUND_ENTITY|-lrb-|0.5|,|1.0|2.0|micrograms.kg-1|.	1053509	0.0	11
effect|dietary|fish|oil|DISEASE_ENTITY|patient|include|:|-lrb-|1|-rrb-|decrease|arachidonate|content|cellular|lipid|augmented|COMPOUND_ENTITY|content|,|-lrb-|2|-rrb-|decrease|ltb4|generation|pmn|isolate|effect|,|indicate|inhibition|epoxide|hydrolase|enzyme|.	1053769	0.0	11
DISEASE_ENTITY|accidental|overdose|COMPOUND_ENTITY|.	1054406	0.0	11
investigate|relationship|COMPOUND_ENTITY|secretion|pathophysiology|neuroleptic-induced|dystonic|movement|,|presence|size|pineal|calcification|-lrb-|pc|-rrb-|ct|scan|study|relation|severity|dystonic|movement|34|neuroleptic-treated|chronic|DISEASE_ENTITY|schizophrenic|patient|.	1055418	0.0	11
use|double-blind|placebo-controlled|multiple|crossover|design|,|53|patient|DISEASE_ENTITY|headache|placebo|,|acetaminophen|,|2|dose|COMPOUND_ENTITY|2|combination|caffeine|acetaminophen|.	1055825	1.0	11
use|double-blind|placebo-controlled|multiple|crossover|design|,|53|patient|DISEASE_ENTITY|headache|placebo|,|acetaminophen|,|2|dose|caffeine|2|combination|COMPOUND_ENTITY|acetaminophen|.	1055830	1.0	11
describe|evidence|pineal|calcification|,|reflect|disturbance|COMPOUND_ENTITY|function|,|appear|nongenetic|factor|DISEASE_ENTITY|schizophrenia|associate|perinatal|injury|.	1056293	0.0	11
relationship|myocardial|COMPOUND_ENTITY|concentration|antiarrhythmic|effect|dog|DISEASE_ENTITY|myocardial|infarction|electrically|induce|ventricular|arrhythmia|.	1056768	0.0	11
twenty-two|patient|affect|relapse|refractory|non-hodgkin|lymphoma|-lrb-|DISEASE_ENTITY|-rrb-|treat|combination|COMPOUND_ENTITY|-lrb-|ifo|-rrb-|dose|1.2|g/m2|intravenous|-lrb-|i.v.|-rrb-|-lrb-|1|h|infusion|-rrb-|5|consecutive|day|mesna|uroprotector|plus|mitoxantrone|-lrb-|nov|-rrb-|dose|12|mg/m2|i.v.|day|1|;|drug|recycle|3-4|week|.	1056992	1.0	11
-lsb-|management|use|COMPOUND_ENTITY|cerebral|vasospasm|secondary|subarachnoid|hemorrhage|cause|rupture|DISEASE_ENTITY|intracranial|aneurysm|-rsb-|.	1057033	1.0	11
datum|suggest|mechanism|memory|loss|DISEASE_ENTITY|disease|differ|find|COMPOUND_ENTITY|amnesia|.	1057206	0.0	11
COMPOUND_ENTITY|levodopa|DISEASE_ENTITY|Parkinson|disease|.	1057400	0.0	11
patient|DISEASE_ENTITY|leiomyoma|,|preliminary|datum|suggest|COMPOUND_ENTITY|beneficial|render|surgery|conservative|reduce|fibroid|size|,|appear|unlikely|preclude|surgical|intervention|.	1057593	1.0	11
alteration|COMPOUND_ENTITY|secretion|occur|non-affective|psychiatric|disorder|,|chronic|DISEASE_ENTITY|schizophrenia|.	1057609	0.0	11
patient|rheumatoid|arthritis|develop|life-threatening|DISEASE_ENTITY|result|low|dose|oral|methotrexate|-lrb-|COMPOUND_ENTITY|-rrb-|toxicity|potentiate|probenecid|.	1057873	0.0	11
study|demonstrate|COMPOUND_ENTITY|effectively|ablate|induce|ictal|activity|significant|DISEASE_ENTITY|cardiorespiratory|depression|similar|eeg|effect|benzodiazepine|.	1058139	1.0	11
article|describe|drug|,|COMPOUND_ENTITY|,|selectively|affect|cholinergic|system|model|aspect|DISEASE_ENTITY|alzheimer|disease|phenomenology|animal|human|.	1058213	0.0	11
prospective|open|study|,|15|patient|DISEASE_ENTITY|colitis|unresponsive|conventional|therapy|treat|enema|contain|COMPOUND_ENTITY|subsalicylate|-lrb-|700|800|mg|b.d.|-rrb-|.	1058331	1.0	11
twenty-two|patient|refractory|intermediate|-|high-grade|DISEASE_ENTITY|lymphoma|treat|dexamethasone|10|mg|hour|COMPOUND_ENTITY|1|g/m2|,|cisplatin|25|mg/m2|,|etoposide|100|mg/m2|-lrb-|dice|-rrb-|,|mesna|uroprotection|daily|x4|3|4|week|.	1058837	1.0	11
prophylactic|use|COMPOUND_ENTITY|patient|DISEASE_ENTITY|osteoarthritis|abdominal|pain|receive|non|steroid|anti-inflammatory|drug|reduce|incidence|gastric|ulcer|factor|15|.	1059097	1.0	11
seventy-two|patient|recurrent|refractory|malignant|lymphoproliferative|disease|treat|mime|combination|chemotherapy|-lrb-|methyl-gag|,|COMPOUND_ENTITY|,|methotrexate|,|etoposide|-rrb-|concurrent|mesna|prevent|urothelial|toxicity|;|41|patient|high/intermediate-grade|non-hodgkin|lymphoma|-lrb-|DISEASE_ENTITY|nhl|-rrb-|,|18|low-grade|nhl/chronic|lymphocytic|leukemia|-lrb-|cll|-rrb-|,|13|hodgkin|disease|-lrb-|hd|-rrb-|.	1059377	0.0	11
seventy-two|patient|recurrent|refractory|malignant|lymphoproliferative|disease|treat|mime|combination|chemotherapy|-lrb-|methyl-gag|,|COMPOUND_ENTITY|,|methotrexate|,|etoposide|-rrb-|concurrent|mesna|prevent|urothelial|toxicity|;|41|patient|high/intermediate-grade|non-hodgkin|lymphoma|-lrb-|nhl|-rrb-|,|18|low-grade|nhl/chronic|lymphocytic|leukemia|-lrb-|DISEASE_ENTITY|cll|-rrb-|,|13|hodgkin|disease|-lrb-|hd|-rrb-|.	1059387	0.0	11
-lsb-|effect|COMPOUND_ENTITY|result|surgical|treatment|DISEASE_ENTITY|intracranial|aneurysm|--|preliminary|report|-rsb-|.	1059847	0.0	11
artificial|bicistronic|mrna|base|rabbit|beta-globin|bacterial|COMPOUND_ENTITY|acetyltransferase|protein-coding|sequence|test|translation|activity|mouse|DISEASE_ENTITY|astrocytoma|cell-free|extract|.	1060192	0.0	11
62-year-old|man|DISEASE_ENTITY|arthritis|develop|jaundice|COMPOUND_ENTITY|.	1060620	0.0	11
result|consistent|hypothesis|dopaminergic|overactivity|DISEASE_ENTITY|,|cause|altered|amino|acid|precursor|availability|relate|decrease|COMPOUND_ENTITY|reduction|thyroid|hormone|level|.	1061195	0.0	11
bfa|cause|dose-dependent|inhibition|chondroitin|COMPOUND_ENTITY|glycosaminoglycan|elongation|sulfation|core|protein|DISEASE_ENTITY|melanoma-associated|proteoglycan|major|histocompatibility|complex|class|ii-associated|invariant|chain|.	1061338	0.0	11
objective|:|DISEASE_ENTITY|unusual|complication|low-dose|COMPOUND_ENTITY|therapy|rheumatoid|arthritis|.	1061399	0.0	11
seek|determine|patient|chronic|obstructive|pulmonary|disease|-lrb-|DISEASE_ENTITY|-rrb-|capable|obtain|physiologic|training|effect|,|manifest|reduction|blood|COMPOUND_ENTITY|ventilation|-lrb-|ve|-rrb-|level|exercise|.	1061801	0.0	11
conclude|DISEASE_ENTITY|subject|study|increase|blood|COMPOUND_ENTITY|low|work|rate|.	1061863	0.0	11
neuronal|discharge|hypersynchrony|intracranial|water|balance|relation|glutamic|acid|COMPOUND_ENTITY|redistribution|:|DISEASE_ENTITY|migraine|epilepsy|.	1061910	0.0	11
elderly|patient|depression|DISEASE_ENTITY|dementia|-lrb-|atd|-rrb-|compare|age-matched|control|subject|use|protocol|measure|COMPOUND_ENTITY|,|adrenocorticotrophic|hormone|-lrb-|acth|-rrb-|n-terminal|pro-opiomelanocortin|-lrb-|n-pomc|-rrb-|determine|diurnal|variation|effect|dexamethasone|administration|.	1062261	0.0	11
elderly|patient|depression|alzheimer-type|dementia|-lrb-|DISEASE_ENTITY|-rrb-|compare|age-matched|control|subject|use|protocol|measure|COMPOUND_ENTITY|,|adrenocorticotrophic|hormone|-lrb-|acth|-rrb-|n-terminal|pro-opiomelanocortin|-lrb-|n-pomc|-rrb-|determine|diurnal|variation|effect|dexamethasone|administration|.	1062267	0.0	11
contrast|,|DISEASE_ENTITY|patient|,|COMPOUND_ENTITY|elevated|dexamethasone|,|acth|,|n-pomc|.	1062333	0.0	11
finding|indicate|association|pathophysiology|neuroleptic-induced|dystonic|movement|presence|enlarged|pc|suggest|disturbance|COMPOUND_ENTITY|secretion|associate|emergence|neuroleptic-induced|dystonic|movement|DISEASE_ENTITY|schizophrenic|patient|.	1062717	0.0	11
rectal|COMPOUND_ENTITY|subsalicylate|therapy|DISEASE_ENTITY|ulcerative|colitis|.	1062764	1.0	11
COMPOUND_ENTITY|-lrb-|p|-rrb-|tetramethyl-pyrazine|-lrb-|t|-rrb-|administer|treat|experimentally|hypoxic|pulmonary|DISEASE_ENTITY|hypertension|rat|expose|hypoxia|380|torr|21-day|.	1063480	1.0	11
``|regulation|''|5-ht2|receptor|:|possible|role|COMPOUND_ENTITY|significance|negative|DISEASE_ENTITY|schizophrenia|.	1063807	0.0	11
COMPOUND_ENTITY|utilise|premedicant|,|sedative|,|induction|agent|produce|minimal|DISEASE_ENTITY|depression|ventilation|cardiovascular|system|.	1064431	0.0	11
lactulose|raise|day-long|concentration|breath|hydrogen|serum|COMPOUND_ENTITY|indicator|increase|DISEASE_ENTITY|colonic|fermentation|78|+|/|-|13|%|-lrb-|p|0.001|-rrb-|24.7|+|/|-|9.5|%|-lrb-|p|0.05|-rrb-|,|respectively|-rrb-|.	1064782	0.0	11
dna|methylation|oncogene|expression|COMPOUND_ENTITY|rat|DISEASE_ENTITY|liver|tumor|treat|hepatocyte|culture|.	1064808	0.0	11
-lsb-|effect|COMPOUND_ENTITY|tetramethyl|pyrazine|hypoxic|pulmonary|DISEASE_ENTITY|hypertension|rat|-rsb-|.	1065844	0.0	11
COMPOUND_ENTITY|,|0.5|%|1|%|,|transiently|dose-dependently|decrease|hr|6|%|+|/|-|2|%|12|%|+|/|-|2|%|increase|avct|4|+|/|-|2|8|+|/|-|2|m|,|decrease|lvp|15|%|+|/|-|3|%|31|%|+|/|-|3|%|,|increase|DISEASE_ENTITY|cf|2|%|+|/|-|1|%|6|%|+|/|-|2|%|.	1066050	0.0	11
present|evidence|propose|diminish|COMPOUND_ENTITY|secretion|associate|pathophysiology|subgroup|DISEASE_ENTITY|schizophrenic|patient|characterize|cerebral|atrophy|ventricular|enlargement|,|negative|symptom|,|impaired|cognitive|psychosexual|development|,|onset|pubescence|,|poor|response|neuroleptic|medication|,|possible|increase|risk|extrapyramidal|symptom|.	1066534	0.0	11
urinary|free|COMPOUND_ENTITY|-lrb-|ufc|-rrb-|,|17-hydroxycorticosteroid|-lrb-|17-ohcs|-rrb-|urine|dexamethasone|suppression|test|-lrb-|dst|-rrb-|examine|patient|dementia|DISEASE_ENTITY|alzheimer|type|-lrb-|DAT|-rrb-|multi-infarct|dementia|-lrb-|mid|-rrb-|,|nondemented|elderly|.	1066636	0.0	11
contrast|hashimoto|patient|,|,|DISEASE_ENTITY|CS|chicken|practically|inorganic|COMPOUND_ENTITY|thyroid|gland|;|electrophoretic|analysis|thyroid|homogenate|reveal|essentially|-lrb-|greater|99.62|%|-rrb-|125i|organify|16|h|strain|bird|test|.	1066645	0.0	11
change|find|DISEASE_ENTITY|,|normal|aging|,|mimic|administration|cholinergic|antagonist|COMPOUND_ENTITY|young|volunteer|.	1066657	0.0	11
acute|hemodynamic|effect|tolerability|intravenous|COMPOUND_ENTITY|,|5|mg/kg|administer|5|minute|,|compare|patient|DISEASE_ENTITY|coronary|artery|disease|normal|-lrb-|left|ventricular|-lsb-|lv|-rsb-|ejection|fraction|greater|equal|45|%|,|n|=|10|,|group|n|-rrb-|impaired|lv|function|-lrb-|ejection|fraction|45|%|,|n|=|9|,|group|l|-rrb-|.	1066912	0.0	11
COMPOUND_ENTITY|plus|mitoxantrone|salvage|treatment|DISEASE_ENTITY|non-hodgkin|lymphoma|.	1067422	1.0	11
conclusion|:|patient|receive|chronic|nsaid|therapy|DISEASE_ENTITY|,|treatment|COMPOUND_ENTITY|3|month|associate|significantly|lower|frequency|gastric|ulcer|formation|,|compare|treatment|sucralfate|-lrb-|p|0.001|-rrb-|.	1067734	0.0	11
initial|treatment|period|COMPOUND_ENTITY|,|testosterone|decrease|54|+|/|-|6|%|-lrb-|mean|+|/|-|sem|-rrb-|DISEASE_ENTITY|PCO|36|+|/|-|3|%|ih|-lrb-|p|=|0.02|-rrb-|.	1203658	0.0	11
hirsute|woman|DISEASE_ENTITY|syndrome|-lrb-|pco|-rrb-|idiopathic|hirsutism|-lrb-|ih|-rrb-|undergo|selective|ovarian|suppression|COMPOUND_ENTITY|5-6|month|randomize|receive|,|addition|,|dexamethasone|placebo|4|month|.	1203691	1.0	11
hirsute|woman|polycystic|ovarian|syndrome|-lrb-|DISEASE_ENTITY|-rrb-|idiopathic|hirsutism|-lrb-|ih|-rrb-|undergo|selective|ovarian|suppression|COMPOUND_ENTITY|5-6|month|randomize|receive|,|addition|,|dexamethasone|placebo|4|month|.	1203696	1.0	11
47|patient|generalize|DISEASE_ENTITY|vulgaris|23|healthy|subject|effectiveness|hepatic|metabolism|reflect|drug|biotransformation|assess|COMPOUND_ENTITY|elimination|test|.	1203778	0.0	11
,|therapeutic|efficacy|mexiletine|prevention|suppression|symptomatic|ventricular|arrhythmia|greater|antiarrhythmic|drug|,|-lrb-|e.g.|COMPOUND_ENTITY|-rrb-|,|effective|significant|proportion|patient|refractory|treatment|administer|cause|adverse|haemodynamic|effect|patient|complicate|factor|DISEASE_ENTITY|acute|myocardial|infarction|congestive|heart|failure|.	1204075	0.0	11
vivo|efflux|COMPOUND_ENTITY|account|loss|mtx|3-4|time|greater|lose|age|dependent|DISEASE_ENTITY|erythrocyte|destruction|.	1204701	0.0	11
myocardial|tissue|concentration|COMPOUND_ENTITY|desethylamiodarone|exceed|plasma|concentration|find|present|study|indicate|capability|compound|easily|distribute|accumulate|DISEASE_ENTITY|myocardium|.	1205254	0.0	11
effect|novel|anticonvulsant|,|zonisamide|-lrb-|COMPOUND_ENTITY|,|ci-912|-rrb-|,|experimental|model|DISEASE_ENTITY|photosensitive|epilepsy|.	1205737	0.0	11
one-week|therapy|COMPOUND_ENTITY|greater|potential|sulindac|increase|systolic|bp|well-controlled|DISEASE_ENTITY|hypertensive|patient|receive|atenolol|;|,|increase|minor|unlikely|clinical|significance|.	1206316	0.0	11
incidence|positive|profile|low|overall|sample|-lrb-|11/116|,|9|%|-rrb-|,|significantly|lower|incidence|rate|report|known|cholinergic|deficient|group|-lrb-|DISEASE_ENTITY|disease|;|COMPOUND_ENTITY|-rrb-|.	1206504	0.0	11
-lsb-|intravascular|volume|expansion|intravenous|COMPOUND_ENTITY|treatment|cerebral|vasospasm|surgical|treatment|DISEASE_ENTITY|intracranial|aneurysm|-rsb-|.	1206571	0.0	11
significant|correlation|concentration|carhb|plasma|COMPOUND_ENTITY|DISEASE_ENTITY|uremic|subject|.	1206610	0.0	11
COMPOUND_ENTITY|cause|dose-dependent|central|neural|DISEASE_ENTITY|depression|assess|critical|flicker|fusion|frequency|,|dose-dependent|amnesia|word|card|.	1207114	0.0	11
effect|novel|anticonvulsant|,|COMPOUND_ENTITY|-lrb-|3-sulfamoylmethyl-1|,2|-|benzisoxazole|-rrb-|,|photically|induce|DISEASE_ENTITY|seizure|study|lateral|geniculate-kindled|cat|.	1207432	0.0	11
effect|novel|anticonvulsant|,|zonisamide|-lrb-|COMPOUND_ENTITY|-rrb-|,|photically|induce|DISEASE_ENTITY|seizure|study|lateral|geniculate-kindled|cat|.	1207436	0.0	11
result|indicate|etodolac|effective|naproxen|,|COMPOUND_ENTITY|,|diclofenac|treatment|DISEASE_ENTITY|rheumatoid|arthritis|osteoarthritis|.	1207779	1.0	11
myeloid|differentiate|human|DISEASE_ENTITY|-lrb-|hl-60|-rrb-|cell|contain|soluble|phospholipase|c|hydrolyse|phosphatidylinositol|4.5-bisphosphate|markedly|stimulate|metabolically|stable|gtp|analogue|COMPOUND_ENTITY|triphosphate|-lrb-|gtp|-lsb-|s|-rsb-|-rrb-|.	1208996	0.0	11
present|result|suggest|COMPOUND_ENTITY|effective|treatment|human|DISEASE_ENTITY|photosensitive|epilepsy|.	1209346	1.0	11
-lsb-|DISEASE_ENTITY|pancytopenia|female|patient|rheumatoid|arthritis|COMPOUND_ENTITY|amidopyrine|simultaneously|-rsb-|.	1209452	1.0	11
little|direct|evidence|available|researcher|demonstrate|advanced|DISEASE_ENTITY|lesion|experimental|animal|marked|improvement|blood-lipid-reduce|regimen|combine|measure|,|increase|ambient|oxygen|COMPOUND_ENTITY|therapy|.	1209544	0.0	11
specific|radioactivity|correspond|lactate|,|glutamate|+|COMPOUND_ENTITY|asparagine|total|protein|total|lipid|,|lower|DISEASE_ENTITY|obese|group|.	1210844	0.0	11
correction|human|immunodeficiency|virus-associated|DISEASE_ENTITY|delayed-type|hypersensitivity|-lrb-|dth|-rrb-|COMPOUND_ENTITY|therapy|:|dth|,|cd4|+|t-cell|number|,|epidermal|langerhans|cell|density|independent|variable|.	1211056	0.0	11
activation|COMPOUND_ENTITY|hydroxylase|expression|follow|genomic|dna|transfection|DISEASE_ENTITY|hepatoma|cell|.	1211116	0.0	11
2300|hour|DISEASE_ENTITY|group|mdd|patient|normal|dexamethasone|suppression|significantly|greater|COMPOUND_ENTITY|level|mdd|patient|dexamethasone|nonsuppression|idd|group|.	1211424	0.0	11
overall|,|DISEASE_ENTITY|group|significantly|greater|mean|COMPOUND_ENTITY|level|group|,|depressive|group|differ|significantly|.	1211722	0.0	11
combined|analysis|27|article|COMPOUND_ENTITY|nonsuppression|60|%|patient|concurrent|dementia|depression|,|47|%|patient|depression|,|41|%|patient|dementia|,|46|%|patient|multi-infarct|dementia|,|36|%|patient|DISEASE_ENTITY|primary|degenerative|dementia|,|10|%|control|.	1212674	0.0	11
pharmacokinetic|COMPOUND_ENTITY|active|metabolite|,|quinaprilat|,|evaluate|12|patient|end-stage|renal|disease|-lrb-|DISEASE_ENTITY|esrd|-rrb-|chronic|hemodialysis|.	1213210	0.0	11
pharmacokinetic|quinapril|active|metabolite|,|COMPOUND_ENTITY|,|evaluate|12|patient|DISEASE_ENTITY|end-stage|renal|disease|-lrb-|esrd|-rrb-|chronic|hemodialysis|.	1213215	0.0	11
-lsb-|evaluation|metabolic|efficiency|liver|patient|DISEASE_ENTITY|COMPOUND_ENTITY|test|-rsb-|.	1213542	0.0	11
previous|study|suggest|DISEASE_ENTITY|disease|-lrb-|pd|-rrb-|negatively|associate|early-life|intake|COMPOUND_ENTITY|e-rich|food|positively|associate|rural|experience|.	1214412	0.0	11
chronic|stress-adaptation|failure|lead|vicious|circular|reaction|,|:|intense|,|stressful|stimulus|--|neocortico-limbic|excitation|--|hypothalamo-pituitary-adrenocortical|-lrb-|hpa|-rrb-|axis|activation|--|excessive|secretion|neurohormone|include|COMPOUND_ENTITY|--|stimulation|inhibitory|glucocorticoid|sensitive|hippocampal|neuron|--|failure|terminate|hpa|axis|response|--|chronic|excessive|secretion|neurohormone|include|cortisol|--|overstimulation|degeneration|glucocorticoid|sensitive|hippocampal|inhibitory|neuron|--|progressive|cognitive-affective|behavioral|disorganizational|failure|typical|dementia|DISEASE_ENTITY|alzheimer|type|.	1214599	0.0	11
chronic|stress-adaptation|failure|lead|vicious|circular|reaction|,|:|intense|,|stressful|stimulus|--|neocortico-limbic|excitation|--|hypothalamo-pituitary-adrenocortical|-lrb-|hpa|-rrb-|axis|activation|--|excessive|secretion|neurohormone|include|cortisol|--|stimulation|inhibitory|glucocorticoid|sensitive|hippocampal|neuron|--|failure|terminate|hpa|axis|response|--|chronic|excessive|secretion|neurohormone|include|COMPOUND_ENTITY|--|overstimulation|degeneration|glucocorticoid|sensitive|hippocampal|inhibitory|neuron|--|progressive|cognitive-affective|behavioral|disorganizational|failure|typical|dementia|DISEASE_ENTITY|alzheimer|type|.	1214604	0.0	11
overall|,|COMPOUND_ENTITY|quinaprilat|pharmacokinetic|patient|DISEASE_ENTITY|esrd|chronic|hemodialysis|markedly|different|previously|observe|patient|moderate|severe|renal|dysfunction|-lrb-|clcr|29|ml/min|-rrb-|require|hemodialysis|-lrb-|rdnd|-rrb-|.	1215403	0.0	11
circadian-shaped|infusion|COMPOUND_ENTITY|progressive|DISEASE_ENTITY|metastatic|renal|cell|carcinoma|.	1215740	0.0	11
twenty-eight|patient|mild|moderate|essential|DISEASE_ENTITY|control|atenolol|enter|five-week|,|double-blind|,|placebo-controlled|trial|effect|sulindac|COMPOUND_ENTITY|blood|pressure|-lrb-|bp|-rrb-|control|.	1216385	1.0	11
finding|suggest|low|dose|COMPOUND_ENTITY|decrease|mortality|1st|year|DISEASE_ENTITY|myocardial|infarction|patient|high|risk|sudden|death|.	1216507	1.0	11
long-term|investigation|author|investigate|group|schizophrenic|grade|1|relative|immunological|response|DISEASE_ENTITY|cortex|-lrb-|frontal|temporal|lobe|-rrb-|LDH|viral|antigen|-lrb-|COMPOUND_ENTITY|dehydrogenase|virus|-rrb-|.	1216596	0.0	11
COMPOUND_ENTITY|mitoxantrone|-lrb-|i-m|-rrb-|relapse|refractory|high|grade|DISEASE_ENTITY|non-hodgkin|lymphoma|hodgkin|disease|.	1216836	0.0	11
COMPOUND_ENTITY|e|therapy|DISEASE_ENTITY|Parkinson|disease|.	1217372	1.0	11
long-term|COMPOUND_ENTITY|administration|protect|global|DISEASE_ENTITY|myocardial|ischemia|.	1217820	1.0	11
DISEASE_ENTITY|carcinoma|cisplatin|,|COMPOUND_ENTITY|,|cyclophosphamide|.	1218080	1.0	11
endometriosis|DISEASE_ENTITY|,|minimum|release|rate|-lrb-|urinary|COMPOUND_ENTITY|-rrb-|require|maintenance|steroid|suppression|establish|-lrb-|buserelin|excretion|0.5|microgram/g|creatinine|-rrb-|.	1218817	1.0	11
COMPOUND_ENTITY|,|member|methyl-xanthine|group|,|interesting|molecule|study|DISEASE_ENTITY|migraine|patient|chronic|intake|substance|,|contain|numerous|analgesic|,|relate|chronic|nature|pain|.	1219208	0.0	11
purpose|27|patient|angiographically|confirm|dilated|cardiomyopathy|DISEASE_ENTITY|disease|highgrade|ventricular|arrhythmia|,|average|class|antiarrhythmic|drug|prove|ineffective|,|stabilize|COMPOUND_ENTITY|.	1219422	1.0	11
freely|rat|,|intrathecal|injection|COMPOUND_ENTITY|carbachol|-lrb-|1-5|microgram|-rrb-|produce|dose-related|DISEASE_ENTITY|hypertensive|response|strain|rat|.	1219951	0.0	11
effect|COMPOUND_ENTITY|beta|blocker|,|significantly|attenuate|adrenergic|stimulation|,|provide|pharmacologic|probe|define|crucial|determinant|efficacy|compound|mortality|reduction|high|risk|survivor|DISEASE_ENTITY|myocardial|infarction|.	1220007	1.0	11
blood|level|COMPOUND_ENTITY|new|clinical|laboratory|indicator|study|bacterial|DISEASE_ENTITY|asthma|patient|advanced|age|.	1220020	0.0	11
COMPOUND_ENTITY|find|reduce|behavioral|severity|DISEASE_ENTITY|seizure|response|photic|stimulation|dose-related|manner|.	1220804	1.0	11
human|immunodeficiency|virus|-lrb-|hiv|-rrb-|nef|suggest|exert|regulatory|effect|hiv|long|terminal|repeat|-lrb-|ltr|-rrb-|activity|,|transiently|transfect|hiv|ltr|COMPOUND_ENTITY|acetyltransferase|luciferase|expression|vector|human|DISEASE_ENTITY|astrocytoma|clone|-lrb-|u-373nef|-rrb-|constitutively|express|hiv|nef|gene|.	1221055	0.0	11
subcellular|change|rat|DISEASE_ENTITY|treatment|COMPOUND_ENTITY|desethylamiodarone|,|study|electron|microscopy|.	1221360	1.0	11
activity|2|glucocorticoid-sensitive|enzyme|,|glycerol-3-phosphate|dehydrogenase|COMPOUND_ENTITY|synthetase|,|increase|hippocampus|DISEASE_ENTITY|obese|rat|.	1221366	0.0	11
objective|antitumor|response|number|tumor|type|;|13|patient|DISEASE_ENTITY|cancer|treat|high-dose|p.o.|COMPOUND_ENTITY|,|5-fu|,|folinic|acid|respond|.	1221697	1.0	11
result|support|conclusion|reach|previous|study|cognitive|profile|COMPOUND_ENTITY|young|subject|similar|nondemented|elderly|DISEASE_ENTITY|alzheimer|disease|patient|.	1222133	0.0	11
zonisamide|-lrb-|COMPOUND_ENTITY|-rrb-|additionally|administer|19|patient|DISEASE_ENTITY|refractory|epilepsy|receive|multiple|antiepileptic|drug|effect|zonisamide|serum|immunoglobulin|investigate|.	1223778	1.0	11
zonisamide|-lrb-|ad-810|-rrb-|additionally|administer|19|patient|DISEASE_ENTITY|epilepsy|receive|multiple|antiepileptic|drug|effect|COMPOUND_ENTITY|serum|immunoglobulin|investigate|.	1223783	0.0	11
result|DISEASE_ENTITY|arthritis|osteoarthritis|study|etodolac|-lrb-|200|300|mg|b.i.d.|200|mg|t.i.d.|-rrb-|comparable|naproxen|-lrb-|500|mg|b.i.d.|-rrb-|,|COMPOUND_ENTITY|-lrb-|20|mg|daily|-rrb-|,|diclofenac|-lrb-|50|mg|t.i.d.|-rrb-|.	1223977	0.0	11
sixty-eight|unselected|patient|progressive|DISEASE_ENTITY|carcinoma|-lrb-|rcc|-rrb-|treat|March|1985|November|1988|continuous|infusion|COMPOUND_ENTITY|-lrb-|fudr|-rrb-|.	1224281	1.0	11
seventeen|patient|DISEASE_ENTITY|failure|18|patient|normal|renal|function|anaesthetize|0.5|%|COMPOUND_ENTITY|nitrous|oxide|oxygen|receive|doxacurium|initial|dose|25|microgram|kg-1|-lrb-|estimate|available|datum|ed95|dose|-rrb-|,|incremental|dose|5|microgram|kg-1|.	1224306	1.0	11
diminish|superoxide|production|synovial|fluid|neutrophil|patient|DISEASE_ENTITY|arthritis|follow|COMPOUND_ENTITY|treatment|.	1224433	1.0	11
62-year-old|woman|treat|squamous|cell|carcinoma|head|neck|develop|chemotherapy-related|DISEASE_ENTITY|syndrome|second|cycle|neoadjuvant|chemotherapy|consist|cisplatin|,|bleomycin|,|COMPOUND_ENTITY|.	1224889	0.0	11
nausea/vomiting|DISEASE_ENTITY|significantly|common|cisplatinum|arm|COMPOUND_ENTITY|arm|,|toxicity|combination|regimen|significantly|greater|cisplatinum|use|single|agent|.	1225233	0.0	11
COMPOUND_ENTITY|low|dose|-lrb-|200|mg/day|-rrb-|administer|combination|type|antiarrhythmic|drug|first-line|agent|33|patient|ventricular|tachycardia|-lrb-|vt|-rrb-|-lrb-|n|=|24|-rrb-|ventricular|fibrillation|-lrb-|VF|-rrb-|-lrb-|n|=|9|-rrb-|secondary|DISEASE_ENTITY|coronary|artery|disease|heal|myocardial|infarction|.	1389934	1.0	11
